· ii UVA Health System Nutrition Educational Programs Dietetic Internship Program The Dietetic...
Transcript of · ii UVA Health System Nutrition Educational Programs Dietetic Internship Program The Dietetic...
Department of Nutrition Services | Morrison Healthcare Foodservice
Pediatric Nutrition Support Handbook
i
Pediatric Nutrition Support Handbook
Department of Nutrition Services
UVA Children’s Hospital
University of Virginia Health System
Charlottesville, Virginia 22908
Editors:
Ana Abad-Jorge, MS, RD, CNSC
Brandis Roman, MS, RD, CNSC
Contributing Authors:
Ana Abad-Jorge, MS, RD, CNSC
Marcia Buck, PharmD
Allie Hubbard, RD
Patti Perks, MS, RD, CNSD
Brandis Roman, MS, RD, CNSC
This handbook is intended to serve as a reference or guide in the area of pediatric enteral and parenteral nutrition support for clinical nutritionists, medical and nursing staff as well as dietetic interns and medical and nursing students.
Acknowledgements:
The administrative assistance of Nancy Carpenter in the preparation of this handbook is greatly appreciated.
This handbook was funded by the Department of Nutrition Services.
Copyright 2012 University of Virginia Health System and Morrison Management
Specialists
ii
UVA Health System Nutrition Educational Programs
Dietetic Internship Program
The Dietetic Internship Program at the University of Virginia Health System, established in 1975, has as its mission to provide a broad-based, comprehensive dietetics education in both traditional and emerging diverse settings. This progressive program furnishes the intern with the skills to function as a competent entry-level dietitian with a specialization in the medical nutrition therapy areas of paediatrics and adult nutrition support, while emphasizing a commitment to life-long learning. Interns are also given the opportunity for advanced training and multi-skilling in the areas of research, computer technology, effective oral and written communication and clinical assessment. With a high staff/intern ratio, interns have the opportunity to work one-on-one with nutritionist and management preceptors, but can also work collaboratively with teams and other interns. This environment provides the intern with theoretical, didactic, pre-planned and on-the-job learning experiences in a variety of challenging and progressive settings. The internship program, which is 43 weeks in length, starts at the beginning of September and is completed during the last week of June. The program consists of a comprehensive 2 week orientation to the program and rotations, supervised practice on-the-job learning experiences, weekly classes and professional meetings. Rotations and affiliations are directed by Registered Dietitians and department managers. During the program, interns will actively participate in clinical, community and foodservice management rotations. Program goals include:
To provide the health care system with entry-level dietitians competent to practice in general medical nutrition therapy areas, as well as the specialized areas, pediatrics and adult nutrition support.
To train and empower interns to enter the field with the necessary skills to conduct basic practice based research, publish in the field of nutrition and dietetics, and educate students, health care professionals and the public through a variety of formal and informal training formats.
To prepare interns to demonstrate exemplary professional behaviors, leadership within their profession or community, and a commitment to active community service and life-long learning.
Nutrition Support Traineeship
The UVA Health System Nutrition Support Traineeship provides a unique, five-day opportunity to achieve a higher level of practice in nutrition support. Our evidence-based program utilizes actual patient cases, physician-led nutrition support team rounds, small group discussions, critical evaluation of research, and a practical, hands-on approach to learning. Our goal is to optimize continuing educational time and expenses by focusing on the individual's learning needs. Also included is an elaborate, fully referenced syllabus. Modules are based on the most current evidence-based information, and provide a template for education at the bedside. Experiences during the traineeship week are structured to spend time observing and participating in completing nutrition support consults, nutrition team rounds, review of syllabus modules, case studies and questions.
iii
Table of Contents
Chapter 1 - Pediatric Nutrition Services and Nutrition Screening at UVA HS ....... 1 Pediatric Nutrition Goals............................................................................................. 1 Pediatric Nutrition Services Provided at UVA Health System .................................... 2 Role of the Pediatric and Neonatal RDs..................................................................... 2
Chapter 2 - Nutritional Assessment of Pediatric Patients ....................................... 9 Growth and Anthropometric Measurements ............................................................... 9 Assessment of Malnutrition ...................................................................................... 12 Medical History ......................................................................................................... 13 Nutritional Intake History .......................................................................................... 14 Laboratory Data ...................................................................................................... 15
Chapter 3 - Nutritional Requirements in Term Infants and Children .................... 17 Non-Critically Ill Infants and Children ....................................................................... 17 Critically Ill Children .................................................................................................. 22 Catch-Up Growth in the Term Infant and Child ....................................................... 24 Energy Requirements for Pediatric Burn Patients ................................................... 25 Fluid Requirements .................................................................................................. 25
Chapter 4 - Nutritional Assessment, Requirements, and Enteral Nutrition
Management in the Preterm Infant .......................................................................... 27 Preterm Infant Weight Classification and Assessment ........................................... 27 Micronutrient and Macronutrient Requirements ....................................................... 28 Fluid Requirements .................................................................................................. 30 Meeting the Increased Needs of the Preterm Infant ................................................ 30 Preterm Formula Selection ...................................................................................... 32 Modifying Formula Caloric and Nutrient Density ...................................................... 33 Feeding Protocols for NICU Infants.......................................................................... 35
Chapter 5 - Enteral Nutrition Support ...................................................................... 37 Advantages of Enteral Nutrition................................................................................ 37 Indications for Enteral Feedings ............................................................................... 37 Enteral Tube Feeding Formula Selection ................................................................. 38 Modifying Formula Caloric and Nutrient Density ...................................................... 41 Tube Feeding Routes of Delivery ............................................................................. 44 Tube Feeding Administration Methods..................................................................... 46 General Guidelines for the Initiation and Progression of Tube Feedings ................. 47 Management of Combination Enteral and Oral Feedings ........................................ 49 Management of Complications Encountered with Enteral Feedings ........................ 49
iv
Chapter 6 - Nutrition Management of High Risk Nutrition Disease States ........... 55 Congenital Heart Defects ........................................................................................ 55 Cystic Fibrosis .......................................................................................................... 56 Renal Disease .......................................................................................................... 60 Severe Gastrointestinal Impairment ........................................................................ 65 Chylous Ascites/Chylothorax ................................................................................... 69 Burns ....................................................................................................................... 71
Chapter 7 - Parenteral Nutrition ............................................................................... 77 Peripheral vs. Central Parenteral Nutrition ............................................................... 77 Guidelines for Initiation & Advancement of Parenteral Nutrition ............................. 78 Monitoring of Pediatric Patients on Parenteral Nutrition .......................................... 87 Managing Metabolic and Long Term Complications of Parenteral Nutrition ............ 88
Chapter 8 - Pharmacology and Nutrition Support .................................................. 95 Medication Information Resources ........................................................................... 95 Common Drug-Nutrient Interactions Seen in Hospitalized Patients ......................... 95 Drug Interactions with Enteral Products ................................................................... 97 Drug Interactions with Parenteral Nutrition ............................................................... 99 Common Enteral Electrolyte Supplementation ....................................................... 101
APPENDIX ................................................................................................................ 103 A – Growth Charts for Normal Infants and Children
• World Health Organization Growth Standards for Infants (Charts 1 – 3) • National Center for Health Statistics (CDC) Growth Charts for Children
Aged 2-20 Years (Charts 4 – 8) • Fenton Growth Chart for Preterm Infants (Chart 9)
B - Specialized Growth Charts: Down Syndrome C – Triceps Skinfold Percentile Charts D – Mid Upper Arm Circumference Percentile Charts E - Developmental Self-Feeding Checklist F - Selected Lab Values with Nutritional Implications G - Estimated Energy Requirements (EER) for Infants and Children H - Guide to Number of Servings and Serving Size for Children I - Electrolyte Conversion Information J- Oral Multivitamin and Mineral Supplements Available at UVA K - Tips for Increasing Calories for Children L - Sites of Nutrient Malabsorption Resulting from Intestinal Resections M – Therapeutic Algorithm for Management of Post-operative Chylothorax
Chapter 1 Pediatric Nutrition Services and Nutrition Screening at University of Virginia Health System
1
Chapter 1
Pediatric Nutrition Services and Nutrition Screening
At University of Virginia Health System
The University of Virginia (UVA) Health System, located in Charlottesville and comprised of the School of Medicine, School of Nursing, Claude Moore Health Sciences Library and the Medical Center, has been declared time after time as one of the Nation’s Top 100 Hospitals. The Medical Center, a teaching and research hospital with over 550 beds, includes University Hospital, Kluge Children’s Rehabilitation Center (KCRC), Northridge, the Primary Care Center and satellite clinics. UVA provides quality care to a primarily rural population serving the community and the Commonwealth, and receives referrals from other states and countries. At UVA, patients receive specialized care in a variety of areas including pediatrics, women’s health, diabetes, cardiology and digestive health. Through the Continuum Home Health Program, UVA professionals bring care and expertise into thousands of homes. Our state-of-the art medical facility offers multi-disciplinary centers focused on specialty areas such as the Cancer Center, the Children’s Hospital and the Women’s Place, to name a few. The Medical Center, designated as a Level I Trauma Center, contains numerous intensive care units including the medical, surgical, pediatric and newborn intensive care units.
Pediatric nutrition services at UVA Health System are provided by a number of pediatric registered dietitians (RDs) in the areas of general pediatrics, the pediatric intensive care unit (PICU), the newborn intensive care unit (NICU), KCRC and in the outpatient areas including: pediatric nephrology, pediatric gastroenterology, inborn errors of metabolism, children’s fitness clinic, and pediatric endocrinology. The inpatient pediatric RDs work closely with the respective unit medical teams to provide nutritional assessment, care plan development and patient and staff education. The pediatric RDs also closely follow patients in the pediatric units, NICU and PICU who are at nutrition risk and require specialized enteral or parenteral nutrition support.
Pediatric Nutrition Goals
1. To decrease the incidence of morbidity and mortality associated with nutritional problems in our pediatric patient population.
2. To improve patient clinical outcomes by providing timely, optimum, safe and cost-
effective nutrition through either the oral route, or for those children who are critically or chronically ill, using tube feedings or parenteral nutrition support.
3. To identify patients who will benefit from nutrition intervention. 4. To provide patient education in the areas of specialized or therapeutic diets, or for
specialized enteral or parenteral nutrition support, including but not limited to,
Chapter 1 Pediatric Nutrition Services and Nutrition Screening at University of Virginia Health System
2
diabetes diet education, low fat or low sodium diets, and specialized formula preparation.
5. To provide medical and health care staff and student education in the areas of
pediatric nutrition or specialized nutrition support via formal lectures and patient unit and discharge planning rounds.
6. To develop and review hospital and departmental policies and procedures to
promote the appropriate and effective use of nutrition therapy and support.
Pediatric Nutrition Services Provided at UVA Health System
Comprehensive nutrition assessment
Follow-up assessment
Nutrition intake analysis
Patient and family education
Staff and student education in the area of pediatric nutrition and nutrition support
Resource for health care team and staff in the area of pediatric nutrition support
Active participation in unit-based quality improvement activities and projects with the goal of improving patient care and clinical outcomes
Role of the Pediatric and Neonatal RDs
Conduct in-depth nutritional assessment
Provide medical nutrition therapy recommendations for children with a wide variety of nutritional disorders or those at risk for malnutrition
Provide nutrition support recommendations and pended orders for parenteral nutrition.
Provide nutrition support recommendations and verbal order for therapeutic diets, enteral nutrition , and related laboratory values, in order to expedite the timely ordering and delivery of effective nutrition support to infants and children.
Provide monitoring for complications, lab abnormalities, response to nutritional intervention and support, timely follow-up and intervention
Conduct nutrient analyses and compare intake to estimated needs
Assist in the provision of patient and family education on specialized and therapeutic diets and home nutrition support, as related to formula preparation, delivery and monitoring for enteral feeding complications
Provide education to pediatric residents, nursing staff, medical and nursing students, and dietetic interns
Chapter 1 Pediatric Nutrition Services and Nutrition Screening at University of Virginia Health System
3
Pediatric Nutrition Services within the General Pediatric Units (7- Acute)
Nutrition Screening
The 7-Acute RDs screen pediatric patients on the unit to determine those at nutrition risk. Per Nutrition Services policy, all children are screened for nutrition risk upon admission by the unit nursing staff. The 7-Acute pediatric RD receives a nursing referral for those children determined to be at risk. The initial screening by the nursing staff is based on presence of the following:
Special diet or formula
Poor oral intake for > 5 days
Pressure ulcer(s) or poor wound healing
Burns > 15% total body surface area
Problems chewing or swallowing
Use of specialized nutrition support: enteral or parenteral
Current diagnosis of malnutrition, cystic fibrosis, failure to thrive or new onset diabetes mellitus
The patient’s family is also asked if they wish to see an RD during the admission.
Comprehensive Nutrition Assessment: High Risk Nutrition Diagnoses and
Conditions The following conditions or diagnoses are often indicative of high nutrition risk. 1. Patients on nutrition support 2. High risk diagnoses or conditions
a. Anemia b. Bronchopulmonary dysplasia/chronic lung disease c. Burns d. Cancer e. Congenital heart defects f. Cystic fibrosis g. Diabetes mellitus h. Failure to thrive i. Gastrointestinal anomalies/disorders: gastroschesis, malrotation, necrotizing
enterocolitis, omphalocele, short gut syndrome, tracheo-esophageal fistula, volvulus
j. Inflammatory bowel disease: Crohn’s disease, ulcerative colitis k. Liver disease l. Malabsorption syndromes m. Neurologically/developmentally impaired n. Preterm Infants – particularly very low birth weight infants (<1500 grams) o. Pulmonary disease
Chapter 1 Pediatric Nutrition Services and Nutrition Screening at University of Virginia Health System
4
p. Renal disease q. Trauma patients
3. Weight below or above standards
a. Weight/height < 3rd
%-ile on age- and disease-appropriate growth charts b. Height or Length< 3
rd%-ile
c. Weight for height <3rd
%ile or > 95th
-ile d. Recent weight loss (over the past 6 months) of > 10% of usual body weight
4. Catabolic state: sustained fever, major organ failure 5. Diet order and patient intake inadequate in meeting patient nutritional
requirements. a. NPO > 3 days in previously malnourished children or NPO > 5 days in
previously well-nourished children, without parenteral or enteral nutrition b. Patients on clear or full liquid diets for > 5 days
Pediatric Nutrition Services within the Pediatric Intensive Care Unit (PICU)
Nutrition support of the critically ill, post-trauma or post-operative pediatric patient continues to develop as a clinical science in light of advances in nutrition, pharmacology and technology. Given the wide diversity in pediatric critical care states, we are challenged to accurately assess the nutritional requirements of our patients and the best mode of nutrition support to optimize their recovery and their nutritional and medical outcomes.
Role of the PICU RD
Screen all PICU patients for nutritional risk
Comprehensive nutritional assessment of all patients determined to be at risk
Development of nutrition care plan with recommendations for enteral or parenteral nutrition support, as needed (within 48 - 72 hours of PICU admission)
Monitoring of nutritional status; timely follow-up and intervention
Conduct nutritional analysis and compare intake to nutrition goals
Family and staff education on nutrition support
Assist the PICU team with nutrition management through entering pended orders for TPN, and verbal orders for enteral feedings, labs, and therapeutic diets using the electronic medical record system (Epic).
Chapter 1 Pediatric Nutrition Services and Nutrition Screening at University of Virginia Health System
5
Purpose and Goals of Nutrition Support in the PICU Patient
Provision of adequate calories and protein during catabolism to prevent protein-energy malnutrition (PEM), i.e., sepsis, trauma, post-surgery.
Promote improved immunological status and wound healing to minimize the risk of iatrogenic infections.
Prevent or minimize the catabolic response and breakdown of both somatic and visceral protein stores.
Improvement of nutritional status; management of disease-specific deficiencies
Reversal of growth failure and when applicable, promotion of “catch-up” growth.
Indications for Nutrition Support: Patients at Nutrition Risk
Hypermetabolic states: trauma: closed head injury, spinal cord injury
Post-surgical patients
Cardiorespiratory illness: congenital heart defects, bronchopulmonary dysplasia, cystic fibrosis
Gastrointestinal disease and dysfunction: short gut syndrome, exacerbation of inflammatory bowel disease with history of PEM, hepatic failure, biliary atresia, pancreatitis
Neurologic, muscular disease: genetic syndromes, Guillan-Barre’, muscular dystrophy, history of Cerebral Palsy or Mental Retardation requiring G-tube feedings
Pediatric Nutrition Services within the Newborn Intensive Care Unit (NICU)
The Newborn Intensive Care Unit is a special care nursery for the medical management of the preterm or critically ill neonate. The unit at UVA Health System is comprised of more than 40 beds and is staffed by neonatologists, neonatology fellows, neonatal nurse practitioners, and neonatal RNs. The NICU RD plays an active role in the NICU.
Role of Neonatal RD
Initial assessment for all at-risk infants within 72 hours of admission
Assist NICU residents with entry of TPN orders and with enteral feeding orders
Be available to the NNPs as a consultant regarding the nutrition management of their infants
Weekly follow-up for all infants
Participation in team rounds
Parent & caretaker education for infants being discharged on high calorie formula or fortified breast milk or any other specialized formula, when needed
Chapter 1 Pediatric Nutrition Services and Nutrition Screening at University of Virginia Health System
6
Monthly Neonatal Nutrition lecture to the new interns
Nutrition education and orientation of new NICU nurses
Screening in the Newborn Intensive Care Unit In the NICU, interns and residents complete a thorough assessment within the first 24 hours which includes the following basic nutrition screening data:
Birth weight, length and head circumference
Intrauterine %-iles for weight, length and head circumference using the Intrauterine growth charts
Gestational age
Major diagnoses
Based on the above documented nutrition screening data, the neonatal RD will
determine which infants are at risk and will complete a full assessment on the
following neonates:
All infants under 1200 grams
All infants requiring parenteral nutrition
Infants with major gastrointestinal anomalies
Infants with intrauterine growth retardation (IUGR) and who are small for gestational age
Infants with congenital heart defects requiring surgical repair
Infants with severe respiratory distress syndrome (RDS)
Infants with complex genetic disorders impacting nutritional status
Chapter 1 Pediatric Nutrition Services and Nutrition Screening at University of Virginia Health System
7
Pediatric Nutrition Outpatient Services
UVA Children’s Hospital
University of Virginia Health System
SERVICE DIETITIANS PHONE/PAGER
Primary Care
Center
Nephrology Brandis Roman 243-7656, PIC 6433
Gastroenterology Brandis Roman 243-7656, PIC 6433
Inborn Errors of Metabolism
Barbara Goodin
924-2665 or 979-6530 (beeper)
Continuum
Home Health
Pediatric Home Nutrition Support Patients
Amy Mentrikoski 924-8193
Northridge
Weight management, failure to thrive, behavioral eating issues, allergy, well child issues
Ashleigh Sellman
243-7314
Kluge
Children’s
Rehab Center
CP, myelomengiocele, muscular dystrophy, trauma, infant & young child clinic, Down syndrome, neurodevelopmental clinic, autism, other
Audrey Kocher, Amy Mentrikoski
924-8193
Children’s Fitness Clinic
Angela Hasemann
982-1607
Diabetes
Amy Mentrikoski Barbara Goodin
924-8193 924-2665
Feeding encouragement, feeding and swallowing
Audrey Kocher
924-8193
Cystic fibrosis Barbara Goodin 924-2665
Chapter 1 Pediatric Nutrition Services and Nutrition Screening at University of Virginia Health System
8
Chapter 2 – Nutritional Assessment of Pediatric Patients
9
Chapter 2
Nutritional Assessment of Pediatric Patients Assessment of the nutritional status of pediatric patients while in the hospital setting is important for identifying the goals of nutritional intervention, increasing the quality of care and diagnosing malnutrition. Nutritional status can be determined by the assessment of body weight, growth, adipose tissue, skeletal muscle, visceral protein stores and cellular immune function (1, 2). Components of a thorough nutritional assessment include (1, 2): 1. Growth assessment and anthropometric measurements 2. Medical, developmental, social and personal history 3. Nutritional intake history and history of food allergies 4. Laboratory evaluation of biochemical and metabolic changes 5. Review of nutrition-focused physical examination findings 6. Educational needs and potential barriers to learning
Growth and Anthropometric Measurements
Growth of infants, children, and adolescents from birth through 20 years of age is evaluated routinely. World Health Organization (WHO) growth standards should be used for children aged 0 to 2 years, and thereafter, National Center for Health Statistics (NCHS) growth curves should be used until 20 years of age (Appendix A). Growth charts exist for each gender. Knowledge of parental height and weight can also be important in growth assessment to gauge genetic potential. Growth charts are used to evaluate the following anthropometric measurements:
Recumbent length (<2 years of age) or standing height (> 2 years) for age
Weight for age
Weight for height
Head circumference for children under the age of 3 years
BMI for 2-20 years
Weight for age serves as a valuable indicator of overall nutritional status. Underweight for age may indicate acute malnutrition. A deficit in height or length usually indicates chronic undernutrition and growth failure. Weight for height assesses body weight in proportion to height and distinguishes wasting from dwarfism (1, 2).
Specialized growth charts are available for specific disease states such as Down syndrome (Appendix B).
Chapter 2 – Nutritional Assessment of Pediatric Patients
10
Additional Anthropometric Measurements (1, 2) Other anthropometric measurements which may be used to evaluate more precise aspects of a child’s nutritional status include:
Triceps Skinfold (TSF): a measurement of a double layer of skin and subcutaneous fat on the back of the upper arm which reflects subcutaneous fat stores. This measurement is taken using a tape measure and calipers, locating the midpoint between the acronium and olecranon processes and using the caliper jaws to grasp the skin and subcutaneous tissue 1 cm above the midpoint (3). To maintain consistency when evaluating the TSF and mid arm circumference (MAC) values for a given patient, the same individual should complete the measurement over the evaluation period and take three serial measurements during each assessment. See Appendix C for percentile tables to interpret measured values.
Midarm Muscle Circumference (MAMC): an index of lean muscle mass calculated from the MAC and TSF using the following equation (3) (see Appendix D for percentile tables):
MAMC (mm) = MAC (mm) - 3.14 x TSF (mm)
Body Mass Index (BMI): the preferred measure of adiposity which is expressed as weight in kg/height in meters
2. BMI provides a more reliable measure of fatness
than triceps skinfold thickness.
Pediatric Obesity Assessment (3 – 5)
The classification system for pediatric overweight/obesity is most commonly evaluated using BMI as follows for children (over 2 years of age) and adolescents (3):
Obesity: BMI 95th
%-ile for age and gender
Overweight: BMI 85th
- 94th
%-ile for age and gender
Refer to the BMI for age percentile charts developed by NCHS (Appendix A).
Growth Velocity The best indicator of a child’s long-term nutritional status is how fast he or she is growing. Consequently, growth velocity is an especially sensitive indicator which requires periodic evaluation (2). Deviations from a child’s normal growth pattern should be noted, especially an increase or decrease across 2 standard deviations or measurements plotting below the 5th %-ile or above the 95
th %-ile (3). It is important
to note, however, that approximately 2/3 of all children do cross growth curves in the first 2 years of life due to genetic reasons. The following parameters (Tables 2.1, 2.2, and 2.3) reflect growth velocity of normal term infants and children and are useful in making adjustments in nutrition goals (2).
Chapter 2 – Nutritional Assessment of Pediatric Patients
11
Table 2.1 Normal Weight Gain Velocity for Children 0 - 36 Months*
Age (months) Male (g)/day Female (g)/day
1 - 3 31 24
3 - 6 20 20
6 - 9 25 15
9 - 12 12 11
12 -15 8 8
15 - 36 6 6
* Infants and children with a history of failure to thrive, who are experiencing catch-up growth, may demonstrate weight gain at 150-200% of normal.
Table 2.2 Normal Weight Gain Velocity for Children Ages 3 -13 Years (6)*
Age (yr) g/month
2 - 7 38
7 - 9 56 - 62
9 -11 66 - 77
11 -13 85 - 110 * Based on 50th %-ile, height and weight, NCHS Growth Charts
Table 2.3 Normal Linear Growth Velocity for Children Birth – 10 Years (2)
Age Length (cm/month)
Birth to 3 months 2.6 - 3.5
3 - 6 months 1.6 - 2.5
6 - 12 months 1.2 - 1.7
1 - 3 years 0.7 - 1.1
4 - 6 years 0.5 - 0.8
7 - 10 years 0.4 - 0.6
Infants: Measure length weekly or biweekly. Toddlers: Measure height monthly. Head Circumference (7): From birth up to 12 months of age: 0.5 - 0.8 cm/wk
Chapter 2 – Nutritional Assessment of Pediatric Patients
12
Assessment of Malnutrition (1, 2, 8)
Weight is a good indicator of acute and chronic nutritional status and may be used to assess a pediatric patient’s degree of malnutrition. Weight may be classified as a percent of standard using the following equation:
th
actual weight measure% standard
expected weight measure (50 % ile) *
* 50
th %-ile for age or 50
th %-ile wt/ht if the child was premature.
The Waterlow criteria (Table 2.4) can be used to assess the degree of both acute and chronic malnutrition (9). It is important to realize, however, that chronic diseases, such as renal failure, may affect linear growth independent of nutrition status; in these cases, the Waterlow criteria may not apply for determination of chronic malnutrition.
Table 2.4 Waterlow Criteria to Assess Malnutrition Status (9)
Acute
(wt/50% wt for ht)
Chronic
(ht/50% ht for age)
Stage 0 >0.90 >0.95
Stage 1 (mild malnutrition) 0.80 - 0.90 0.90 - 0.95
Stage 2 (moderate malnutrition) 0.70 - 0.79 0.85 - 0.89
Stage 3 (severe malnutrition) <.70 <0.85
Clinical Assessment of Malnutrition
Although growth assessment is most commonly used for assessing nutritional status in children, in advanced stages of malnutrition children will exhibit physical signs and symptoms indicative of specific nutrient deficiencies. Table 2.5 reviews common clinical changes which may become evident with prolonged malnutrition in children.
Chapter 2 – Nutritional Assessment of Pediatric Patients
13
Table 2.5 Clinical Assessment of Malnutrition in Children: Physical Signs
of Nutrient Deficiency (10)
Physical Sign Nutrient Deficiency
General appearance: edema, muscle wasting, decreased subcutaneous fat, growth failure
Protein, calories
Hair: dull, dry, may be thin and sparse, easily pluckable; color changes
Protein, calories
Skin: Dry and flaky, follicular hyperkeratosis, dyspigmentation, petechiae, pellagrous dermatosis
Vitamin A, protein, niacin, Vitamin C, riboflavin, vitamin B6 Essential fatty acids
Eyes: Pale and dry membranes, or red and inflamed membranes, Bitot’s spots, corneal xerosis (dull & hazy) or scarring, cracking in the corners of eyes
Vitamin A, iron, folate
Lips: Redness and swelling, angular stomatitis Niacin, riboflavin, vitamin B6
Tongue: Swelling (glossitis), raw tongue, magenta or purplish in color, smooth tongue, sores
Riboflavin, niacin
Teeth and Gums: May be missing teeth, bad color and visible decay or cavities, spongy, swollen and bleeding gums, recession of gums
Fluoride, Vitamin C
Cardiovascular system: tachycardia, enlarged heart, abnormal heart rate or rhythm
Potassium, selenium, phosphorus, thiamine
GI System: spleen or liver enlargement, GI dysfunction
Protein, calories
Adapted from: Isaacs, J, Cialone, J, Horsley, et al. Children with Special Health Care Needs: A Community Nutrition Pocket Guide, 1997.
Medical History A complete nutritional assessment should include information on the following (2):
Past medical history including recent hospitalizations
Review of systems and history of allergies
Personal and social history
Presence of chronic illness such as congenital heart disease, cystic fibrosis, kidney disease, short bowel syndrome, and bowel atresias
Previous growth pattern via examination of growth charts
Chapter 2 – Nutritional Assessment of Pediatric Patients
14
Recent surgeries, other deterioration in medical condition or procedures impacting nutritional intake, status and management
Medications
Gestational age (for children < 3 years)
Identification of low and very low birthweight infants
Achievement of developmental milestones
Presence of congenital abnormalities or genetic errors
Nutritional Intake History Dietary history may be obtained by the following (2):
Twenty-four hour recall
Three day food intake
Food frequency questionnaire
General interview The following should be assessed:
For all infants: o type of formula, brand name o formula preparation (including water source) and storage o addition of substances other than water i.e. rice cereal, Karo syrup o volume and frequency of feedings o other beverage intake i.e. water, Kool-aid, tea and soda o solid food intake and texture progression o history of formula changes o history of emesis and/or diarrhea o stooling frequency and consistency
For breastfed infants: o how long the infant feeds o if the infant nurses from each breast during one feeding o how frequently the infant nurses o appearance and frequency of stools o number of wet diapers per day
For older infants and children: o family eating patterns, cooking & storage o vitamin and mineral supplementation o history of food allergy/intolerances and/or loose stools o evaluation of oral motor skills, feeding patterns, history of fatigue and/or
increased respiratory rate while feeding (Appendix E – Developmental Self-Feeding Checklist)
o interaction during feeding o self-imposed diets and outcomes; assessment of child’s own body image o supplemental feeding programs (WIC, food stamps)
Chapter 2 – Nutritional Assessment of Pediatric Patients
15
Laboratory Data (2, 11)
Various laboratory values are useful in the assessment of a patient’s nutritional status. Table 2.6 summarizes lab values that are most often used for the nutritional assessment of pediatric patients. A more complete list of other labs with nutrition related implications may be found in Appendix F.
Table 2.6 Laboratory Assessment of Nutritional Status
LAB PARAMETER INTERPRETATION OF VALUES POTENTIAL CAUSES FOR:
High Values Low Values
Prealbumin
used to assess protein status
sensitive indicator of recent protein nutriture
Half life: 2-3 days
Preterm: 9-33 mg/dl Term: 11-34 mg/dl Older Children: 20-50 mg/dl
Dehydration Steriods ( i.e. Prednisone)
Acute protein malnutrition Trauma & Stress Infection Chronic liver disease Aggressive hydration Metabolic liver disease
Transferrin
used to assess protein status
synthesized in the liver to carry iron in the blood; also acts as an acute phase reactant
Half life: 8-10 days
Preterm: 140-370 mg/dl Term: 200-370 mg/dl Older Children: 180-260 mg/dl
Iron deficiency Hypoxia Chronic blood loss Stress
Impaired synthesis Protein malnutrition Chronic infection Chronic liver disease Protein-losing enteropathies
Albumin
used to assess protein status
poor indicator of early protein depletion due to large body pool
Half life: 15-20 days
Preterm: 2.5-4.5 g/dl Term: 2.5-5.0 g/dl 1-3 mo.: 3.0-4.2 g/dl 3-12 mo.: 2.7-5.0 g/dl > 1 year: 3.2-5.0 g/dl
Dehydration
Protein malnutrition Impaired digestion or absorption of protein Excessive protein losses Chronic liver disease Advanced malignancies Hypervolemic dilution Chronic infection Aggressive hydration Nephrotic syndrome
Chapter 2 – Nutritional Assessment of Pediatric Patients
16
References
1. American Academy of Pediatrics. Committee on Nutrition. Assessment of nutrition status. In: Pediatric Nutrition Handbook. 2004:407-423.
2. Bessler S. Nutritional assessment. In: Samour PQ, King K, eds. Handbook of Pediatric Nutrition. 3
rd edition. Sudbury, MA: Jones and Bartlett Publishers Inc;
2005:11-34. 3. Spears B. Childhood obesity. In: Samour PQ, King K, eds. Handbook of Pediatric
Nutrition. 3rd
edition. Sudbury, MA: Jones and Bartlett Publishers Inc; 2005:181-212.
4. Barlow SE and the Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007; 120(S4): S164-192.
5. American Academy of Pediatrics. Committee on Nutrition. Pediatric obesity. In: Pediatric Nutrition Handbook. 2004:551-592.
6. Schwenck WF, Olson D. Pediatrics. In: Gottschlich M, Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:347-372.
7. Katrine KF. Anthropometric assessment. In: Groh-Wargo S, Thompson M, Hovasi Cox J, eds. Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 2000:11-22.
8. American Academy of Pediatrics. Committee on Nutrition. Failure to thrive. Pediatric Nutrition Handbook. 2004:443-457.
9. Waterlow JC. Classification and definition of protein calorie malnutrition. In: Beaton
G, Bengoa X, eds. Nutrition in Preventive Medicine. WHO monograph series (62); Geneva: WHO; 1976.
10. Miles A, Reed G. Feeding challenges in children with neurologic impairment.
Support Line. 2004;26(2):16-23.
11. Moyer-Mileur L. Laboratory assessment. In: Groh-Wargo S, Thompson M, Hovasi Cox J, eds. Nutritional Care for High Risk Newborns. Chicago, IL: Precept Press; 2000:47-54.
Chapter 3 Nutritional Requirements in Term Infants and Children
17
Chapter 3
Nutritional Requirements in Term Infants and Children The first step in providing infants and children who are established to be at nutritional risk with the most appropriate nutrition intervention is to assess actual requirements. Nutritional needs are highly individualized and vary widely, particularly with activity and disease.
Non-Critically Ill Infants and Children The following tables review the range of enteral and parenteral nutrient requirements for term infants (1, 2).
Table 3.1 Estimated Caloric, Protein, and Fluid Needs of Term Infants for
Enteral and Parenteral Nutrition
Infant
Condition/Disease
Enteral Parenteral
Calories (kcal/kg)
Protein (g/kg)
Fluid (ml/kg)
Calories (kcal/kg)
Protein (g/kg)
Well-Nourished
Term/ AGA 90-110 2.0-3.0 150-200 85-110 2.5-3
BPD or CHD 120-150 3.0-4.0 120-130 90-130 2.5-3.5
Well-Nourished Term/AGA = Appropriate for Gestational Age (10-90th %-ile on growth chart for weight for age)
BPD = Bronchopulmonary Dysplasia CHD = Congenital Heart Disease
Dietary Reference Intakes Dietary Reference Intakes (DRIs) expand on and replace the Recommended Dietary Allowances (RDAs) last published in 1989. DRIs consist of 4 categories (3):
Estimated Average Requirement (EAR): the average daily nutrient intake level estimated to meet the requirement of half the healthy individuals in a particular life stage and gender group.
Recommended Dietary Allowance (RDA): the average daily dietary nutrient intake level sufficient to meet the nutrient requirement of nearly all (97 to 98 percent) healthy individuals in a particular life stage and gender group.
Adequate Intake (AI): the recommended average daily intake level based on observed or experimentally determined approximations or estimates of nutrient intake by a group (or groups) of apparently healthy people that are assumed to be adequate—used when an RDA cannot be determined.
Chapter 3 Nutritional Requirements in Term Infants and Children
18
Tolerable Upper Intake Level (UL): the highest average daily nutrient intake level that is likely to pose no risk of adverse health effects to almost all individuals in the general population. As intake increases above the UL, the potential risk of adverse effects may increase.
Energy
None of the above 4 DRI categories are used to describe estimated needs for energy; instead, the Estimated Energy Requirement (EER) is used. This is defined as the average dietary energy intake that is predicted to maintain energy balance in adults and energy deposition (i.e., weight gain and growth) for infants and children (4). Prediction equations for normal weight individuals were developed from data on total energy expenditure (TEE) measured by the doubly labeled water technique. Equations for infants and toddlers are based on weight and estimated needs for energy deposition. Equations for children and adolescents are based on height, weight, age, physical activity level (ranging from sedentary to high activity) and also take into account needs for energy deposition (4). Table 3.2 presents the EER values for infants and children; data for infants and toddlers are based on reference weights (normal weights for various ages), and data for older children and adolescents are based on reference weights and heights and physical activity levels corresponding to sedentary or low activity. For the development of calorie ranges, sedentary and low activity levels were chosen for physical activity coefficients instead of active or very active levels due to the thought that hospitalized children will not have high activity levels. Published EER formulas and physical activity coefficients are available in Appendix G and can be used to calculate more individualized needs, if necessary.
Overweight Children (4)
In general, for children who are overweight or obese, a goal weight loss of 1 pound per month might be reasonable. The general goal for children who are at overweight or obese is weight maintenance with the hope that BMI will improve as linear growth continues. See Appendix G for formulas to estimate energy needs in overweight children.
Chapter 3 Nutritional Requirements in Term Infants and Children
19
Protein
The recommended intakes of protein for infants 0-6 months of age are based on an Adequate Intake (AI) that reflects the observed mean protein intake of infants fed principally with human milk. For older infants and children, the RDA is determined using data available from nitrogen balance studies, measurement of the rates of protein deposition for growth, and estimates of efficiency of protein utilization (3). Table 3.2 reflects the DRIs for protein for various age groups.
Fiber
No DRIs exist for fiber for infants 0-12 months of age. This is because the gold standard for feeding infants 0-6 months of age is breast milk, and breast milk contains no dietary fiber. For infants 7-12 months of age, there are no data on dietary fiber intake and, according to published information, no theoretical reason to establish a DRI for fiber. Dietary fiber recommendations for children ages 1-18 years are based on data extrapolated from adult studies that show that 14 grams of fiber per 1000 calories reduces risk of coronary heart disease (3).
Table 3.2 Estimated Energy, Protein, and Fiber Requirements
for Infants and Children (4-6)
* Protein requirements for hospitalized children may vary significantly based on clinical condition.
ND = not determined
Micronutrients
Although clinical signs of vitamin and mineral deficiency are rare in the United States, dietary intake studies have reported that the nutrients most likely to be low or deficient in the diets of children and adolescents are calcium, iron, ascorbic acid, vitamin A, folic acid, and vitamin B6. Certain populations of children, such as low-income, Native American,
Age Energy (kcals/kg)
Protein* (g/kg)
Fiber (g/day)
Males Females Males Females
Infants 1-3 months 95-107 1.52 ND
4-6 months 82-83 1.52 ND
7-12 months 79-82 1.2 ND
Toddlers 1-3 years 81-83 1.05 19
Children 3-4 years 75-93 72-89 0.95 25
5-6 years 64-80 62-77 0.95 25
7-8 years 57-70 53-66 0.95 25
9-10 years 50-62 45-57 0.95 31 26
11-12 years 44-55 39-49 0.95 31 26
Adolescents 13-14 years 41-50 35-43 0.85 31 26
15-16 years 38-47 32-40 0.85 38 26
17-18 years 35-43 30-37 0.85 38 26
Chapter 3 Nutritional Requirements in Term Infants and Children
20
and other groups with limited food and health resources, are more at risk for nutrient deficiencies.
Table 3.3 Dietary Reference Intakes: Recommended Dietary Allowance for Vitamins
for Infants and Children (7)
Age
(years)
Fat-Soluble Vitamins
Water-Soluble Vitamins
Vit A
(g)
Vit D (IU)
Vit E (mg)
Vit K
(g)
Vit C (mg)
Thiamin (mg)
Ribo-
flavin (mg)
Niacin (mg)
Vit B6 (mg)
Folate
(g)
Vit B12
(g)
Infants 0-6 mo. 400 400 4 2.0 40 0.2 0.3 2 0.1 65 0.4
7-12 mo. 500 400 5 2.5 50 0.3 0.4 4 0.3 80 0.5
Children 1-3 300 600 6 30 15 0.5 0.5 6 0.5 150 0.9
4-8 400 600 7 55 25 0.6 0.6 8 0.6 200 1.2
Males 9-13 600 600 11 60 45 0.9 0.9 12 1.0 300 1.8
14-18 900 600 15 75 75 1.2 1.3 16 1.3 400 2.4
Females 9-13 600 600 11 60 45 0.9 0.9 12 1.0 300 1.8
14-18 700 600 15 75 65 1.0 1.0 14 1.2 400 2.4
Values in bold type presents Recommended Dietary Allowances (RDAs), while Adequate Intakes (AIs) are in ordinary type.
Vitamin A: 1 g Retinol = 1 RE; 0.3 RE = 1 IU
Table 3.4 Dietary Reference Intakes: Recommended Dietary Allowances for Selected
Minerals in Infants and Children (7)
Age
(years)
Calcium (mg)
Phosphorus (mg)
Magnesium (mg)
Selenium
(g)
Iron (mg)
Zinc (mg)
Iodine
(g)
Copper
(g)
Infants 0-6 mo. 200 100 30 15 0.27 2 110 200
7-12 mo. 260 275 75 20 11 3 130 220
Children 1-3 700 460 80 20 7 3 90 340
4-8 1000 500 130 30 10 5 90 440
Males 9-13 1,300 1,250 240 40 8 8 120 700
14-18 1,300 1,250 410 55 11 11 150 890
Females 9-13 1,300 1,250 240 40 8 8 120 700
14-18 1,300 1,250 360 55 15 9 150 890
Values in bold type presents Recommended Dietary Allowances (RDAs), while Adequate Intakes (AIs) are in ordinary type.
Vitamin and Mineral Supplementation
Breastfed term infants are recommended to take in vitamin supplements, as recommended in Table 3.5, primarily to ensure adequate vitamin D intake. Additionally, term infants who are fluid restricted or consistently unable to take in 750 ml of formula per day should also receive a pediatric multivitamin supplement. Appendix J contains information on various pediatric multivitamin supplements and their micronutrient contents.
Chapter 3 Nutritional Requirements in Term Infants and Children
21
Table 3.5 Recommendations for Vitamin Supplementation in the Term Infant
Formula Currently Receiving Supplementation needed per day
Breast milk (initiate as soon as possible after birth)
1 ml/day of vitamin D or multivitamin drops (consider changing to iron-containing supplementation at 4-6 months of age, depending on iron content of complementary foods)
Term Formula – with intake less than 750 ml per day
0.5 - 1 ml/day of vitamin D or multivitamin drops (consider changing to iron-containing supplementation at 4-6 months of age, depending on iron content of complementary foods)
Formulations “with iron” do not contain folic acid; this may need to be supplemented separately.
Fluoride supplementation is only indicated after 6 months of age when (8): 1. “Ready-to-feed” formula is used 2. Formula concentrate or powder is mixed with non-fluoridated bottled water 3. Local tap water is < 0.6 parts per million (ppm) 4. Baby is breast fed past 6 months
Table 3.6 Recommendations for Fluoride Supplementation in Infants and
Children (8)
Water Fluoride (ppm) 6 mo. – 3 yr. 3 – 6 yr. 6 – 16 yr.
< 0.3 0.25 mg 0.50 mg 1.0 mg
0.3 – 0.6 0 0.25 mg 0.50 mg
> 0.6 0 0 0
Examples of fluoride-containing liquid drops (see Appendix J for details):
Poly-Vi-Flor and Tri-Vi-Flor (Mead Johnson) contain 0.25 mg fluoride per 1 ml
Pediaflor (Abbott) contains 0.25 mg fluoride per 0.5 ml
Chapter 3 Nutritional Requirements in Term Infants and Children
22
Critically Ill Children The nutritional requirements of critically ill children are often quite different from the EERs for a variety of reasons. Depending on the extent or type of injury or illness, the medications being used to manage the patient or the presence or degree of previously existing malnutrition, calorie or protein requirements may be elevated or even decreased in the critically ill pediatric patient (9, 10).
The following table reviews factors, which may increase or decrease nutrient requirements.
Table 3.7 Factors Affecting Calorie and Protein Requirements in
Critically Ill Children
Increasing Requirements Decreasing Requirements
Trauma Surgery Sepsis Fever Tumor Burns Athetoid CP, Hypertonia Seizures Spinal Cord Injury (acute) Increased Work of Breathing Weaning from Ventilator Sustained Agitation
Lack of activity / Bed rest Mechanical ventilation Medical sedation Medical paralysis Hypotonia, Spastic CP Reduced Insensible losses Hypothyroid condition
Studies in critically ill pediatric patients have demonstrated the importance of not using standard EER calorie calculations to calculate energy requirements as these are meant for healthy, active children. Instead, using the patient’s basal energy needs and multiplying it by a corrective stress factor provides an appropriate estimated of energy needs (9).
Determining total caloric and protein needs during critical illness:
1. Estimate basal energy needs (caloric requirements, post- absorptive, recumbent, and at room temperature - Table 3.8)
2 Estimate patient’s protein requirements (RDAs - Table 3.2)
3. Determine patient’s stress factor (Table 3.9)
Total Calories = BEE x Stress Factor Total Protein = Protein RDA x Stress Factor
4. Continue to evaluate and adjust recommendations based on response (weight
gain or weight loss)
Chapter 3 Nutritional Requirements in Term Infants and Children
23
Table 3.8 Basal Energy Needs for Infants and Children (9)
Adolescents
Alternatively, Harris and Benedict Equation may be more appropriately used in adolescents for determination of basal energy expenditure (BEE): For men: BEE = 66 + (13.7 x ideal wt. in kg) + (5 x height in cm) – (6.8 x age in years) For women: BEE = 655 + (9.6 x ideal wt in kg) + (1.7 x height in cm) – (4.7 x age in years)
Table 3.9 Determining Stress Factor (9, 10)
Clinical State Stress Factor
Maintenance without stress Fever Routine surgery, minor sepsis Cardiac failure Elective Surgery Major surgery Sepsis Major Trauma Burns
1.0 - 1.2 12% per degree >37
o
1.1 - 1.3 1.25 - 1.5 1.0 - 1.2 1.2 -1.4 1.4 -1.8 1.5 - 1.7 1.5 - 2.0
Age 1 wk to 10 mo Age 11 to 36 mo Age 3 to 16 yr
Weight
(kg) Metabolic Rate
(kcal/day)
Weight
(kg)
Metabolic Rate (kcal/day)
Weight (kg)
Metabolic Rate (kcal/day)
Male or Female
Male Female Male Female
3.5 202 9.0 528 509 15 859 799
4.0 228 9.5 547 528 20 953 898
4.5 252 10.0 566 547 25 1046 996
5.0 278 10.5 586 566 30 1139 1092
5.5 305 11.0 605 586 35 1231 1190
6.0 331 11.5 624 605 40 1325 1289
6.5 358 12.0 643 624 45 1418 1387
7.0 384 12.5 662 646 50 1512 1486
7.5 410 13.0 682 665 55 1606 1584
8.0 437 13.5 701 684 60 1699 1680
8.5 463 14.0 720 703 65 1793 1776
9.0 490 14.5 739 722 70 1886 1874
9.5 514 15.0 758 741 75 1980 1973
10.0 540 15.5 778 760
10.5 566 16.0 797 782
11.0 593 16.5 816 802
Chapter 3 Nutritional Requirements in Term Infants and Children
24
Prevention and Complications of Overfeeding (11) In many cases, critically ill children in the Pediatric Intensive Care Unit (PICU) have caloric requirements at 60-80% of the EERs due to inhibited growth, reduced resting energy expenditure, reduced insensible losses, medications and decreased activity. Overfeeding involves the provision of calories and/or substrate in excess of the requirements to maintain metabolic homeostasis. From a clinical standpoint, the harmful effects of overfeeding may result in respiratory compromise, hepatic dysfunction, and an increased risk of mortality. Complications of overfeeding:
1. Excessive CO2 production 2. Increased minute ventilation (VE) 3. Respiratory failure 4. Pulmonary edema 5. Hyperglycemia 6. Lipogenesis (increased insulin, decreased fatty oxidation) 7. Hepatic cellular injury (increased serum conc. of liver enzymes) 8. Fatty liver 9. Intrahepatic cholestasis 10. Immunosuppression
Catch-Up Growth in the Term Infant and Child (12)
Children who are below normal growth parameters due to chronic undernutrition or illness affecting their nutritional intake and status require additional calories and protein to achieve catch-up growth. During this phase of growth recovery, a child may grow at rates well above the norm for his or her age.
EER* (kcal/kg) for weight age** x Ideal weight (kg)***Catch-up calories (kcal/kg) =
Actual weight
* Use EER (Table 3.2) ** Age at which present weight is at the 50
th %-ile
*** 50th
%-ile for age or ideal body weight for height
Grams of Protein/Kg = 8% of catch-up growth calories
catch-up growth (kcal/kg) x 0.08
Protein catch-up calories = 4
Chapter 3 Nutritional Requirements in Term Infants and Children
25
Energy Requirements for Pediatric Burn Patients (13, 14)
Daily metabolic expenditure of burn patients can be estimated by numerous formulas, predicted on data obtained from adults, but altered for children addressing their metabolic differences. Clinicians may choose to use several of the following formulas in order to develop a range of calories for individual patients.
Table 3.10 Selected Formulas for Calculating Energy Requirements of Burned
Children
* See Table 3.8 for estimations of basal energy needs
** BSA = body surface area (total), calculated as: ht [cm] x wt [kg]
3600
Fluid Requirements
Fluid requirements can be calculated by estimating normal water requirements adjusted for specific disease related factors. However, special consideration must be given to monitoring fluid balance of infants and children receiving high calorie, high nitrogen formulas, those who have severe neurological impairment or those with emesis, diarrhea, fever, or polyuria. In order to prevent dehydration and ensure adequate provision of fluids during the administration of enteral and parenteral nutrition, use Table 3.11 to assess fluid needs.
Table 3.11 Daily Fluid Maintenance Requirements
Weight (kg) Maintenance Fluid
Requirements
Fluid Requirements to Meet
Calorie and Nutrient Needs
2.0-3.0 120 ml/kg/day 150 – 180 ml/kg
3.0-10.0 100 ml/kg/day 140 – 165 ml/kg
11-20
1,000 ml plus 50 ml/kg for each kg > 10 kg
Use maintenance fluids
Above 20 1,500 ml plus 20 ml/kg for each kg > 20 kg
Use maintenance fluids
Formula
Name/Authors
Age % BSAB Calories/Day
Davies and
Liljedal
Child Any (60 kcal x weight [kg]) + (35 kcal x % burn)
Curreri Junior 0-1 years <50 Basal* + (15 kcal x % burn)
1-3 years <50 Basal* + (25 kcal x % burn)
4-15 years <50 Basal* + (40 kcal x % burn)
Hildreth 0-1 years (2100 kcal/m2 BSA**) + (1000 kcal/m2 burn)
<12 years (1800 kcal/m2 BSA**) + (1300 kcal/m2 burn)
12-18 years (1500 kcal/m2 BSA**) + (1500 kcal/m2 burn)
Chapter 3 Nutritional Requirements in Term Infants and Children
26
References
1. American Academy of Pediatrics. Committee on Nutrition. Protein. In: Pediatric Nutrition Handbook. 2004:29-240.
2. American Academy of Pediatrics. Committee on Nutrition. Energy. In: Pediatric Nutrition
Handbook. 2004:241-259.
3. Institute of Medicine. Food and Nutrition Board. Energy: Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). 2005:21-37.
4. Institute of Medicine. Food and Nutrition Board. Energy: Dietary Reference Intakes for energy,
carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). 2005:107-264.
5. Institute of Medicine. Food and Nutrition Board. Energy: Dietary Reference Intakes for energy,
carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). 2005:2005:589-768.
6. Institute of Medicine. Food and Nutrition Board. Energy: Dietary Reference Intakes for energy,
carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). 2005:2005:339-421.
7. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes. Available
at:http://www.iom.edu/Activities/Nutrition/SummaryDRIs/~/media/Files/Activity%20Files/Nutrition/DRIs/5_Summary%20Table%20Tables%201-4.pdf.
8. American Academy of Pediatrics. Committee on Nutrition. Nutrition and oral health. In:
Pediatric Nutrition Handbook, 6th ed. 2009:1041-1056.
9. Canete A, Duggan C. Nutrition support of the pediatric intensive care unit patient. Curr Opin
Pediatr. 1996;8:248-255.
10. Iyer P. Nutritional support in the critically ill child. Indian J Pediatr. 2002;69:405-410.
11. Chwals WJ. Overfeeding the critically ill child: fact or fantasy? New Horiz. 1994;2:147-155.
12. Peterson KE, Washington J, Rathburn JM. Team management of failure to thrive. J Am Diet Assoc. 1984;84(7):810.
13. Gottschlich MM, Mayes T. Nutrition in the burned pediatric patient. In: Samour PQ, King K,
eds. Handbook of Pediatric Nutrition. 3rd edition. Sudbury, MA: Jones and Bartlett Publishers
Inc; 2005:483-498.
14. Rodriguez DJ. Nutrition in patients with severe burns: state of the art. J Burn Care Rehabil. 1996;17:62-70.
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
27
Chapter 4
Nutritional Assessment, Requirements and Enteral
Nutrition Management in the Preterm Infant
Preterm infants are a challenge to manage nutritionally due to their complicated medical treatment course, immature physiology, and numerous complications, which can delay progression of enteral nutrition. Potential difficulties in providing adequate nutritional support include respiratory instability, drug therapy, fluid restriction, predisposition to necrotizing enterocolitis (NEC) and immature renal and gastrointestinal systems (1).
Preterm Infant Weight Classification and Assessment (2) Preterm infants, those born less than 37 weeks, are frequently placed at higher risk for impaired nutrition due to reduced stores, GI immaturity, and metabolic and/or digestive deficiencies. Infants may be classified as the following:
Low Birth Weight (LBW): Less than 2500 g
Very Low Birth Weight (VLBW): Less than 1500 g
Extremely Low Birth Weight (ELBW): Less than 1000 g
Assessment of Intrauterine Growth (2) Premature infants’ rate of weight gain may be compared to infants of similar gestational age using the following growth charts:
Lubchenco growth charts: intrauterine growth curves often used to classify the infant’s size at birth; fail to account for normal postnatal weight loss and differences in rates of weight gain among different populations.
Dancis growth curves: postnatal daily growth curves; reflect early postnatal weight loss related to fluid changes, but in general may not reflect ideal growth of the preterm infant. The Dancis grid is useful for monitoring growth trends and initially, changes in hydration status.
Fenton or updated Babson growth charts (Appendix A): intrauterine growth curves; SGA and LGA are defined as two standard deviations from the mean birth weight. The Babson charts are useful in the assessment of weekly premature infant growth through the first year of life.
Small for Gestational Age (SGA): Birth weight < 10th
%-ile
Appropriate for Gestational Age (AGA): Birth weight 10th
-90th
%-ile
Large for Gestational Age (LGA): Birth weight > 90th
%-ile
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
28
SGA infants are at greater nutritional risk due to decreased nutritional reserves, increased nutritional requirements to allow for rapid catch-up growth, and frequently a lack of functional maturity such as absent suck and swallow, and delayed gastric emptying. LGA infants are common in mothers with diabetes. Frequent complications seen in LGA infants include hypoglycemia and birth trauma. Correcting for Prematurity Growth of premature infants should be adjusted to reflect gestational age; weight should be corrected until the child is 24 months of age, length until 36 months of age, and head circumference until 18 months of age (2). Generally, correction for all 3 parameters up to 24 months of age is appropriate.
Growth Velocity in Preterm Infants (2) Preterm infants, once having regained their birth weight and stable from both a respiratory and clinical standpoint should approach intrauterine growth rates between 15-20 g/kg/day, averaged over a minimum period of 5-7 days. Average rate of weight gain over days to weeks is more important than single 1 or 2 day measurements, which can reflect changes in fluid status or equipment differences. Weight gain based on intrauterine growth averages 10-20 g/day for infants <27 weeks and 20-35 g/day for infants 27-40 weeks gestation.
Weight Gain Goal AGA (Appropriate for Gestational Age):
15-20 g/kg/day
SGA (Small for Gestational Age): 20 - 25 g/kg/day
When infants are > 2 kg, it is more appropriate to aim for weight gain of 20-40 g/day, no
longer adjusting per kg.
Assessment of linear growth with incremental gains in length and head circumference should also be monitored. As with weight gain, once preterm infants are stable from a respiratory and clinical standpoint, linear growth should proceed optimally at intrauterine rates. Length
should be measured weekly in the preterm infant. Length gain should average between
3.2 – 4.4 cm per month, or about 0.75 – 1 cm per week. Head circumference increase
should average 2-3 cm per month, or 0.5-0.7 cm/week.
Micronutrient and Macronutrient Requirements Tables 4.1 and 4.2 review the range of enteral calorie, protein and micronutrient requirements for preterm infants (3).
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
29
Table 4.1 Estimated Enteral Caloric, Protein, and Fluid Needs in the Preterm Infants
Infant
Condition/
Disease
Enteral Parenteral
Nutrient Calories
(kcal/kg)
Protein
(g/kg)
Fluid
(ml/kg)
Calories
(kcal/kg)
Protein
(g/kg)
Fluid
(ml/kg)
AGA
105-130 3.0-4.0 150-200 90-100 3.0-4.0 120
SGA or
ELBW
120-140 3.5-4.5 150-200 95-105 3.5-4.0 120-130
BPD, CHD,
or CLD
120-150 3.0-4.0 120-135 90-105
3.0-4.0 100-120
AGA = Appropriate for Gestational Age (10-90th %-ile on growth chart for weight for age)
SGA = Small for Gestational Age (<10th %-ile on growth chart for weight for age)
BPD = Bronchopulmonary Dysplasia CHD = Congenital Heart Disease CLD = Chronic Lung Disease
Growth measurements to monitor adequacy of intake include
daily weight (goal = 15-20 g/kg/day if < 2 kg; 20-40 g/day if > 2 kg)
weekly length (goal = 0.75-1.0 cm/week since birth)
head circumference (goal = 0.5-0.7 cm/week since birth)
Table 4.2 Enteral and Parenteral Vitamin and Mineral Needs in Preterm Infants (3, 4)
VITAMINS MINERALS
Enteral Parenteral Enteral Parenteral
Vitamin A 700-1500 IU/kg 700-1500 IU/kg Calcium 120-230 mg/kg 50-80 mg/kg
Vitamin D 400 IU/day (200-1000)
1.5 – 10 ug/kg Phosphorus 60-140 mg/kg 40-60 mg/kg
Vitamin E 6-12 IU/kg 2.8 – 3.5 IU/kg Magnesium 7.2-.9.6 mg/kg 4.3-7.2 mg/kg
Vitamin K 8-10 ug/kg 10 ug/kg Iron 2-4 mg/kg 250-670 ug/kg
Vitamin C 30-40 mg/kg 25 mg/kg Sodium 2-3 mEq/kg 3-4 mEq/kg
Thiamine 180-240 ug/kg 350 ug/kg Potassium 2-3 mEq/kg 2-4 mEq/kg
Riboflavin 250-360 ug/kg 0.15 mg (150 mcg)/kg
Chloride 2-3 mEq/kg 3-4 mEq/kg
Niacin 4.5-6 mg/kg 5-6.8 mg/kg Zinc 1000-2000 ug/kg 400 ug/kg
Vitamin B6 180-300 ug/kg 180-400 ug/kg Copper 120-150 ug/kg 20 ug/kg
Vitamin B12 0.3 ug/kg 0.3 ug/kg Manganese 0.75-7.5 ug/kg 1 ug/kg
Folic Acid 45-50 ug/kg 56 ug/kg Selenium 1.3-4.5 ug/kg 1.5-4.5 ug/kg
Pantothenic Acid 1.2-2 mg/kg 2 mg/kg Chromium 0.1-2.25 ug/kg 0..05-.3 ug/kg
Biotin 3.6-6.0 ug/kg 6-8 ug/kg Molybdenum 0.3-4ug/kg 0.25-1.0 ug/kg
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
30
Fluid Requirements
Fluid requirements can be calculated by estimating normal water requirements and adjusting for specific disease related factors. However, special consideration must be given to monitoring fluid balance of children receiving high calorie, high nitrogen formulas, those who have severe neurological impairment or those with emesis, diarrhea, fever, or polyuria. Fluid management of preterm infants or critically ill newborns is complex and affected by numerous factors including cardiorespiratory status, renal status, degree of prematurity and insensible losses.
In order to prevent dehydration and ensure adequate provision of fluids during the administration of enteral and parenteral nutrition, use Table 4.3 for general guidelines in the assessment of fluid needs.
Table 4.3 Daily Fluid Maintenance Requirements in the Neonate
Weight (kg) Maintenance Fluid
Requirements
Fluid Requirements For
Enteral Nutrient Needs
0.5 – 3.0 kg 100 – 140 ml/kg/day 135 – 180 ml/kg
3.0 – 10.0 kg 100 ml/kg/kg/day 125 – 180 ml/kg
Meeting the Increased Needs of the Preterm Infant Preterm infants have increased requirements for Vitamins A, D, E, C and iron. Breast milk is
the preferred feeding for preterm infants. However, breast milk does not provide
adequate protein, calcium, phosphorous, magnesium, sodium, copper, zinc, folate, B-
vitamins, and iron for infants who weigh <1500 g at birth (4). Supplementation of Breast Milk
The caloric and nutrient density of breast milk can be increased by two methods:
Method 1 - Enfamil Human Milk Fortifier or Similac Human Milk Fortifier
Method 2 - Use of Powdered Infant Formula: EnfaCare or NeoSure Breast fed preterm infants who are admitted to the PICU, are still below 2500 grams and are unable to take in 180 ml/kg will need to receive fortified breast milk using: Method 1: Enfamil or Similac Human Milk Fortifier as follows:
Table 4.4 Fortification of Breast Milk with Human Milk Fortifier
Step Fortifier Breast Milk Caloric Density Increased mOsm
1 1 packet 50 ml 22 kcal/oz 32 mOsm/kg
2 1 packet 25 ml 24 kcal/oz 63 mOsm/kg
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
31
Method 2: Breast milk caloric and nutrient density for older preterm infants > 3.0 kg infants
may be increased to 24 - 30 kcal/oz according to the following:
Table 4.5 Increasing Nutrient Density of Breast Milk Using NeoSure of Enfacare
Powder
Caloric Density
(kcal/oz.)
Breast Milk Volume
(oz.)
Formula Powder
(tsp.)
Endpoint Volume
24 3 1 3 oz.
27 3 2 4 oz.
30 3 3 5 oz.
Home Fortification: Fortification with NeoSure or Enfacare powder is the preferred method for fortification at discharge as human milk fortifiers are not readily available in retail establishments. Vitamin and Mineral Supplementation
Table 4.6 Recommendations for Vitamin Supplementation in the Preterm Infant
Feeding Fluid Currently Receiving Supplementation needed per day
Plain breast milk (no fortifier) 1 ml/day multivitamin with iron
Fortified breast milk Abbott HMF: 0.5 ml/d multivitamin with iron; if total volume/day is < 240 ml, add 0.5 ml/d multivitamin, or multivitamin with iron
Fortified formula Determine if need vitamins with iron or Fer-in-sol to treat anemia. (Therapeutic range for iron deficiency anemia = 4-6 mg/kg/d)
Use of vitamin supplements, as recommended in Table 4.6, is primarily to ensure adequate vitamin D and iron intake in preterm infants.
Similac Special Care 24 Advance contains marginal vitamin D to meet daily requirements until an infant is able to take more than 400 ml/day. If a preterm infant is on Similac Special Care, rather than Enfamil Premature Lipil, vitamin D may be supplemented via the addition of 0.5 ml of a pediatric multivitamin (see Table 4.6).
For treatment of iron deficiency anemia, supplement with 4 - 6 mg/kg/day of iron.
For prevention of iron deficiency anemia, provide iron fortified formula, fortified breast milk or at least 2 mg/kg/day of iron if on Similac Human Milk Fortifier. (Enfamil Human Milk Fortifier already contains extra iron).
For preterms or fluid-restricted infants not taking at least 750 ml of a standard infant formula per day, should receive 0.5 ml of multivitamin with iron per day.
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
32
Preterm Formula Selection
Selection of an optimal preterm formula depends upon a number of factors including patient factors such as degree of prematurity, diagnosis, associated nutritional problems and requirements, and GI function. Important formula factors which need to be considered include higher calorie, calcium, and phosphorus intakes (1).
Table 4.7 Overview of Preterm Formulas
Formula Type Description Indications/Formulations Formula Examples
Preterm
Formulas
Formulas designed to meet the increased nutritional and altered physiological needs of preterm infants. Used for infants born < 2000 grams or < 35 weeks gestational age.
Preterm infants < 2000 grams
Partial substitution of corn syrup solids for lactose
Increased protein concentration and higher whey composition
Partial substitution of long chain fatty acids with medium chain triglycerides (MCT)
Increased caloric density: 24-30 kcal/oz
Increased concentrations of sodium, calcium, phosphorus, and vitamins (specifically D and E)
Enfamil Premature Lipil 24
(Mead Johnson)
Similac Special Care Advance 24 (Abbott)
Similac Special Care Advance 30 (Abbott)
Gerber Good Start Premature 24 (Nestle)
Transitional
Preterm
Formulas
Preterm formulas have been developed to meet the increased needs of the preterm infant during the first 9 months to 1st year of life.
Preterm infants who can tolerate ≥ 165 mL/1g/day during the 1st year of life
Increased caloric density: 22 kcal/oz
Partial substitution corn syrup solids for lactose
Partial substitution of long chain fatty acids with MCT
Increased levels of protein, vitamins & minerals compared to term formula
EnfaCare Lipil (Mead Johnson)
Similac NeoSure Advance (Abbott)
Gerber Good Start Nourish (Nestle)
Table adapted from proprietary product literature.
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
33
Modifying Formula Caloric and Nutrient Density Preterm infants who are critically or chronically ill may be unable to take adequate formula volume to meet their nutritional needs. Infant and pediatric formulas may be prepared differently to provide a greater caloric or nutrient density. The caloric or nutrient density of an infant or enteral feeding formula can be increased by any one or a combination of the following methods (3,5):
1. Concentration - Increasing the amount of formula base or decreasing the amount of free water added when mixing the formula. This method will increase the concentration of all formula solutes and osmolality. Similarly, adding powdered formula to ready-to-feed formula will increase total nutrient density. The addition of ½ scoop of powdered infant formula to ready-to-feed formula will generally add an additional 4 kcal/oz.
2. Supplementation - Adding a macronutrient module in order to increase caloric density without increasing all other nutrient sources. This may be accomplished through the addition of:
Carbohydrate source: Powdered Polycose (Abbott), or Karo syrup
Fat source: Microlipid (Nestle), vegetable oil, or MCT oil (Nestle)
Protein source: Resource Beneprotein (Nestle)
Combined carbohydrate and fat source: Duocal (Nutricia)
Guidelines for Using Concentrated and High Nutrient Density Formulas
In general, formulas for use in infants should not be concentrated through the reduction of free water to a density greater than 27 kcal/oz as these preparations may not meet their free water needs.
Increases in formula caloric density should be done gradually by 2 – 3 kcal/oz to ensure patient tolerance.
Infants with gastroesophageal reflux (GER) may experience aggravated reflux with concentrated preparations. These infants may do better with the addition of additives such as Polycose or infant cereal.
Infants with renal insufficiency may need to have their formula caloric densities increased through the use of additives alone to prevent excessive increases in renal solute load.
Infants on concentrated formulas should be monitored closely for frequency of urination and urine specific gravity to ensure adequate fluid intake.
Excessive formula concentration may also result in diarrhea, dehydration or conversely, constipation.
Parents should be appropriately instructed on formula preparation prior to discharge from the hospital.
Modules may or may not be readily available outside the hospital; discharge needs should be considered.
Preterm infants > 1800 g or tolerating 165 mL/1g/day should be discharged home on preterm formula Neosure or EnfaCare (22 kcal/oz).
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
34
Enteral Feeding Recipes for the NICU Infant
The following tables provide recipes for increasing formula caloric density to more adequately meet the requirements of infants with increased nutritional needs.
Table 4.8 Preparation of Enfacare or Neosure Formula at Various Caloric
Concentrations
Caloric Density
(kcal/oz)
Formula Powder
and water (ml)
Ready to Feed and
Formula Powder
Approximate
Yield (ml)
22 4 scoops + 240 ml 240 ml 240 ml
24 4 scoops to 215 ml 240 ml + ½ scoop 240 ml
27 4 ½ scoops + 215 ml 240 ml + 1 scoop 240 ml
30 5 scoops + 215 ml 240 ml + 1 ½ scoops 250 ml
Table 4.9 Increasing the Caloric and Nutrient Density of Transitional Preterm Formula
EnfaCare through Supplementation with Powder
Caloric Density EnfaCare or Similac
Neosure - fluid oz
EnfaCare or Neosure
Powder
24 kcal/oz 5 1 teaspoon
26 kcal/oz 3 1 teaspoon
Table 4.10 Recipes for Preterm Infants
Formula
(kcals/oz)
Base
Component
Additive Recipe Volume
Premature 27 Premature 24 –80% ratio
Term Concentrate 20% ratio
200 ml Preterm 24 + 50 ml term concentrate
250 ml
Premature 27 Premature 24 50% ratio
Premature 30 cal/oz, 50% ratio
120 ml Preterm 24 + 120 ml Preterm 30
240 ml
Premature 26 Preterm 24 (2 parts)
Preterm 30 (1 part)
80 ml Preterm 24 + 40 ml Preterm 30
120 ml
Premature 27 Preterm 24 (1 part)
Preterm 30 (1 part)
60 ml Preterm 24 + 60 ml Preterm 30
120 ml
Premature 28 Preterm 24 (1 part)
Preterm 30 (2 parts)
40 ml Preterm 24 + 80 ml Preterm 30
120 ml
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
35
Feeding Protocols for NICU Infants
Trophic Feeding: Advantages and Guidelines for the NICU
Trophic feedings provide small volume enteral feedings for the promotion and protection of the structural and functional integrity of the GI tract (6, 7). Trophic feedings elicit a GI hormonal response in preterm infants thus mediating postnatal intestinal adaptation. Goals and Advantages of Trophic Feedings (6 - 9)
Stimulated GI hormonal response
Enhances GI growth and development
Promotes maturation of GI motor patterns
Decreases incidence of cholestatic jaundice and metabolic bone disease
Increases overall growth and feeding tolerance
Encourages earlier progression to full feedings and hospital discharge.
Accomplishes above goals without an increase in the risk of necrotizing enterocolitis (NEC)
Table 4.11 UVA Trophic Feeding Guidelines for Infants < 1200 grams
Day of Feedings Feeding Schedule Volume: ml/kg
1 & 2 2 ml/kg q 3 hours 16 ml/kg
3 & 4 2 ml/kg q 2 hours 24 ml/kg
Enteral Feeding Guidelines
Table 4.12 UVA Enteral Standard Feeding Guidelines
Birth Weight Schedule & Advance
< 1200 g Trophic feeds x 4 days; advance by 1ml/kg q 12 hrs.
1200-1800 g and < 35 weeks Begin at 2 ml/kg q 3 hr; advance by 1ml/kg q 9 hrs.
>1800 g and ≥ 35 weeks Begin at 5 ml q 3 hr; advance by 5 ml q 6 hrs.
Chapter 4 Nutritional Assessment, Requirements and Enteral Nutrition Management in the Preterm Infant
36
References 1. Abad-Sinden, A, Bollinger R. Challenges and controversies in the nutrition support of the
preterm infant. Support Line. 2001;24(2):5-16.
2. Katrine KF. Anthropometric assessment. In: Groh-Wargo S, Thompson M, Hovasi Cox J, eds. Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 2000:11-22.
3. Groh-Wargo S. Recommended enteral nutrient intakes. In: Groh-Wargo S, Thompson M,
Hovasi Cox J, eds. Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 2000:231-263.
4. Krug SK. Parenteral nutrition: vitamins, minerals and trace elements. In: Groh-Wargo S,
Thompson M, Hovasi Cox J, eds. Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 2000:151-175.
5. Abad-Sinden A, Sutphen JL. Enteral nutrition. In: Walker WA, Durie PR, Hamilton JR,
Walker-Smith JA, Watkins JB, eds. Pediatric Gastrointestinal Disease. Philadelphia, PA: B.C. Decker, Inc.; 2003:1981-1994
6. Schanler RJ, Shulman RJ, Lau C, et al. Feeding strategies for premature infants:
randomized trial of gastrointestinal priming and tube feeding method. Pediatrics. 1999;103(2):434-439.
7. Turner-McKinley LT. Dilemmas in feeding extremely low-birth-weight infants. Support
Line. 1996;1- 5. 8. Berseth CL. Minimal enteral feedings. J Perinatol. 1995;22(1):195-204. 9. Meetze WH, Valentine C, McGuigan JE, Conlon M, Sacks N, Neu J. Gastrointestinal
priming prior to full enteral nutrition in very low birth weight infants. J Pediatr Gastroenterol Nutr. 1992;15:163-170.
Chapter 5 Enteral Nutrition Support
37
Chapter 5
Enteral Nutrition Support
Introduction Pediatric patients unable to tolerate or voluntarily take in adequate oral feedings may be nutritionally managed with enteral tube feedings. 1. Hospitalized normally nourished infants and children with sub-optimal nutrient intake for at
least 3-5 and 5-7 days, respectively, should receive nutrition support, preferably from the enteral route (1).
2. Previously malnourished children, children who have experienced significant trauma or
those with underlying diagnoses which put them at increased nutritional risk and are unable to meet their nutritional intake goals should receive nutrition or nutrition support, preferably from the enteral route, within 48 hours of admission.
Advantages of Enteral Nutrition Enteral tube feedings are generally considered the preferred modality for critically and chronically ill pediatric patients for a number of reasons (2, 3):
Physiological presentation of nutrients
Trophic effects on the intestinal tract
Stimulation and maintenance of the gut mucosa
Reduced metabolic and infectious complications
Improved hepatic function versus parenteral nutrition
Simplified fluid and electrolyte management
More “complete” nutrition: glutamine, trace elements, fiber, and iron
Blunts hypermetabolic response in burn patients
May reduce the incidence of pathogen entry or bacterial translocation into the peritoneal cavity or circulation
Less expensive: $10 - $20 per day versus $200 - $300 per day for parenteral nutrition
Indications for Enteral Feedings Pediatric patients who are unable to meet their nutritional needs through oral nutrition may be nutritionally supported using enteral tube feedings. Tube feedings may also be used for patients who have lost 10% or more of their usual body weight and are unwilling or unable to take in sufficient calories using oral nutrition. Table 5.1 on the following page presents common indications for enteral feedings in pediatric patients (2).
Chapter 5 Enteral Nutrition Support
38
Table 5.1 Conditions Under Which Enteral Feedings are Commonly Warranted in
Pediatric Patients
Preterm Infants
Cardiorespiratory Distress
Bronchopulmonary Dysplasia
Cystic Fibrosis
Congenital Heart Defects
Gastrointestinal Disease and Dysfunction
Inflammatory Bowel Disease
Short Gut Syndrome
Biliary Atresia
Severe Gastroesophageal Reflux
Protracted Diarrhea of Infancy
Post-Surgical Patients
Chronic Nonspecific Diarrhea
Renal Disease
Hypermetabolic States
Cancer
Burn Injury
Severe Trauma/Closed Head Injury/Spinal Cord Injury
Neurologic Disease/Cerebral Palsy
Enteral Tube Feeding Formula Selection Selection of an optimal infant or pediatric tube feeding formula depends upon a number of factors including patient factors such as diagnosis, associated nutritional problems and requirements, and GI function. Important formula factors which need to be considered include (2, 3):
osmolality (not to exceed 450 mOsm/kg for infant formula)
renal solute load
caloric density and viscosity
nutrient composition: type of carbohydrate, protein and fat
product availability (i.e., from WIC) and cost (especially if patient must pay out-of-pocket at home)
Chapter 5 Enteral Nutrition Support
39
Table 5.2 Overview of Term Infant and Pediatric Formulas (2, 4 – 7)
Formula
Type
Description/Indication Formulations Formula Examples
Standard
Term Cow’s
Milk Based
For standard, term infant feeding during the first year of life.
Meets the recommendations of the American Academy of Pediatrics (AAP) for infant formulas (4).
Standard caloric density: 20 kcal/oz
24 kcal/oz (ready to feed) for hospital setting
Carbohydrate: lactose
Protein: casein/whey
Fat: vegetable oil blend, DHA/ARA
Enfamil Lipil (Mead Johnson)
Enfamil 24 Lipil (Mead Johnson)
Similac Advance (Abbott)
Similac Expert Care 24 (Abbott)
“Sensitive” May contain reduced lactose or partially hydrolyzed protein.
Standard caloric density: 20 kcal/oz
Carbohydrate: corn syrup solids and/or lactose
Protein: casein/whey (intact or partially hydrolysed)
Fat: vegetable oil blend, DHA/ARA
Similac Sensitive (Abbott) – lactose free
Enfamil Gentlease (Mead Johnson) – reduced lactose, partially hydrolysed protein
Gerber Good Start (Nestle)– partially hydrolyzed whey
Added Rice Added rice starch for gastroesophageal reflux.
Standard caloric density: 20 kcal/oz
Carbohydrate: lactose or corn syrup solids, rice starch
Protein: cow’s milk protein, casein/whey
Fat: vegetable oil blend, DHA/ARA
Enfamil AR (Mead Johnson)
Similac Sensitive for Spit-Up (Abbott)
Soy Protein Cow’s milk protein sensitivity, lactose intolerance, or galactosemia.
Standard caloric density: 20 kcal/oz
Carbohydrate: corn syrup solids, sucrose (lactose-free)
Protein: soy protein isolate and methionine
Fat: vegetable oil, DHA/ARA
Similac Soy Isomil (Abbott)
Enfamil Prosobee (Mead Johnson)
Extensively
Hydrolyzed
Extensively hydrolysed for milk and/or soy protein sensitivity; considered hypoallergenic
May have partial substitution of LCT as MCT for malabsorptive conditions (6, 7).
Standard caloric density: 20 kcal/oz, some available in 24 kcal/oz (ready to feed) for hospital setting
Carbohydrate: sucrose, tapioca starch, corn syrup solids (all are lactose free)
Protein: extensively hydrolyzed casein
Fat: vegetable oil blend, DHA/ARA, some MCT
Pregestimil Lipil (Mead Johnson) – 55% of fat as MCT
Similac Expert Care Alimentum (Abbott) – 33% of fat as MCT
Nutramigen Lipil (Mead Johnson) – 5% of fat as MCT
Elemental Amino acid based for severe malabsorption or allergy.
Standard caloric density: 20 kcal/oz
Carbohydrate: corn syrup solids (all are lactose free)
Protein: amino acids
Fat: vegetable oil blend, DHA/ARA, some MCT
Neocate Infant (Nutricia) – 33% of fat as MCT
Elecare Infant (Abbott) – 33% of fat as MCT
Fat
Modified
Significant fat malabsorption, lymphangectasia, chylothorax.
85% of fat as MCT
Standard caloric density: 30 kcal/oz (can be diluted)
Carbohydrate: corn syrup solids
Protein: casein Fat: soy oil, MCT oil, DHA/ARA
Enfaport (Mead Johnson)
Renal Chronic kidney disease, requirement for altered electrolyte composition
Standard caloric density: 20 kcal/oz
Carbohydrate: lactose
Protein: casein
Fat: vegetable oils
Simliac PM 60/40 (Abbott)
Chapter 5 Enteral Nutrition Support
40
Table 5.2 Overview of Infant and Pediatric Formulas (2, 4 – 7) Continued
Formula Type Description/Indication Indications/Formulations Formula Examples
Pediatric
Enteral
Formulas
Balanced nutrition for the enteral feeding of children ages 1-13 years of age. Meets 100% of the RDA in 1000 - 1300 ml (depending on the age).
For children with normal GI function.
May be used as oral supplements.
Protein: casein and/or whey
Carbohydrate: maltodextrin, sucrose (lactose free)
Fat source: vegetable oil blend
Fiber source: can include pea fiber, FOS, inulin
PediaSure (oral product, with and without fiber) (Abbott)
PediaSure Enteral 1.0 (with and without fiber) (Abbott)
Pediasure 1.5 Cal (with and without fiber) (Abbott)
Nutren Junior (with and without fiber) (Nestle)
Boost Kid Essentials 1.0
Boost Kid Essentials 1.5 (with and without fiber) (Nestle)
Compleat Pediatric (Nestle) – blenderized food
Pediatric
Enteral
Formulas (Soy)
Balanced nutrition for the enteral feeding of children ages 1-10 years of age. Meets 100% of the RDA in 1000 - 1300 ml (depending on the age).
May be used as oral supplement.
Protein: soy protein based
Carbohydrate: maltodextrin, sucrose (lactose free)
Fat source: vegetable oil blend i.e. soy, high-oleic safflower oil, corn oil & MCT oil
Contains fiber
Bright Beginnings Soy (PBM Products)
Pediatric
Hydrolyzed
Balanced nutrition for the enteral feeding of children ages 1-13 with generalized malabsorption of protein and/or fat.
Potential indications: cystic fibrosis, short gut syndrome, inflammatory bowel disease, chronic diarrhea.
May be used as oral supplements.
Protein: peptide based, usually milk-based
Carbohydrate: maltodextrin, sucrose, cornstarch (lactose free)
Fat: vegetable oils, MCT
Fiber source: can include FOS, inulin
Pediasure Peptide 1.0 (Abbott)
Pediasure Peptide 1.5 (Abbott)
Peptamen Jr (without fiber, with fiber, and with PreBio) (Nestle)
Peptamen Jr 1.5 (Nestle)
Pepdite Jr (Nutricia) – soy and pork based protein
Pediatric
Amino Acid
Balanced nutrition for the enteral feeding of children ages 1-13 with severe protein allergy or malabsorption
May be used as oral supplements.
Protein: amino acids
Carbohydrate: corn syrup solids
Fat: vegetable oils, MCT oil
EleCare Jr (Abbott)
Neocate Jr (Nutricia) – with and without prebiotics
Neocate Splash (Nutricia) – oral product
Pediatric
Reduced
Calorie
Balanced nutrition (including optimal vitamin/minerals) for the enteral feeding of children ages 1-13 with reduced calorie needs
Protein: milk, soy protein
Carbohydrate: sucrose
Fat: vegetable oil
Caloric density: 0.63 – 0.66 kcal/oz
PediaSure SideKicks 0.63 Cal (Abbott)
Compleat Pediatric Reduced Calorie (Nestle)
Table 5.2 adapted from references 2, 6, 7 and proprietary enteral product literature.
Chapter 5 Enteral Nutrition Support
41
Modifying Formula Caloric and Nutrient Density Children who are critically or chronically ill may be unable to take adequate formula volume to meet their nutritional needs. Infant and pediatric formulas may be prepared differently to provide a greater caloric or nutrient density. The caloric or nutrient density of an infant or enteral feeding formula can be increased by any one or a combination of the following methods (2, 6):
1. Concentration - Increasing the amount of formula base (powder or concentrate) or decreasing the amount of free water added when mixing the formula. This method will increase the concentration of all formula solutes and osmolality.
2. Supplementation - Adding a macronutrient module in order to increase caloric density without increasing all other nutrient sources. This may be accomplished through the addition of:
Carbohydrate source: Polycose (Abbott)
Fat source: Microlipid (Nestle), MCT oil (Nestle), or vegetable oil
Protein source: Beneprotein (Nestle), Prosource Liquid Protein (Active Home Nutrition)
Combined carbohydrate and fat source: Duocal (Nutricia) Guidelines for Using Concentrated and High Nutrient Density Formulas
In general, formulas for use in infants should not be concentrated through the reduction of free water to a density > 27 kcal/oz as these preparations may not meet their free water needs.
Increases in formula caloric density should be done gradually by 2 – 3 kcal/oz to ensure patient tolerance.
Infants with gastroesophageal reflux (GER) may experience aggravated reflux with concentrated preparations. These infants may do better with the addition of additives such as Polycose or infant cereal.
Infants with renal insufficiency may need to have their formula caloric densities increased through the use of additives alone to prevent excessive increases in renal solute load.
Children on concentrated formulas should be monitored closely for frequency of urination and urine specific gravity to ensure adequate fluid intake.
Excessive formula concentration may also result in diarrhea and dehydration or, conversely, constipation.
Parents should be appropriately instructed on formula preparation prior to discharge from the hospital.
Modules may or may not be readily available outside the hospital; discharge needs should be considered.
Formula Concentration Standard infant formulas in either ready-to-feed or prepared according to the manufacturer’s instructions provide 20 kcal/oz. Table 5.3 presents several methods for increasing the caloric density to 24 kcal/oz or 27 kcal/oz from these standard formulas.
Chapter 5 Enteral Nutrition Support
42
Table 5.3 Increasing Formula Caloric Density to 24 - 27 kcal/oz through Concentration
Method Caloric Density
(kcal/oz)
Recipe
1 24 13 oz concentrate formula + 9 oz water
2 24 2 ½ scoops powdered formula + 4 oz water
3 24 ½ scoop powdered formula + 4 oz ready to feed
4 27 13 oz concentrate formula + 6 oz water
5 27 5 scoops powder + 7 oz water
Formula caloric density may be increased to 27 kcal/ounce via concentration using powdered or concentrate formulas. However, this method can increase formula osmolality to > 450 mOsm/kg, and can also result in increased renal solute load. Consequently, infants on higher caloric density formulas should be closely monitored for GI tolerance and hydration
status. For additional specific information on concentrating formulas to > 27
kcal/ounce, please contact the appropriate pediatric dietitian on your unit.
Formula Supplementation
Infants who require a 27 or 30 kcal/ounce formula may alternately receive a 24 kcal/ounce standard or preterm formula as the base with added modular products to achieve a caloric density of 27-30 kcal/ounce. Tables 5.4 and 5.5 present guidelines for increasing formula caloric density up to 33 kcal/ounce. In general, the use of polycose and vegetable oil may be more successful for orally fed patients, as it may be difficult to get vegetable oil to stay emulsified for longer hangtimes with enteral feeds. The effect of volume displacement caused by the addition of Polycose and Duocal (2 ml volume per tsp of powder) has been used to calculate all the caloric densities in Tables 5.4 and 5.5.
Table 5.4 Formula Supplementation with Polycose Powder and Vegetable Oil
Method Formula Volume Polycose Canola Oil kcal/ml kcal/oz
1 4 oz of 24 kcal/oz 1 tsp 1 ml 0.9 27
2 4 oz of 24 kcal/oz 2 tsp 2 ml 1.0 30
3 4 oz of 24 kcal/oz 3 tsp 3 ml 1.1 33
Table 5.5 Formula Supplementation with Duocal Powder
Method Formula Volume Duocal
(tsp)
Duocal
(scoops)
kcal/ml kcal/oz
1 4 oz of 24 kcal/oz 1 2.8 0.9 27
2 4 oz of 24 kcal/oz 2 5.7 1.0 30
3 4 oz of 24 kcal/oz 3 8.5 1.1 33
Chapter 5 Enteral Nutrition Support
43
Formula Caloric Modification in Renal Patients When increasing formula caloric density for pediatric renal patients or for other pediatric patients who cannot tolerate increased electrolyte concentrations, it is preferable to use a specialized low electrolyte formula such as Similac PM 60/40 (Ross Labs) concentrate to 24 or even up to 27 kcal/oz. and then add modules, as needed, to achieve 27-30 kcal/oz.
Supplementation of Breast Milk
The caloric and nutrient density of breast milk can be increased by one of two methods:
Method 1 - Enfamil Human Milk Fortifier or Similac Human Milk Fortifier
Method 2 - Use of Powdered Infant Formula: Enfamil or Similac Powder Breast fed preterm infants who are admitted to the PICU, are still below 2500 grams and are unable to take in 180 ml/kg will need to receive fortified breast milk using: Method 1: Human Milk Fortifier as follows:
Table 5.6 Fortification of Breast Milk with Human Milk Fortifier
Step Human Milk Fortifier Breast Milk Caloric Density Increased mOsm
1 1 packet 50 ml 22 kcal/oz 32 mOsm/kg
2 1 packet 25 ml 24 kcal/oz 63 mOsm/kg
Method 2: Breast milk caloric and nutrient density for term infants may be increased to 24-
30 kcal/oz according to the following:
Table 5.7 Increasing Nutrient Density of Breast Milk Using Formula Powder
Method Product Preparation
A Standard Term or Discharge Preterm Powdered Formula
Mix ½ scoop powder per 120 ml breast milk (24 kcal/oz)
B Standard Term or Discharge Preterm Powdered Formula
Mix 1 scoop powder per 150 ml breast milk (27 kcal/oz)
Note: The caloric density of 24 kcal/oz breast milk may be increased further by following the formula supplementation guidelines found in Tables 5.4 and 5.5.
Home Fortification: Fortification with NeoSure of Enfacare powder is the preferred method for fortification at discharge as human milk fortifiers are not readily available in retail establishments.
Chapter 5 Enteral Nutrition Support
44
Supplementation of Pediatric Enteral Formula
The caloric and nutrient density of enteral formula can be increased by one of two methods:
Method 1 - Use of Modulars: Duocal
Method 2 - Increasing Pediatric Enteral Formula Nutrient Density with Tube Feeding Mixers
Method 1: Increasing Pediatric Enteral Formula Nutrient Density with Modulars
Children ages 1 - 13 years of age who have elevated energy and/or protein needs in the face of limited fluid tolerance may require nutritional management with a pediatric formula such as PediaSure (1 kcal/ml), available with or without fiber, supplemented with modular components. The following tables present the gradual advancement of formula caloric density using Duocal.
Table 5.8 Increasing Pediatric Enteral Formula Caloric Density with Modular
kcal/oz Standard pediatric
enteral formula
volume
Powdered
Duocal (tsp)
Powdered
Duocal (weight
in grams)
33 240 ml 2 5.7
36 240 ml 4 11.3
39 240 ml 6 17.0
Method 2: Increasing Pediatric Enteral Formula Nutrient Density with Tube Feeding Mixes
Alternatively, higher caloric densities may be achieved by mixing pediatric formula with calorically dense pediatric or adult formulas. Pediatric tube feeding caloric density of 1.25
kcal/ml can be achieved by mixing 1:1 a standard 1.0 calorie pediatric formula and a
calorically dense 1.5 cal pediatric formula (or an adult 1.5 formula).
Tube Feeding Routes of Delivery
The enteral nutrition delivery route chosen is highly individualized and dependent upon the anticipated duration of the tube feeding as well as individualized tolerance and the child’s medical history. The predominant routes of enteral nutrition include:
Nasogastric (NG) and orogastric (OG)
Gastrostomy (Surgical or Percutaneous Endoscopic Gastrostomy)
Transpyloric Table 5.9 on the following page summarizes the major indications for each of these enteral feeding routes. Even when providing tube feedings, it is important to provide oral stimulation, both nutritive and non-nutritive, whenever possible to preserve the development or preservation of normal suck and swallow. Therapy sessions with the occupational therapist or the speech language pathologist should be directed towards the prevention of oral motor dysfunction and oral tactile defensiveness.
Chapter 5 Enteral Nutrition Support
45
Table 5.9 Routes of Tube Feeding Deliveries and their Indications
Delivery Method Common Indications
Or Advantages
Contraindications and/or
Precautions Nasogastric (NG) or Orogastric (OG)
Prematurity (< 32 wk EGA) Requires presence of func- tioning GI tract with non- obstructive passage from oral or nasal cavity to stomach Usually indicated for short term use (<3 months) Smaller bore tubes associated with increased comfort Often used for nocturnal feedings Tubes can be inserted, removed and reinserted with relative ease
Patients with intractable vomiting Patients with increased risk of aspiration, history of aspiration pneumonia Discouraged in the presence of severe gastroesophageal reflux Otitis media or sinusitis can be potential complications NG and OG tubes can be easily dislodged and thus must be secured
Transpyloric Feedings Nasoduodenal or Nasojejunal
For infants and children with a high risk for aspiration For infants with history of severe gastroesophageal reflux For those with impaired gastric motility or emptying (i.e. preterm infants) For use in patients with gastric dysfunction following head injury, general trauma or surgery
More difficult to place tube; may require fluoroscopic or endosco- py placement of tube Increased potential for GI intoler- ance while advancing to goal rate i.e. malabsorption Tube displacement and potential aspiration Must use continuous pump infusion to optimize tolerance
Gastrostomy Feedings Surgically Placed or PEG PEGs are generally less costly than surgical gastrostomies.
Indicated for long term feedings Requires normal emptying of gastric and duodenal contents Indicated for infants and children with swallowing dysfunction, or for those with esophageal ob- struction but with functioning stomach and small intestine Patients should have intact gag Those with history of GE reflux
who do not respond to medical management may require a Nissen procedure
May be required for nutritional management of congenital anomalies i.e. TE fistula Large bore tubes provide less risk of tube occlusion with meds or viscous blenderized formulas
Should be discouraged under the following conditions: a. Severe GE reflux (may require a Nissen fundoplication) b. Poor gastric emptying c. Intractable vomiting Tube must be secured to prevent pyloric outlet obstruction Potential complications include: a. Aspiration with aspiration pneumonia b. Tube migration c. Localized skin breakdown, leakage of gastric contents An NG feeding trial may be
recommended prior to PEG placement to establish tube feeding tolerance
Jejunostomy Feedings Indicated for long term use Indicated for infants and children with obstructions above the jejunum or poor gastric motility Reduced risk of aspiration Requires slow continuous infusion
Use of intact formulas is possible if feeding into proximal intestine May require more elemental formula if feeding is delivered more distally Potential complications: dumping syndrome, malabsorption, skin breakdown, tube migration, or bacterial overgrowth
Adapted from References 3 and 9
Chapter 5 Enteral Nutrition Support
46
Tube Feeding Administration Methods
Tube feedings can be administered via continuous drip using a pump or via intermittent feedings, using gravity drip or a pump. The method of feeding chosen is dependent upon the following:
Child’s diagnosis
Nutritional history and gastrointestinal status
Route of feeding delivery
Degree of patient mobility
Tolerance to oral feedings
Individual family and caretaker home situation Table 5.10 presents an overview of indications for and advantages of continuous versus intermittent feedings (3, 8).
Table 5.10 Continuous versus Intermittent/Bolus Feedings
Continuous Feedings Intermittent/Bolus Tube Feedings
Better tolerated than intermittent or bolus delivery particularly in patients with limited absorptive surface area; generally results in less reflux, dump- ing and diarrhea. Better tolerated in critically ill children. In the PICU, best to start with a con- tinuous schedule and to progress to intermittent schedule once clinical status is improved. Recommended for delivery of nutrients directly into the small bowel. Recommended for infants with persistent feeding intolerance, significant respiratory instability or significant gut resection. Useful for overnight nasogastric for children with chronic diseases i.e. renal disease, CF, CHD.
More physiological and practical for home enteral feedings. Indicated for children who are more medically stable, have achieved full tolerance of continuous feedings and are ready to transition to a more intermittent schedule. Allows for greater patient mobility, more appropriate for both the rehab and the home setting. Promotes cyclic bursts of GI hormones such as gastrin in preterm infants, thus promoting GI development and maturation.
Chapter 5 Enteral Nutrition Support
47
Transitioning from Continuous to Intermittent Feeds
Once the infant or child is medically stable and able to be transitioned over to a more physiological feeding method, the continuous feeding schedule may be transitioned to intermittent feedings via one of the following three methods:
Table 5.11 Transitioning from Continuous to Intermittent Feeds
Guidelines for Gradual Transition
from Continuous to Intermittent/Bolus Feedings
Method 1
Progressively increase the hours between feedings. Increase the tube feeding interval by 2, 3, and 4 hour intervals to provide 12, 8, and 6 feedings per day, respectively.
Method 2 When anticipating intolerance to intermittent feedings, the volume delivered in 4 hours can be delivered over gradually shorter time periods, over 3 hours, then 2 hours, then 1-1/2 hours, and finally over 1 hour using a constant infusion pump.
Method 3 Continue with continuous feeds overnight over 8 to 12 hours. Divide daily enteral feeding volume over intermittent feedings every 3 to 4 hours during the day.
General Guidelines for the Initiation and Progression of Tube Feedings
The following are some general guidelines for the initiation and progression of tube feedings (1, 3, 8). These represent “general” guidelines and the tube feeding management of each child needs to be individualized to meet specific needs and to ensure appropriate tolerance.
1. For pediatric patients with neurologic impairment and a high risk of aspiration, elevate the head of the bed to at least a 30 degree angle to minimize the risk of aspiration.
2. When using continuous feeds, a 4 hour cycle of tube feeding formula should be
placed in the administration set or syringe. Hang time in the hospital setting should not exceed 4 hours to minimize the risk of bacterial contamination.
3. When using intermittent feeds, place appropriate volume of feeding into the
administration set or syringe. The feeding can be administered via gravity drip, and should generally be administered in 30 - 45 minutes.
4. Initiation and Advancement – See Tables 5.12 and 5.13. 5. Administer tube feeding at room temperature. Refrigerate opened or mixed tube
feedings; discard all unused formula within 48 hours. 6. In children 2 years of age and older and not on a strict fluid restriction, administer at
least 5 - 10 ml of water, or more if needed, every 4 hours or after each intermittent feed to ensure tube patency.
Chapter 5 Enteral Nutrition Support
48
7. In general tube feedings may be started at full strength, but at a sufficiently low rate or volume to ensure feeding tolerance.
8. If diluted formula is started, generally advance the formula strength first over the first
24 hours, and then advance the feeding volume. This will ensure that the child receives optimal nutritional intake as the parenteral nutrition or other intravenous fluids are being weaned.
9. In the hospital setting, the formula name, its rate and strength, gastric residual volume,
as well as urine and stool volume and consistency should be recorded in the patient’s bedside flowsheet.
10. Administration container and tubing should be changed every 24 hours.
Pediatric Tube Feeding Progression The following tables review tube feeding progression guidelines for both continuous and intermittent feeding schedules in pediatric patients. This table may be used when writing pediatric tube feeding orders.
Table 5.12 Continuous Tube Feeding Progression
Age/Weight Initial Infusion Rate Daily Increases Goal Rate
2.0 - 15 kg 2 - 15 ml/hr (1 ml/kg/hr)
2 - 15 ml/hr q 4-8 hr (1 ml/kg q 8 hr)
15 - 55 ml/hr
16 - 30 kg 8 - 25 ml/hr (0.5 - 1 ml/kg/hr)
8 - 15 ml/hr q 4-8 hr (0.5 ml/kg q 8 hr)
45 - 90 ml/hr
30 - 50 kg 15 - 25 ml/hr (0.5 ml/kg/hr)
15 - 25 ml/hr q 4-8 hr (0.5 ml/kg/ q 8 hr)
70 - 130 ml/hr
> 50 kg 25 ml/hr 25 ml/hr q 4-8 hr 90 - 150 ml/hr
Table 5.13 Intermittent Tube Feeding Progression
Age/Weight Initial Volumes Daily Increases Goal Volume
2.0 - 15 kg 5 - 30 ml q 3 - 4 hr 5 - 30 ml q 8 - 12 hr 50 - 200 q 4 hr
12 - 30 kg 20 - 60 ml q 4 hr 20 - 60 ml q 8 - 12 hr 150 - 350 ml q 4 hr
> 30 kg 30 - 60 ml q 4 h 30 - 60 ml q 8 - 12 hr 240 - 400 ml q 4 hr
Chapter 5 Enteral Nutrition Support
49
Management of Combination Enteral and Oral Feedings A combination of both oral feedings and tube feedings, wherever possible, is recommended for the promotion of or maintenance of oral motor developmental skills. Pediatric patients on hospital or home enteral feedings may be managed with a combination of:
Continuous nocturnal feedings via NG tube or gastrostomy over a period of 10 - 14 hours.
Daytime intermittent every 3 - 4 hours to include a combination of oral intake of formula and/or solids as well as tube feedings to supplement the oral intake as needed.
The pediatric dietitian will work closely with the nursing staff as well as the child’s parents or caretakers to develop a feeding schedule/regimen that is appropriate and manageable in the home setting.
Management of Complications Encountered with Enteral Feedings
Complications associated with enteral feedings fall into three major categories:
1. Mechanical 2. Gastrointestinal 3. Infectious
While these complications may be seen in conjunction with enteral feedings, in most cases the complications may have nothing to do with the enteral formula itself, but rather to the method of delivery, administration, medications i.e. antibiotics, as well as the physiological/anatomical problems related to the patient’s illness or condition. Table 5.14 on the following pages reviews the most common complications in pediatric patients, potential causes and guidelines for prevention or intervention.
Chapter 5 Enteral Nutrition Support
50
Table 5.14 Management of Complications Encountered During Tube Feedings
Problem Possible Causes Prevention/Intervention Nausea & Vomiting Gastric retention
Ileus or constipation High fat content of formula Gastric hypomotility Improper tube placement Infusion rate too rapid Hypertonic meds Unpleasant odor of formula Constipation
Maintain head of bed elevated Consider prokinetic medications Initiate tube feeding at low rates, advance slowly, as tolerated Consider alternate feeding route i.e. duodenal/jejunal Use lower fat content formula Use standard polymeric formulas unless contraindicated Monitor for correct tube placement
Abdominal distention, bloating, gas Delayed gastric emptying
Infusion rate too rapid Rapid infusion via syringe Rapid infusion of cold formula Delayed gastric emptying Malabsorption Medications (opiates) Constipation
Administer tube feeding via a continuous infusion at low rate, gradually increase as tolerated Administer feedings at room temperature Consult pharmacist for evalua- tion of medications impacting gastric emptying Consider prokinetic medications i.e. Metoclopramide
Constipation Inadequate fluid GI obstruction Inadequate fiber Inadequate physical activity Concentrated formula
Increase free water intake Digital disimpaction Choose fiber containing formula or add fiber or prune juice Increase physical activity Implementation of a bowel regimen
Diarrhea (Not formula related)
Concurrent drug therapy, such as antibiotic therapy Sorbitol containing medications GI disorder/disease Malnutrition, mucosal
atrophy
Constipation with overflow
Consult pharmacist for review of medications and possible discontinuation Look for Sorbitol on label of oral prescription medications Consider switch to continuous feedings. Begin tube feeding at slow infusion rate, advance slowly, as tolerated
Diarrhea (Formula related)
Inadequate fiber Rapid tube feeding infusion Bacterial contamina- tion of formula Carbohydrate malab- sorption or lactose intolerance Fat malabsorption Impaction
Use fiber containing formula or add fiber to the tube feeding Reduce tube feeding rate to previously tolerated rate, advance slowly, as tolerated Use commercially prepared formula Use lactose-free formula i.e. soy-based or a carbohydrate free formula & replace the carbohydrate Use low fat formula
Continued on following page.
Chapter 5 Enteral Nutrition Support
51
Table 5.14 Management of Complications Encountered During Tube Feedings,
Continued
Problem Possible Causes Prevention/Intervention Clogged feeding tube Improper irrigation of
the feeding tube Administration of medications via the feeding tube High viscosity formula Undissolved formula due to poor mixing
Flush tube with water every 4 - 8 hours Replace tubing Use liquid elixirs when possible Consult pharmacist regarding crushed or diluted medications Blenderize powdered enteral formulas thoroughly Switch to lower viscosity formula Use appropriate size tube for formula viscosity or TF method
Aspiration Gastric hypomotility Gastroesophageal reflux Neurologic damage Displacement or migration of feeding tube to esophagus Oral-motor dysfunc-tion.
Infuse feedings past the pylorus Consider continuous infusion Child may need anti-reflux medications/surgical procedure for long term management Verify tube placement prior to each feed or every 4-8 hours on continuous feedings Replace tube
Electrolyte imbalance Medications which alter electrolyte Previous malnutrition, refeeding syndrome Cardiac or renal insufficiency Formula intolerance (unlikely)
Consult pharmacist regarding medications which may cause electrolyte wasting Infuse tube feeding at low rates; may need to supplement with potassium or phosphorus Manage underlying diagnosis to correct electrolyte imbalance
Dumping syndrome Too rapid infusion Bolus feeds into small bowel Hypertonic formula
Switch to continuous feedings Use a more elemental formula for children with severe malab- sorption or short gut
Hyperglycemia Diabetes Trauma or sepsis Excess carbohydrate intake
Switch to a formula with fiber. Switch method of administration i.e. to continuous feedings Administer insulin (sliding scale)
Azotemia High protein intake Renal insufficiency or
renal immaturity Liver disease Metabolic disease (i.e. inborn error)
Reduce protein content of formula
Dehydration Inadequate fluid intake High caloric density formula
Increase fluid intake via free water flushed q 3 - 4 hours Decrease formula caloric density
Adapted from References 3 and 10
Chapter 5 Enteral Nutrition Support
52
Transition from Enteral to Full Oral Feedings
The transition from enteral to full oral feedings can be prolonged. If infants and children are completely deprived of oral feedings during critical maturation phases, difficulties will be encountered when oral feedings are resumed. Reinstitution of oral feedings in children with G-tubes may evoke such responses as gagging, choking and vomiting. To promote oral feeding transition:
G-tube feedings should be arranged to stimulate oral feeding in timing and amount
Oral stimulation with the speech language pathologist or occupational therapist should occur to diminish the child’s oral defensiveness. Treatment may require weeks on an inpatient basis and up to years on an outpatient basis.
The pediatric and neonatal nutritionists will work closely with the speech language pathologist and/or occupational therapist, as appropriate, as well as the nursing staff on the following patients:
Enteral or parenteral nutrition patients who have been on nutrition support for an extended period of time and are thus unable to take oral feedings
ECMO patients who develop orally defensive behaviors
Bronchopulmonary dysplasia patients who are unable to meet their nutrition needs via oral intake
Chapter 5 Enteral Nutrition Support
53
References
1. Schwenck WF, Olson D. Pediatrics. In: Gottschlich M, Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:347-372.
2. Abad-Sinden A, Sutphen J. Enteral nutrition. In: Walker WA, Goulet O, Kleinman RE, Sherman PM, Shneider BL, Sanderson IR, eds. Pediatric Gastrointestinal Disease. 4
th
edition. Philadelphia, PA: B.C. Decker, Inc.; 2004:1981-1994. 3. Nevin-Folino N, Miller M. Enteral nutrition. In: Samour PQ, King K, eds. Handbook of
Pediatric Nutrition. 3rd
edition. Sudbury, MA: Jones and Bartlett Publishers Inc; 2005:499-524.
4. United States Congress: Infant Formulas Act of 1980, Public-Law 96-359, Sept. 26, 1980. 5. Committee on Nutrition. Soy protein formulas: recommendations for use in infant feeding.
Pediatrics. 1983;72:359-363. 6. American Academy of Pediatrics. Committee on Nutrition. Enteral nutrition. In: Pediatric
Nutrition Handbook. 2004:391-403. 7. Abad-Jorge A, Roman B. Enteral nutrition management of pediatric patients with severe
gastrointestinal impairment. Support Line. 2007; 29(3): 3–11. 8. Charney P. Enteral nutrition: indications, options and formulations. In: Gottschlich M,
Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:141-166.
9. Minard G, Lysen LK. Enteral access devices. In: Gottschlich M, Fuhrman MP, Hammond
KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:176 - 188.
10. Russell M, Cromer M, Grant J. Complications of enteral nutrition. In: Gottschlich M,
Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:189-210.
Chapter 5 Enteral Nutrition Support
54
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
55
Chapter 6
Nutrition Management of High Risk Nutrition Disease States
Congenital Heart Defects (1, 2)
Congenital heart defects (CHD) result from abnormal formation of the heart or major blood vessels, which either obstruct blood flow or cause abnormal blood flow. Infants with congenital heart defects have an increased incidence of malnutrition due to prenatal, genetic and postnatal factors. Postnatal factors contributing to malnutrition include:
Hypoxia and hemodynamic abnormalities: results in fatigue, discoordinated suck and swallow and increased work of breathing
Decreased nutritional intake: related to dyspnea, tachypnea and fatigue associated with chronic hypoxia; may also be related to imposed fluid restriction to prevent fluid overload and cor pulmonale; may be related to delayed or impaired gastric emptying or motility due to stomach pressure causing early satiety
Increased metabolic expenditure related to an increase in cardiac and respiratory work, also related to body composition due to decreased fat stores and increased lean body mass
Mild malabsorption may play a role in the etiology of malnutrition when combined with poor nutritional intake and increased metabolic rate
Nutrition Goal: to promote catch-up growth in previously malnourished infants and children or to maintain appropriate growth in well-nourished infants or children to allow for a more timely surgical repair of the cardiac defect and to promote normal growth potential and development.
Medical Nutrition Therapy
Estimated needs
Increase caloric and protein intake above the recommended levels of the DRIs. Refer to Table 6.1 for calorie, protein and sodium guidelines.
Table 6.1 Nutritional Requirements for Children with CHD
Age (years) Energy (kcal/kg) Protein (g/kg) Sodium (mg/day)
0-0.5 120 – 150 2.2 – 3.5 230
0.5-1 110 – 140 1.5 – 2.5 500
1-3 100 – 120 1.2 - 2 650
4-6 80 – 100 1.2 – 1.5 900
7-10 60 – 90 1.0- 1.5 1200
11-14 Male: 55 – 60 Female: 45 - 60
1.0 – 1.5 1800
15-18 45 – 55 1.0 – 1.5 1800
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
56
Interventions
Increase formula caloric density via formula concentration or supplementation with caloric modulars. Formulas may be concentrated to 24 - 27 kcal/oz via concentration and if needed, up to 30 - 35 kcal/oz, by using Polycose and Microlipid. Refer to formula recipes in Chapter 5.
o Breast milk may be used if the caloric and nutrient density is appropriately increased via: a) supplementation with powdered infant formula or commercial fortifiers (for preterm infants), b) mixing breast milk with higher calorie formula, or c) supplementation with caloric modular.
Enteral nutrition support with either continuous feedings over 24 hours in the hospital setting or with oral intake by day of calorically dense formula and continuous nocturnal feeds over 8 - 12 hours
o 24-hour continuous feeds: achieves greatest caloric intake; safe and effective to improve nutritional status; may promote oral-motor dysfunction
o Oral + 12-hour nocturnal continuous feeds: promotes normal feeding development; infants should take as much of a calorically dense formula as possible during an 8-12-hour day, and provide the rest of goal via nocturnal feed
o Intermittent feeds every 3-4 hours: feeds are given every few hours; the goal volume is offered orally for those safe to po feed, and the balance is given via NGT or GT after a 20-minute oral feeding period.
The use of a lower-sodium formula may be desirable, as excessive sodium intake may exacerbate fluid retention and precipitate congestive heart failure.
Tips for increasing calories and protein with oral intake: o Oral intake can be maximized using a variety of every-day ingredients (see
Appendix K) o To increase calories for hospitalized patients, nutritional supplements such
as PediaSure, Mightyshakes, and Ensure are available. For outpatients, PediaSure, Ensure, and Boost are available in the grocery store; however, store brands (such as Target, Walmart, etc.) or Carnation Instant Breakfast may be more economical for families.
o Frequent snacking may be necessary to meet calorie and protein needs.
Cystic Fibrosis (3, 4)
Cystic fibrosis is a genetic, multisystem progressive disease causing the cells producing mucus, sweat, saliva, and digestive juices to create thick and sticky secretions resulting in pancreatic insufficiency, chronic lung disease, excessive loss of sweat electrolytes, and malnutrition.The nutritional needs of children with cystic fibrosis are increased due to pancreatic insufficiency and progressive pulmonary failure. Factors contributing to the nutritional implications include:
Malabsorption of fat and protein
Increased work of breathing and repeated pulmonary infections
Loss of fat-soluble vitamins and essential fatty acids
Decreased oral intake during respiratory exacerbations
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
57
Nutrition Goal: provision of adequate calories and protein to support normal growth and overcome the demands of increased respiratory effort and malabsorption.
Medical Nutrition Therapy
Special Considerations in Nutrition Assessment
Yearly fat soluble vitamin levels (A, D, and E) should be checked. However, vitamin A is a negative acute phase reactant and should not be checked while a patient has active infection.
Estimated Needs
120-150% of the DRIs for calories is needed for optimal growth.
To prevent deficits of essential nutrients, provide additional vitamin A, D, E and K.
Table 6.2 Guidelines to Replace Essential Vitamins A, D, E and K
Essential Vitamin Amount/Day
Vitamin A 5,000 to 10,000 IU/day
Vitamin D 400 to 800 IU/day
Vitamin E 25 to 50 IU for infants; 100-200 IU < 8 years; 200-400 IU > 8 years
Vitamin K 2-5 mg each week or 2-5 mg twice a week for patients on chronic antibiotics or if with cholestatic liver disease; 300-500 mcg > 8 years
Usual dosage for supplemental water soluble vitamins is 1 ml per day pediatric multivitamin for infants 0-2 years old.
Interventions
Oral intake should be maximized as much as possible, through the use of calorically dense foods, double portions, frequent snacks, nutrition supplements (ie, Scandishakes), and caloric modules added to foods (dry milk powder, vegetable oil, butter, Duocal, etc).
A combination of oral and tube feeding is frequently necessary to meet nutritional needs. Nocturnal feeds are preferred, NG for short term; gastrostomy for long term.
Breast milk, standard infant formula or special MCT-containing formulas such as Pregestimil are appropriate. Breast milk and formulas should almost always be high caloric density > 24 kcal/oz.
NaCl supplementation for infants is recommended in the amount of 4 - 6 mEq/kg/day which can be achieved by giving 1/8 - 1/4 teaspoon table salt per day. This should be divided between the first few feedings per day.
For pancreatic enzyme replacement recommendations, see Table 6.3. o If an infant can swallow purees, enzyme beads can be given in an acidic
puree, like applesauce. Enzyme beads should not be given in an alkaline
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
58
fluid, because this will cause premature degradation of the bead’s enteric coating and subsequent denaturing in the stomach.
Table 6.3 Dosing Pancreatic Enzymes in CF Patients
Age
Meal Dose Adjusting Dose
Infants
2000-4000 units lipase/120 ml formula/nursing (mean of 1800 lipase units)
450-900 Units lipase/g of fat
Increase by 2000-2500 units lipase/feed as volume increases or malabsorption returns
Children < 4
years
1000-2000 units lipase/kg/meal
500-4000 units lipase/g fat
Snacks: ½ meal dose
Compare units lipase/g fat when weight dose appear above range
Children > 4
years
500-2000 units lipase/kg/meal
500-4000 units lipase/g fat
Snacks: ½ meal dose
Compare units lipase/g fat when weight dose appears above range
Note: Units of lipase provided for each gram of long chain triglycerides provided by the formula. A formula whose fat source is predominantly MCT oil, i.e., Pregestimil can be beneficial for decreasing the quantity of enzyme dosing.
o For continuous 24 hour feedings: The total calculated lipase dose provided per 24 hours of the selected formula should be 500-4000 lipase units (mean of 1800 lipase units) per gram of LCT divided in equal amounts and administered every 3 to 4 hours.
o For cycled overnight tube feedings: 50-75% of the calculated enzyme dosage should be administered at the beginning of the feeding and the remaining 25-50% at the end.
Option A: Taking enzyme orally: Provide meal dose of enzymes by mouth at the beginning of feeds. Following completion of feeds, give ½ of a meal dose by mouth.
Option B: Pre-digesting formula: Dissolve 1 3/4 tsp. sodium bicarbonate (baking soda) in 100 ml water. Mix beads from enzyme capsule in the sodium bicarbonate solution; use 5 ml of solution per capsule. Leave beads in solution for 15-20 minutes. Add mixture to formula after beads have dissolved.
o For intermittent tube feedings: The calculated enzyme dose should be given just prior to each feeding.
o Dosing should not exceed 4,000 units lipase per gram of fat.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
59
Figure 6.1: Vitamin D Treatment Algorithm from the Cystic Fibrosis Foundation
Guidelines on Vitamin D for Children Age 1 – 10 Years Old
Age: 1-10 years Baseline Dose of Vitamin D3:
800-1000 IU Vit D3/day
Check 25-OH Vit D yearly, preferably at the end of winter
25-OH Vit D <30 ng/ml
25-OH Vit D >30 ng/ml
Double dose of adherent patient to:
1600-2000 IU Vit D3/day Continue Baseline Dose of 800-1000
IU Vit D3/day
Recheck 25-OH Vit D level in 3 months
25-OH Vit D <30 ng/ml
25-OH Vit D >30 ng/ml
Double dose of adherent patient to:
3200-4000 IU Vit D3/day
Recheck 25-OH Vit D level in 3 months
25-OH Vit D <30 ng/ml
25-OH Vit D >30 ng/ml
Continue adherent patient at present
IU Vit D3 dose/day
Confirm patient is adherent and has been receiving 4000 IU Vit D3/day for the past 3 months
For adherent patient taking <4000 IU Vit D3/day,
increase to 4000 IU/day
Recheck 25-OH Vit D level in 3 months
25-OH Vit D <30 ng/ml
*Note: All Vitamin D dosage recommendations include vitamin D contained in multivitamin(s) + additional stand-alone vitamin D supplements
Refer to specialist 25-OH Vit D >30 ng/ml
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
60
Figure 6.2: Vitamin D Treatment Algorithm from the Cystic Fibrosis Foundation
Guidelines on Vitamin D for Children > 10 Years Old Through Adulthood
Recheck 25-OH Vit D level in 3 months
25-OH Vit D <30 ng/ml
Double dose of adherent patient to: 3200-8000 IU Vit D3/day
25-OH Vit D >30 ng/ml
Continue adherent patient at present
IU Vit D3 dose/day
*Note: All Vitamin D dosage recommendations include vitamin D contained in multivitamin(s) + additional stand-alone vitamin D supplements
Age: >10 years through Adulthood
Baseline Dose of Vitamin D3: 800-2000 IU Vit D3/day
Check 25-OH Vit D yearly, preferably at the end of winter
25-OH Vit D <30 ng/ml
25-OH Vit D >30 ng/ml
Double dose of adherent patient to: 1600-4000 IU Vit D3/day
Continue Baseline Dose of 800-2000
IU Vit D3/day
25-OH Vit D >30 ng/ml
Recheck 25-OH Vit D level in 3 months
25-OH Vit D <30 ng/ml
Confirm patient is adherent and has been receiving 6400-10000 IU Vit D3/day for the past 3 months
Recheck 25-OH Vit D level in 3 months
25-OH Vit D <30 ng/ml
Refer to specialist
25-OH Vit D >30 ng/ml
Double dose of adherent patient to: 6400-10000 IU Vit D3/day
Recheck 25-OH Vit D level in 3 months
25-OH Vit D <30 ng/ml
25-OH Vit D >30 ng/ml
For adherent patient taking
10000 IU Vit D3/day
For adherent patient taking <10000 IU Vit D3/day,
increase to 10000 IU/day
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
61
Renal Disease (5 - 8)
Sudden removal of the renal regulating ability produces profound electrolyte and metabolic disturbances resulting in fluid retention, acidosis, hyperkalemia, hyperphosphatemia, nitrogen retention, hypocalcemia and hyperuricemia. Dietary manipulations may change dramatically during the course of renal disease.
Nutrition Goal in Acute Renal Failure: to provide sufficient nutrients to restrain the catabolic response and hasten renal recovery within the restrictions demanded by limited renal capacity.
Nutrition Goal in Chronic Renal Disease: to maintain nutrition sufficient for optimal growth within the margins imposed by limited renal excretory and regulatory capacity while at the same time avoiding excesses of nitrogen, phosphate, sodium, potassium and fluid. Medical Nutrition Therapy
Special Considerations in Nutrition Assessment
Dry weight should be estimated, whenever possible, using nutrition-focused physical findings, such as blood pressure, edema, and weight change with fluid removal via dialysis.
BMI should be plotted against height age, for those patients who are prepubertal with significant stunting.
Skinfold measurements and arm anthropometry are not recommended in this population.
Serum electrolyte levels, parathyroid hormone, and renal profile are important laboratory components in this population.
Serum albumin is often used as a marker of nutrition status because hypoalbuminemia is a risk factor for mortality; however, serum albumin is a better indication of severity of disease and inflammation than it is of nutrition status.
25(OH) vitamin D levels should be measured at least yearly.
Estimated Needs
Initially, use DRI/EER for age and weight or catch-up growth, when appropriate, and adjust caloric delivery based on growth parameters. Provision of at least 80% of the DRI/EER for height age is recommended for normal growth.
Estimated protein needs are in Table 6.4.
Fluid needs are determined by the patient’s clinical status. o If fluid limitation becomes necessary due to edema or hypertension, provide
insensible losses (Table 6.5) plus measured urine output and amount to replace other losses (vomiting, diarrhea, ostomy output).
o Children with polyuria may require 180-240 ml/kg/day.
Generally, micronutrient needs are 100% of the DRI for age for B vitamins, zinc, copper, folic acid, and vitamins A, C, D, E, and K.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
62
Table 6.4 Protein Recommendations for Dialysis Patients
Table 6.5 Insensible Fluid Losses
Age Group
Fluid Loss
Preterm Infants Up to 40 ml/kg/d
Neonates 20-30 ml/kg/d
Children & Adolescents 20 ml/kg/d or 400 ml/m²
Interventions
Diets should be liberalized as much as possible, to allow a palatable diet with adequate variety to promote growth, development, and quality of life.
Oral supplements, either standard products like PediaSure or renal products like Nepro or Suplena, may be indicated for patients with anorexia related to dialysis.
Generally, a low renal solute load, low electrolyte formula such as Similac PM 60/40 is indicated for infants with renal insufficiency. Soy formulas should be avoided if at all possible due to their high phosphorus content. Formulas can be concentrated to 24-27 kcal/oz, and then supplemented to 30 kcal/oz using modulars.
Infants should be encouraged to start solid foods at ~6 months of age, as any normal infant would.
Enteral supplementation should be considered, particularly in infants and toddlers with poor growth and in those with polyuria requiring high fluid volumes. Table 6.7 provides a formula comparison. o Standard formulas may be appropriate for toddlers and younger children,
depending on electrolyte status. o Use of a high calorie (1.8 kcal/ml), defined renal formula i.e., Nepro may be
recommended for enteral nutrition support either continuous in the hospital setting or as an overnight feeding regimen for children over 24 months. In situations where Nepro provides too much protein for a child, Suplena (1.8 kcal/ml) can be used instead.
Intradialytic parenteral nutrition should be considered in patients on hemodialysis in whom oral and enteral supplementation are not effective in correcting malnutrition.
Use 1 ml multivitamin drops (need to supplement folic acid) or 1 children’s chewable multivitamin per day to provide vitamin and mineral needs, or use ½
Age Group Hemodialysis (g/kg)
Peritoneal dialysis (g/kg)
0-6 months 1.6 1.8
7-12 months 1.3 1.5
1-3 years 1.15 1.3
4-13 years 1.05 1.1
14-18 years 0.95 1.0
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
63
tablet Nephrovite for children <3 years of age and 1 tablet for children >3 years of age.
Supplement salt as needed; table salt can be added to a daily supply of feeds. 1/8 teaspoon of table salt provides 11 mEq of sodium.
Iron may be supplemented in addition to erythropoietin for management of anemia.
Vitamin D should be replaced in the case of deficiency, as per Table 6.6, even if the child is receiving calcitriol to control PTH levels.
Growth hormone can be an important adjunct to nutrition management in treating growth retardation.
Table 6.6 Recommended Supplementation for Vitamin D Deficiency/Insufficiency in
Children
Serum 25
(OH) D
(ng/mL)
Definition Ergocalciferol (D2) or Cholecalciferol
(D3) Oral/Enteral
Duration
(mo)
< 5 Severe deficiency 8000 IU X 4 wk or (50000 IU 2X per mo for) X 2 mo
3
5-15 Mild deficiency 4000 IU/d x 12 wk or (50000 IU q other wk for 12 wk)
3
16-30 Insufficiency 2000 IU/d or (50000 IU q 4 wk) 3
≥ 30 Homeostasis 200-1000 IU/d daily
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
64
Table 6.7 Nutrient Content of Selected Renal Formula, per 100 kcals
Adapted from proprietary product literature.
Enfamil
Lipil
Similac PM
60/40
Gerber Good
Start Plus
DHA/ARA
Pediasure Nepro with
Carb
Steady
Suplena
with Carb
Steady
Fluid, ml 150 148.0 150 100.0 55.6 55.6
Protein, g 2.1 2.2 2.2 3.0 4.5 2.5
Fat, g 5.3 5.6 5.1 5.0 5.3 5.3
Carbohydrate, g 10.9 10.2 11.2 11.0 9.3 11.2
Fiber, g 0 0.0 0 0.5 0.9 0.9
Linoleic acid, mg 860 1300.0 900 1071.7 Not available Not available
Vitamin A, IU 300 300.0 300 257.4 176.7 176.7
Vitamin D, IU 60 60.0 60 50.6 4.7 4.7
Vitamin E, IU 2 2.5 2 2.3 5.3 5.3
Vitamin K, mcg 8 8.0 8 3.8 4.7 4.7
Thiamin (B1), mcg 80 100.0 100 270.0 133.3 144.4
Riboflavin (B2), mcg 140 150.0 140 211.0 150.0 144.4
Vitamin B6, mcg 60 60.0 75 261.6 472.2 472.2
Vitamin B12, mcg 0.3 0.3 0.33 0.6 0.5 0.5
Niacin, mcg 1000 1050.0 1050 1687.8 1777.8 1777.8
Folic acid, mcg 16 15.0 15 37.1 58.9 58.9
Pantothenic acid, mcg 500 450.0 450 1012.7 888.9 888.9
Biotin, mcg 3 4.5 4.4 32.1 26.4 26.4
Vitamin C, mg 12 9.0 9 10.1 5.8 5.8
Choline, mg 24 12.0 12 30.0 35.3 35.3
Inositol, mg 6 24.0 6 8.0 Not available Not available
L-carnitine, mg 2 Not available Not available Not available 14.7 14.7
Calcium, mg 78 56.0 64 97.0 58.9 58.9
Phosphorus, mg 43 28.0 36 80.2 38.9 38.9
Magnesium, mg 8 6.0 7 19.8 11.7 11.7
Iron, mg 1.8 0.7 1.5 1.4 1.1 1.1
Zinc, mg 1 0.8 0.8 1.2 1.4 1.4
Manganese, mcg 15 5.0 7 101.3 116.7 116.7
Copper, mcg 75 90.0 80 101.3 116.7 116.7
Iodine, mcg 10 6.0 12 9.7 8.9 8.9
Selenium, mcg 2.8 1.8 2 2.3 4.1 4.1
Sodium, mg 27 24.0 27 38.0 58.9 43.9
Potassium, mg 108 80.0 108 130.8 58.9 62.2
Chloride, mg 63 59.0 65 101.3 46.9 51.9
Osmolality, mosm/kg water
300 280.0 Not available 430.0 600.0 600.0
Osmolarity, mosm/L 270 254.0 Not available 364.0 556.0 344.0
Price (per 100 kcals) $0.64 $0.74 $0.64 $0.74 $0.30 $0.30
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
65
Severe Gastrointestinal Impairment (8 - 13)
Severe gastrointestinal impairment caused by chronic diarrhea/malabsorption, cystic fibrosis, Crohn’s disease, radiation enteritis, delayed gastric emptying, pancreatitis, HIV/AIDS, or short bowel syndrome may be characterized by:
Malabsorption Diarrhea Electrolyte instability Malnutrition
Nutrition Goal: To provide adequate nutrition through appropriate formula selection to promote better total nutrient absorption and avert fat malabsorption, protein sensitivity, and carbohydrate intolerance in order to improve GI adaptation and deliver optimal nutrition. Medical Nutrition Therapy
Special Considerations in Nutrition Assessment
Children on parenteral nutrition should have routine monitoring of serum electrolytes, trace element status, and iron status.
Children with malabsorptive conditions should have fat soluble vitamin levels, particularly vitamin D, measured
Children with an ileal resection should be evaluated for B12 deficiency.
Consider potential deficiencies based on site of intestinal resections (Appendix L). Estimated Needs
Estimated needs may be similar to that of other children of the same age and gender, but should be individualized based on disease acuity and need for catch-up growth. Malabsorption should also be considered in children with some conditions, such as short bowel syndrome.
Intervention
Formula selection: o The algorithm (Figure 6.2) may be used to aid in the decision-making process
to select a clinically appropriate formula. o Refer to Table 6.9 for an overview of semi-elemental and elemental infant and
pediatric formulas for use in children with severe GI impairment o First approach is to try intact protein formula or breast milk to promote intestinal
adaptation and improved GI tolerance. o Breast milk, although nutrients are not hydrolyzed, improves GI adaptation
compared to protein hydrolysate formulas due to bile salt lipase, lymphocytes, macrophages, well-absorbed peptides and amino acids, immunoglobins and growth factors.
o If intact formula or breast milk is not tolerated, a peptide based, higher fat formula may be used to avert allergies, bacterial overgrowth, and exert trophic effects on the GI tract.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
66
o Semi-elemental formulas are typically used for those with severe GI impairment or protein allergies.
o Elemental formulas are typically used when semi-elemental formulas are not tolerated.
o Formulas with higher fat content slow down transit time, promoting absorption, which improves GI adaptation.
o Long chain triglycerides: more trophic effect promoting intestinal adaptation o Medium chain triglycerides: more water soluble, improved absorption in some
children, higher osmotic effect o Trial time of formula should be about 3-5 days before evaluating the need to
change formulas.
Continuous EN provides slow delivery of nutrients to GI tract, promoting better tolerance and nutrient absorption.
Fiber: Addition of water-soluble fiber lengthens transit time and nutrient contact with mucosa increasing absorption and improving GI tolerance.
o Liquid fruit pectin: Certo, SureJell o Hydrolyzed guar gum: Resource Benefiber (institutional version)
Use of prebiotics and probiotics may reduce diarrhea and decrease symptoms of colic.
Oral rehydration solutions may be required in those with high ostomy outputs or those without a colon.
Certain medications containing sorbitol, potassium chloride elixirs, and certain antibiotics may be the cause of diarrhea.
Children with vomiting, diarrhea, abdominal distention, and metabolic acidosis should be evaluated for small bowel bacterial overgrowth.
Table 6.8 Guidelines for Formula Selection in Differing Disease States (Refer to Algorithm in Figure 6.1 and Specialized Formula Table 6.9)
Disease State
Recommended Formula
Cystic Fibrosis Standard polymeric; semi-elemental or partially hydrolyzed formula with appropriate pancreatic enzyme dosing.
Crohn’s Disease Standard polymeric or semi-elemental.
Short Bowel Syndrome Begin with semi-elemental, partially hydrolyzed formula. If not tolerated, back down to elemental formula. Eventually transition back from elemental to standard polymeric to promote better GI stimulation and adaptation.
Severe Malabsorption or Severe
Allergic Complications
Semi-elemental/ partially hydrolylzed; if not tolerated proceed to elemental formula.
Severe Protein Allergy Elemental formula
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
67
.
67
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
68
Table 6.9 Nutrient Information for Semi-Elemental & Elemental Formula for Use with Severe GI Impairment (per 100 kcal)
Nutrient Pregestimil Alimentum Neocate
Infant
Peptamen
Junior Pepdite Junior
PediaSure
Peptide Neocate Jr EleCare Jr
kcal/mL 0.67 0.67 0.67 1.0 1.0 1.0 1.0 1.0
Protein (g) 1.9 1.9 2.08 3.0 3.1 3.0 3.3-3.5 3.1
Protein
Source
Hydrolyzed casein
Hydrolyzed casein
Free amino acids
Whey hydrolysate
Soy and pork hydrolysates +
free amino acids
Whey hydrolysate,
caseine
Free amino acids
Free amino acids
Carbohydrate (g) 6.8 6.8 7.8 13.6 10.6 13.4 10.4-11 10.7
Carbohydrate
Source
Corn syrup and tapioca
Tapioca and sucrose
Corn syrup solids
Maltodextrin and sugar
Maltodextrin and corn syrup
(banana contains sucrose,
sweetener)
Maltodextrin, scFOS
Corn syrup solids (flavors
contain sucrose,
sweetener)
Corn syrup solids
Fat (g) 3.8 3.8 3.0 3.84 5 4.1 4.7-5 4.9
Fat
Source MCT oil, corn oil
MCT, soy, safflower oil
Safflower, soy, coconut
oil
Coconut, soy, canola, soy oil,
lecithin
Coconut, safflower, soy oil
Canola, MCT oil
Coconut, canola,
safflower oil
Safflower, coconut, soy
oil
Distribution
Protein 11% 11% 12% 12% 12% 12% 13-14% 15%
Carbohydrate 41% 41% 47% 54% 42% 53% 42-44% 43%
Fat
LCT
MCT
48% 48% 41% 34% 46% 35% 42-45% 42%
45% 67% 67% 40% 65% 50% 65% 67%
55% 33% 33% 60% 35% 50% 35% 33%
Osmolality
(mOsm/kg) 340 370 375
260 (unflavored) 360-400(flavors)
430 (unflavored) 440 (banana)
250 590(unflavored) 680-700(flavor)
590
Indications
Generalized malabsorption,
short bowel syndrome
Generalized malabsorption Short bowel syndrome
Cow’s milk or multiple food
allergies, GER
Malabsorption, gastrointestinal
impairment
Malabsorption, severe food
allergies, gastrointestinal tract impairment
Mal-absorption,
maldigestion
Multiple food allergy, gastro-intestinal tract impairment,
malabsorption
Malabsorption,
severe food allergies, GI tract
impairment
Adapted from proprietary product literature.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
69
Chylous Ascites/Chylothorax (13 - 18)
Chylous ascites is a condition caused by a complication in which there is an occlusion to a thoracic duct or division of the lymphatic channels leading to chyle leaks in the thoracic and peritoneal cavities. As a result, pleural effusions, abdominal pain, anorexia, hypoalbuminemia, hyponatremia, hypocalcemia, hypercholesterolemia, and elevated alkaline phosphatase are common, which present nutritional challenges to the clinician if left unmanaged. Factors contributing to the nutritional implications include:
Body protein loss White blood cell losses Immunosuppression Lipid losses
Nutrition Goal: To sustain electrolyte, fluid, and nutritional homeostasis by providing adequate nutrients without stimulating chyle flow and increasing lymph production.
Medical Nutrition Therapy
Estimated Needs
Caloric needs are 1.7-1.8 x BEE.
Protein needs may be higher than normal for a hospitalized patient, if there is active chest tube output.
Interventions
Nutrition therapy is an important part of the UVA pediatric chylothorax management algorithm (Appendix M).
A low-fat diet (Table 6.10) or low LCT/high MCT formula is generally needed. o Elimination of long chain triglycerides (LCT) can decrease lymphatic flow
and enhance fistula healing. LCT should be restricted to 10-20 g/day. o In infants or those fed enterally, use special formulas that are high in MCT,
such as Enfaport (Mead Johnson), Monogen (Nutricia), Portagen (Mead Johnson) , or low in total fat, such as Lipisorb (Nutricia), Vivonex (Nestle), or Tolerex (Nestle).
o Nutrition supplements (Resource Breeze or Carnation Instant Breakfast with skim milk) should be utilized to ensure adequate intake.
If oral intake or enteral feeds are not tolerated or if extremely aggressive therapy is required, parenteral nutrition and IV lipids may be used.
To prevent essential fatty acid (EFA) deficiency, EFA should represent 2-4% of calories. Good sources of essential fatty acids include sunflower, safflower, flaxseed, and canola oils.
o Monitor for essential fatty acid (EFA) deficiency; an elevated triene:tetraene ratio is indicative of deficiency. Signs and symptoms of EFA deficiency include skin lesions, eczema, impaired wound healing, thrombocytopenia, and growth problems.
A therapeutic vitamin and mineral may need to be provided to ensure adequate micronutrient delivery.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
70
Table 6.10 Food Selection Guidelines for a Restricted Fat Diet
Food Group Recommended Avoid Tips
Grains
Fat-Free and Low-Fat: bread, pasta,
cereals, rice, barley, and crackers
Breads with eggs or cheese, granola
cereal, cereal with nuts, biscuits,
waffles, pancakes, croissants, muffins, doughnuts, high fat
crackers
Try French bread, pita bread, plain bagels, bread sticks, puffed
rice and Rice Krispies.
Fruits Fresh, frozen,
canned, or dried fruit, juices
Avocado, coconut Use as snacks
Vegetables Fresh, frozen, or
canned vegetables
Vegetables with added fat, cream, or cheese sauce, fried
vegetables
Cook in broth or sprinkle with herbs and
spices to add flavor
Dairy
Skim milk, nonfat cheese, nonfat yogurt, nonfat
cottage cheese, fat-free sour cream or
cream cheese
1%, 2%, whole, or flavored milk,
buttermilk, cream, and regular
processed cheeses
Whole milk can be substituted with skim milk, evaporated skim milk, or nonfat yogurt
Protein
Egg whites, powdered egg
whites, lean cuts of beef, pork, lamb,
veal, poultry without skin, fresh, frozen, or canned fish in
water, nonfat tofu, no added fat beans
Fried, fatty, or heavily marbled
beef, poultry, fish canned in oil,
luncheon meats, pizza, nuts, peanut
butter
Broil, roast, grill, or boil proteins, trim all visible fat before cooking, use natural juices instead of gravies and sauces
Other
Fat-free broths or soups, fruit ice,
popsicles, gelatin, angel food cake, graham crackers, nonfat desserts,
honey, hams, jellies, syrups, hard candy,
soda, fruit drinks
Cream or cheese sauces or soups,
gravy, mayonnaise, cakes, cookies,
pies, and ice cream, coconut, chocolate,
creamed candy, candy with nuts, chips, buttered
popcorn
Try lemon juice, vinegar, garlic, onion
powder, fat-free margarine, fat-free dressings, fat-free mayonnaise, and marshmallows.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
71
Burns (19-21)
Burns create an extreme state of physiologic stress; hypermetabolism is multifactorial and is due to increased circulating cytokines, catecholamines, glucagon, and cortisol; evaporative losses from burn wounds; and infectious complications. Patients with burns have elevated calorie, protein, fluid, and micronutrient needs.
Nutrition Goal: To provide adequate nutrition (including adequate calories, protein, fluid, and micronutrients) to blunt the hypermetabolic response, reduce lean body mass wasting, induce positive or neutral nitrogen balance, and promote wound healing.
Medical Nutrition Therapy
Estimated Needs
See Table 3.10 for predictive energy expenditure equations.
Patients older than 6 months of age with >30% body surface area burned (BSAB) should receive 20-23% of calories from protein (2.4-4 g/kg protein). o Protein needs can also be determined by RDA for age + 1 gram of protein per
% BSAB. o Monitor fluid status and BUN when giving large amounts of protein; watch for
signs of azotemia, hyperammonemia, and acidosis.
Maintenance fluids for burn patients can be calculated as follows:
21500 ml x m2Total maintenance fluids = (35 % burn) x m (ml/hr)
24 hours
Interventions
Snacks and high-protein nutrition supplements are often needed to meet needs in those taking oral nutrition.
Enteral nutrition supplementation should be considered in those not able to meet needs orally, including those with >20% BSAB, facial injury, or inhalation injury.
The daily wound care/sedation schedule will need to be considered, as patients are generally NPO a few hours prior to sedation.
All children should receive an age-appropriate multivitamin. Those with burns > 20% BSAB should receive additional micronutrient supplementation according to Table 6.11.
Table 6.11 Micronutrient Supplementation for >20% BSAB
< 3 years old > 3 years old
Ascorbic acid 250 mg twice daily 500 mg twice daily
Vitamin A 5,000 IU daily 10,000 IU daily
Zinc sulfate 220 mg daily (~50 mg elemental zinc)
100 mg daily (~25 mg elemental zinc)
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
72
Refeeding Syndrome (22-28)
Refeeding syndrome is a constellation of hypokalemia, hypomagnesemia, and hypophosphatemia that occurs with aggressive nutritional repletion of patients who are severely malnourished, underweight, or starved. Refeeding syndrome can result in severe neurologic, cardiac, respiratory, and hematologic abnormalities, and even death. At-risk patients include those with:
Classic marasmus/kwashiorkor
Anorexia nervosa
Chronic diseases causing undernutrition (cancer cachexia, Crohn’s disease, cystic fibrosis, HIV)
Acute weight loss of 10% within the past 1-2 months (even in the presence of morbid obesity)
<80% ideal body weight for height
Arm anthropometrics less than the 5th
percentile for age
Unfed for 7-14 days with evidence of stress/depletion
Prolonged IV hydration without provision of sufficient calories and protein
Failure to thrive due to starvation/neglect
Nutrition Goal: To identify patients at risk for refeeding syndrome and to prevent the metabolic complications of this syndrome while appropriately advancing nutrition support therapy to adequate levels.
Medical Nutrition Therapy
Special Considerations in Nutrition Assessment
Serum electrolytes, particularly potassium, phosphorus, and magnesium must be assessed, and should ideally be corrected with IV supplementation before beginning nutrition support. Electrolytes should be checked, initially, 2-3 times daily, and when the patient is more stable, can be checked once daily or once every other day.
Patients should receive an ECG to obtain baseline cardiac rhythm and check for arrhythmias.
Estimated Needs/Interventions
Calories should begin at 50% of BEE or 80% of current caloric intake. Increase by 10-15% per day to a goal. Daily intakes should be based on actual (not goal) intake from the day prior. Goal calories should be based on catch-up growth calculations or estimated basal needs, plus a factor for weight gain, if desired.
Protein should begin at 50-75% of goal levels, with a gradual increase to goal. Goals may be based on catch-up growth calculations, if accelerated weight gain is desired.
Fluid requirements are 75% of maintenance levels in severely malnourished patients, to prevent cardiac overload.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
73
Electrolyte requirements for parenteral nutrition in at risk patients are: o Na – 1 mEq/kg/day o K – 4 mEq/kg/day o Mg 0.6 - 1.2 mEq/kg/day o Phosphate – 3-4 mEq/kg/day for infants, 1-2 mEq/kg/day for toddlers and
adolescents o Adjust as needed per laboratory values
Standard vitamin/mineral supplementation is prudent: o Standard dosage for Peds or Adult MVI or trace element solutionin TPN (See
Chapter 7) o Enteral nutrition: provide 1 ml multivitamin drops + DRI for folic acid o Oral nutrition: provide children’s multivitamin with minerals for children over 4
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
74
References
1. Abad-Sinden A, Sutphen JL. Growth and nutrition. In: Emmanoullides GC, Riemenschneider TA, Allen HD, Gutgessel HP, eds. Moss and Adams Heart Diseases in Infants, Children and Adolescents, Including the Fetus and Young Adult. 6
th edition.
Baltimore, MD: Lippincott, William & Wilkins; 2001:324-331. 2. Wessel JJ, Samour PQ. Cardiology. In: Samour PQ, King K, eds. Handbook of Pediatric
Nutrition. 3rd
edition. Sudbury, MA: Jones and Bartlett Publishers Inc; 2005:407-420. 3. Goodin B. Nutrition issues in cystic fibrosis. Pract Gastroenterol. 2005;27(5):76-94. 4. Woolridge NH. Pulmonary diseases. In: Queen PM, King K, eds. Handbook of Pediatric
Nutrition. 3rd
edition, Sudbury, MA: Jones and Bartlett Publishers, 2005:307-350. 5. Spinozzi NS. Chronic renal disease. In: Queen PM, King K, eds. Handbook of Pediatric
Nutrition. 3rd
edition. Sudbury, MA: Jones and Bartlett Publishers, 2005:3851-390. 6. National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Pediatric
Guidelines, K/DOQI Update 2008. Available at: www.kidney.org. Accessed May 10, 2010. 7. Belay B, Esteban-Cruciani N, Walsh CA, Kaskel FJ. The use of levo-carnitine in children
with renal disease: a review and a call for future studies. Pediatr Nephrol. 2006;21:308-317.
8. Crill CM, Helms RA. The use of carnitine in pediatric nutrition. Nutr Clin Pract.
2007;22:204-213. 9. Abad-Jorge A, Roman B. Enteral nutrition management in pediatric patients with severe
gastrointestinal impairment. Support Line. 2007;29(3): 3-11. 10. Abad-Sinden A, Sutphen J. Nutritional management of pediatric short bowel syndrome.
Pract Gastroenterol. 2003;12(12):28-48. 11. Serrano MS, Schmidt-Sommerfeld E. Nutrition support of infants with short bowel
syndrome. Nutrition. 2002;18(11-12):966-970. 12. Wessel JJ. Short bowel syndrome. In: Groh-Wargo S, Thompson M, Hovasi Cox J, eds.
Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 2000:469-487. 13. Suddaby EC, Schiller S. Management of chylothorax in children. Ped Nurs. 2004;30(4):
290-295. 14. Chan EH, Russell JL, Williams WG, et al. Postoperative chylothorax after cardiothoracic
surgery in children. Ann Thorac Surg. 2005;80:1864-1871. 15. McCray, S, Parrish CR. When chyle leaks: nutrition intervention. Practical Gastroenterol.
2004;28(5):60.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
75
16. Hamdan MA, Gaeta ML. Octreotide and low-fat breast milk in postoperative chylothorax.
Ann Thorac Surg. 2004;77: 2215-2217. 17. Cormack BE, Wilson NJ, Finucane K, West TM. Use of monogen for pediatric
postoperative chylothorax. Ann Thorac Surg. 2004;77:301-305. 18. Pettei MJ, Saftary S, Levine JS. Essential fatty acid deficiency associated with the use of
a medium-chain-triglyceride infant formula in pediatric hepatobiliary disease. Am J Clin Nutr. 1991;53:1217-1221.
19. Mayes T, Gottschlich MM, Warden GD. Clinical nutrition protocols for continuous quality
improvements in the outcomes of patients with burns. J Burn Care Rehabil. 1997;18:365-368.
20. Rodriguez DJ. Nutrition in patients with severe burns: state of the art. J Burn Care
Rehabil. 1996;17:62-70. 21. Gottschlich MM, Mayes T. Nutrition in the Burned Pediatric Patient. In: Samour PQ, King
K, eds. Handbook of Pediatric Nutrition. 3rd
edition. Sudbury, MA: Jones and Bartlett Publishers Inc; 2005:483-498.
22. Dunn RL, Stettler S, Mascarenhas MR. Refeeding syndrome in hospitalized pediatric
patients. Nutr Clin Pract. 2003;18:327-332. 23. Katzman DK. Medical complications in adolescents with anorexia nervosa: a review of the
literature. Int J Eat Disord. 2005;37:S52-S59. 24. Afzal NA, Addai S, Fagbemi A, Murch S, Thomson M. Heuschkel R. Refeeding syndrome
with enteral nutrition in children: a case report, literature review and clinical guidelines. Clin Nutr. 2005;21:515-520.
25. de Menezes FS, Leite HP, Fernandez J, Benzecry SG, de Carvalho WB.
Hypophosphatemia in children hospitalized within an intensive care unit. J Intensive Care Med. 2006;21:235-239.
26. Mezoff AG, Gremse DA, Farrell MK. Hypophosphatemia in the nutritional recovery
syndrome. AMDC. 1989;143:1111-1112. 27. de Menezes FS, Leite HP, Fernandez J, Benzecry SG, de Carvalho WB.
Hypophosphatemia in critically ill children. Rev Hosp Clin Fac Med S Paulo. 2004;59:306-311.
28. Worley G, Claerhout SJ, Combs SP. Hypophosphatemia in malnourished children during
refeeding. Clin Pediatr. 1998;37:347-352.
Chapter 6 Nutrition Management of High Risk Nutrition Disease States
76
Chapter 7 Parenteral Nutrition
77
Chapter 7
Parenteral Nutrition
Introduction
Pediatric patients who are unable to meet their nutritional needs to promote growth and development via the oral or enteral route will require parenteral nutrition (PN) support (1). Preterm infants under 2000 g who are unable to be started on enteral feeds should be started on parenteral nutrition by no later than day of life 2-3. Pediatric patients who may require parenteral nutrition for either total or partial nutritional support include the following clinical examples (1-3):
Gastrointestinal (GI) anomalies
Necrotizing enterocolitis
Inflammatory bowel disease
Intractable diarrhea
Short gut syndrome
Extreme prematurity with gut dysmotility and severe respiratory distress
Cancer in the presence of underlying malnutrition and/or requiring intensive chemotherapy; inability to tolerate enteral feedings
Critical illness (trauma or sepsis) in the face of ileus, abdominal trauma or persistent GI intolerance
Peripheral vs. Central Parenteral Nutrition
In general, pediatric patients who will require parenteral nutrition for less than 2 weeks or neonates with adequate peripheral venous access and who are able to tolerate at least 140 – 150 ml/kg may be managed with peripheral parenteral nutrition (PPN). Generally a maximum solution osmolality of 1000 - 1200 mOsm/L is recommended for PPN (4-8). Pediatric patients who will require parenteral nutrition for greater than 2 weeks or those with
GI anomalies and surgery will require central parenteral nutrition (CPN). Percutaneously
inserted central catheters (PICC) lines are used for the infusion of parenteral nutrition. These lines are inserted by nurses in the NICU or by trained physicians. Generally, the lines are inserted via a vein in the antecubital area. Any concentration of dextrose may be given through PICC lines. Alternatively, pediatric patients who are not good candidates for PICC lines or those for which attempts at PICC line placement were unsuccessful, may receive surgically placed central lines for CPN.
Chapter 7 Parenteral Nutrition
78
Guidelines for Initiation & Advancement of Parenteral Nutrition (1-13)
For a complete review of pediatric parenteral nutrition requirements, please refer to Chapters 3 and 4.
Use of Dextrose and Insulin
1. Preterm Infants: Begin dextrose at 4 – 6 mg glucose/kg/min and advance by 1 - 2 mg glucose/kg/min or 1 – 2% per day to an endpoint goal of:
D15 – 25% for CPN
D10 – 12.5% for PPN The endpoint goal should be sufficient to meet, but not exceed, nutritional requirements. In general, preterm infants on PN should not receive carbohydrate loads in excess of 12 mg glucose/kg/minute.
2. Term Infants and Children: Begin PN at 10 – 15% dextrose depending on whether the line is peripheral or central and the clinical status and age of the child. Advance by 2.5 – 5% in older infants and children and by 5 – 10% per day in adolescents until an endpoint of D10 – 12% dextrose for PPN or generally between 20 – 25% dextrose for CPN, as needed to meet nutritional needs.
a. In general, the carbohydrate load in children through adolescents generally falls in the range of 6 – 14 mg glucose/kg/min (9).
b. Specific recommendations include (10): i. Term infants – 5-15 mg/kg/min ii. 1-3 years – 5-12 mg/kg/min iii. 4-6 years – 5-11 mg/kg/min iv. 7-10 years – 6-10 mg/kg/min v. 11-18 years – 4-7 mg/kg/min
3. Glucose Infusion Rate (GIR): To minimize the risk of hyperglycemia, overfeeding and hepatic dysfunction including fatty liver and cholestasis, GIR should not exceed the values presented above. GIR can be calculated as follows:
GIR = Rate of TPN x % Dextrose
Wt (kg) x 6
4. Blood glucose should be monitored daily via a Basic Metabolic Profile prior to advancing the % dextrose in the PN solution.
5. Provision of excess carbohydrate calories may lead to the following adverse effects:
Hyperglycemia ● Glycosuria
Hepatotoxicity ● Osmotic diuresis
Cholestasis ● Post infusion hypoglycemia
6. Insulin Use: Preterm or term infants with persistent hyperglycemia allowing only maintenance calories (70-75 kcal/kg) for > 2 weeks or resulting in inadequate weight gain and growth may need to be started on a continuous insulin infusion. Insulin infusion is usually started at 0.05 unit/kg per hour. Blood glucose levels should be
Chapter 7 Parenteral Nutrition
79
checked hourly initially for the first 8 – 12 hours and the insulin infusion rate adjusted accordingly to reduce and maintain blood glucose level between 90 – 150 mg/dL. With older children and adolescents, insulin may be added using the sliding scale method, initially for management, and then adding 2/3 of the previous day’s insulin requirement to the bag of PN (12). Alternatively, insulin may be added to the PN bag. For adults, recommended insulin dosages are 1 unit for every 10 or 15 grams of dextrose in the PN solution (13); however, for children, it may be more prudent to start at a conservative dose of 1 unit of regular insulin per 20 – 30 g of dextrose.
Use of Protein 1. Preterm infants and term infants under 2 years of age should be started on a pediatric
parenteral amino acid solution such as TrophAmine (B. Braun). This amino acid formulation for pediatric patients provides the following advantages:
Provides essential amino acids for infants e.g. histidine, taurine
Promotes plasma amino acid profiles within normal neonatal target range
Decreases the tendency for development of cholestasis
Addition of cysteine hydrochloride, a conditionally essential amino acid in preterms, decreases the pH of the solution thus improving calcium and phosphorus solubility
2. Table 7.1 outlines initiation and advancement for parenteral protein.
Table 7.1 Protein Advancement in Infants (Preterm and Term) and Children
Birthweight Begin Advance By Endpoint Goal
<1 kg – 2 kg >2 kg preterm Term infants
2 g/kg 2-3 g/kg 2.5 -3 g/kg
1 g/kg 1-1.5 g/kg ---
3.5 – 4 g/kg 3 - 3.5 g/kg 2.5 - 3.5 g/kg
May go up to 4 g/kg in preterms with increased needs: post-surgery, bowel perforation
Do not decrease the protein in TPN with moderate elevations in BUN; generally <50.
3. The protein concentration in peripheral parenteral nutrition should not exceed 30 - 35
g protein/L or no more than 2.5 - 3 g protein/kg in infants in order to maintain the solution osmolality within the recommended range.
4. Provision of excess protein via PN may result in the following adverse effects:
Azotemia
Metabolic acidosis possibly secondary to cysteine in the PN
Serum amino acid imbalance
Hyperammonemia
Possible hepatotoxicity, cholestasis 5. Blood urea nitrogen and creatinine should be monitored daily initially via a Basic
Metabolic Profile until the full protein intake goal is reached. An elevated BUN in the face of a normal serum creatinine may not be indicative of excess protein intake, but rather fluid restriction and intravascular depletion. General monitoring guidelines for pediatric patients on PN will be discussed further in a forthcoming section.
Chapter 7 Parenteral Nutrition
80
Use of Lipids 1. Lipids may be safely used on a daily basis in most patients. Begin lipids at 0.5 - 2.0
g/kg and advance by 0.5 - 1.0 g/kg per day depending on a child’s age and lipid clearance to the appropriate endpoint goal. Lipids should be advanced as follows: a. Preterm and Term Infants – see Table 7.2
Table 7.2 Lipid Initiation and Advancement in Term and Preterm Infants
b. Children and Adolescents – Begin 20 % IL at 1 - 2 g/kg and advance by 1 g/kg per day to a goal of 1 – 2.0 g/kg per day depending on age and clinical status.
2. Intravenous fat emulsion, which is only available as 20% Intralipid (2 kcal/ml) at UVA
Health System should be provided at least a minimum dose of 0.5 - 1.0 g/kg per day or for provision of essential fatty acid (EFA) requirements. Signs of EFA deficiency include:
reduced growth rate
impaired wound healing
increased susceptibility to infections
thrombocytopenia
flaky dry skin
poor hair growth 3. Intravenous lipids should be used with caution in infants and children under the
following conditions:
Severe hyperbilirubinemia in preterm infants
Presumed sepsis in light of deteriorating clinical status or confirmed sepsis; once an infant’s blood cultures have been confirmed to be negative for 48 hours and if triglycerides are within normal limits, lipids should be increased gradually back up to goal of 3.0 g/kg.
Hyperlipidemia with serum triglycerides >250. Even under these conditions, the minimal amount of lipids for provision of EFA needs of 0.5 - 1 g/kg may be safely administered.
4. Monitoring:
a. Check triglyceride levels weekly for infants and children on PN by selecting serum triglycerides along with the Hepatic Panel A profile in the other pediatric units.
b. Check triglyceride levels after each 1.0 g/kg increase and then weekly in: a) infants < 28 weeks gestational age or, b) infants with birthweights < 1.0 kg while on TPN.
c. Managing Elevated Serum Triglyceride Levels (UVA Guidelines):
If triglyceride > 250 but < 300, decrease lipids by 1.0 g/kg, then recheck
Birthweight Begin Level Advance By Endpoint Goal
< 1000 grams 0.5 g/kg 0.5-1 g/kg 3.0 g/kg
> 1000 grams & Term Infants
1.0 – 2.0 g/kg 1.0 g/kg 2.5 - 3.0 g/kg
Chapter 7 Parenteral Nutrition
81
If triglyceride > 300, decrease lipids to 0.5 - 1 g/kg for EFA, then recheck
If triglyceride > 400, stop the Intralipid, recheck, and once < 300 restart at 0.5 g/kg for provision of EFA needs
Electrolytes (1, 4, 8) Electrolytes, particularly sodium, potassium, chloride, calcium, phosphorus and
magnesium should be ordered as per the guidelines found in the Table 7.4 Parenteral
Nutrition Guidelines in Pediatric Patients in mEq/kg or mEq per total volume depending on the ordering pathway chosen (neonatal versus pediatric). Acid-Base Balance
In pediatric PN at UVA, the amount of chloride required is included as part of the PN order. Acetate amount is not delineated in the order; the amount of acetate added to the PN bag will be calculated in the compounding pharmacy based on the amount of anions needed to balance ordered cations. There is an option to minimize chloride/maximize acetate OR maximize chloride/minimize acetate in the ordering system. In this case, the minimized ion will be left out of the PN bag, even if an amount has been ordered (ie, if 30 meq of chloride are ordered, but “minimize chloride/maximize acetate” is selected, no chloride will be added). The clinician should take care to understand use of minimize/maximize options, as using these can cause large fluctuations in the amounts of anions given in the PN. Guidelines:
If serum bicarbonate is < 18 and the child is acidotic, then maximize acetate/minimize chloride in the PN solution.
If serum bicarbonate is > 27 and the child is alkalotic, then minimize acetate/maximize chloride in the PN solution.
If the serum bicarbonate is within normal range, then select “none of the above”, the chloride and acetate in the PN solution will be balanced based on the chloride order.
Calcium and Phosphorus Requirements (1, 14, 15) Particular attention needs to be given to the ordering of calcium and phosphorus in preterm infants to promote bone mineralization while preventing calcium-phosphorus precipitation in the PN solution. The recommended parenteral calcium and phosphorus intake for infants and children is given in Table 7.3.
The optimal Calcium to Phosphorus ratio for preterm and term infants is 1.3 - 1.7:1 by weight, which is a 1 – 1.3:1 molar ratio.
The combined total of calcium and phosphate (0.5 mMol phos = 1 mEq) cannot exceed 5.2 mEq/100 ml using a standard amino acid preparation or 7.2 mEq/100
Chapter 7 Parenteral Nutrition
82
ml using TrophAmine.
Calcium and phosphorus should be advanced daily, as tolerated, in preterm infants to meet their increased requirements and to minimize the risk for osteopenia of prematurity.
If the ionized calcium is > 6.0, the calcium in the PN may be slightly decreased, while optimizing the phosphorus. Once the serum Calcium is within normal limits, continue to advance the calcium in the PN to meet goals.
Table 7.3 Recommended Parenteral Calcium & Phosphorus Intake
Recommended Intake Calcium (mEq/kg) Phosphorus (mMol/kg)
Preterm, Term Infants 3.0 - 4.0 1.5 - 2.0
Older Children (10-40 kg) 1.0 - 3 0.5 – 1.5
Adolescents (>40 kg) 1.0 - 1.5 0.5 – 0.75
Guidelines for Ordering Protein, Calcium and Phosphorus to Prevent Precipitation
For every 100 ml/kg of PN solution, the following can be added:
4 g/kg TrophAmine
4 mEq/kg Calcium
1.5 mMol/kg Phosphorus
Chapter 7 Parenteral Nutrition
83
Table 7.4 Parenteral Nutrition Guidelines in Pediatric Patients
Chapter 7 Parenteral Nutrition
84
Pediatric Vitamins, Trace Elements and Minerals (1, 2, 4, 14)
Pediatric patients on parenteral nutrition will receive all or a portion of the 5 ml vial of Pediatric MVI solution (Astra Pharmaceuticals), depending on their weight as follows:
Infants < 2.5 kg: Use 2 ml/kg
Infants and children 2.5 kg: Use 5 ml
Children > 40 kg: Use 10 ml Adult MVI solution (needs to be a “type-in additive”); may need to add 60 – 75 mcg of vitamin K to meet pediatric requirements.
Table 7.5 Pediatric MVI Solution (Astra Pharmaceuticals)
Vitamin Amount (per 5 ml)
Ascorbic Acid 80 mg
Vitamin A 2300 IU
Vitamin D 400 IU
Thiamine 1.2 mg
Riboflavin 1.4 mg
Pyridoxine 1 mg
Niacinamide 17 mg
Pantothenic Acid 5 mg
Vitamin E 7 IU
Folic Acid 140 mcg
Vitamin B12 1 mcg
Biotin 20 mcg
Vitamin K 0.2 mg
Trace element dosing is also based on patient weight:
A total of 0.2 ml/kg/day should be used for children up to 5 years of age.
An additional 100 mcg/kg of zinc is added to the PN solution of preterm infants < 2.5 kg and in infants through 5 kg following open heart surgery.
Add an additional 50 – 100 mcg/kg of zinc for post-operative heart surgery infants < 15 kg.
Children > 40 kg, use Adult Trace Element Solution (ATES), which has selenium. As such, selenium does not need to be ordered separately using the Peds PN Pathway.
Table 7.6 Pediatric Trace Element Solution (PTES)
(American Regent Neonatal)
Trace Element Content (per 0.2 ml)
Zinc 300 mcg
Copper 20 mcg
Chromium 0.17 mcg
Manganese 5 mcg
Chapter 7 Parenteral Nutrition
85
Special considerations for adjustments in the use of pediatric multivitamin and pediatric trace elements include the following:
Zinc: If child has increased diarrhea or ileostomy, add 10 mcg/ml of output (maximum of 5000 mcg/day)
Copper: In biliary obstruction/cholestasis, omit (16) or reduce by 50% (3)
Chromium: In renal insufficiency, omit (16) or reduce (3)
Manganese: In biliary obstruction/cholestasis, omit (16) or reduce by 50% (3)
Selenium: In renal insufficiency, omit (16) or reduce (3)
When omitting copper and manganese due to cholestasis, the PTES solution should be held, and additional zinc and chromium should then be added as a separate additive.
Selenium (14) Selenium should be administered to all infants and children on PN for > 4 weeks at a level of 1 - 2 mcg/kg/day. In the NICU, all preterm infants and neonates will automatically receive 2 mcg/kg/day. Selenium should be decreased in renal insufficiency. Selenium deficiency may occur in children receiving long term selenium free TPN. Severe deficiency leads to:
cardiomyopathy
skeletal muscle tenderness/pain
erythrocyte macrocytosis
loss of pigmentation of hair and skin Carnitine (8, 14) Carnitine is essential for optimal oxidation of fatty acids in the mitochondria. In the healthy child, carnitine is synthesized in the liver and kidney from the precursors, lysine and methionine. Preterm infants < 34 weeks gestational age or those that are SGA on PN may develop carnitine deficiency within 6 – 10 days. Clinical signs of carnitine deficiency include the following:
cardiomyopathy
encephalopathy
nonketotic hypoglycemia
hypotonia
poor growth Carnitine supplementation has been demonstrated to normalize serum carnitine, improve fatty acid metabolism and improve nitrogen balance. Whether preterm infants on PN for a period greater than 4 weeks should be placed on carnitine supplementation remains controversial at this time. Infants or children with persistent hyperlipidemia on long-term TPN, in the absence of other precipitating factors, may benefit from carnitine supplementation at a dose of 10 - 20 mg/kg/day.
Chapter 7 Parenteral Nutrition
86
Parenteral Iron (14)
The use of iron dextran (Imferon) in PN continues to be controversial owing to the potential for the following adverse effects:
potential for increased risk of gram negative septicemia.
potential for hyersensitivity reaction (anaphylaxis); patients with a history of asthma or other allergies may be at higher risk for anaphylactic reaction.
Infants or children on long term PN or those with documented iron deficiency anemia may receive iron dextran according to the following administration guidelines:
1. When initiating therapy, full precautions should be followed including having epinephrine, methylprednisolone, intubation equipment at the bedside. A person skilled in intubation should be available to respond to any anaphylactic response.
2. A test dose of 12 - 25 mg may be given over 5 -15 minutes followed by an hour of
observation period to identify any adverse response.
3. Monitor the infant or child throughout the administration of the first dose as delayed reactions may occur.
4. Recommended Periodic Supplementation for Patients on TPN: At UVA Health
System, we have had some success using periodic administration in our patients on chronic TPN therapy. Use of iron supplementation for a 1 - 3 week period every 2 - 4 months appears adequate for most children.
Dose: 0.5 - 0.8 mg/kg/day in the PN
Imferon can be ordered as a separate additive.
Check indices of iron status prior to and at the end of the treatment including: hemoglobin, hematocrit, MCV, MCHC, serum iron and ferritin.
Ordering Pediatric Parenteral Nutrition
PN for pediatric patients may be ordered via two pathways in Epic:
Neonatal (<10 kg)
Pediatric (>10 kg) The pediatric nutritionists for the NICU, PICU and the pediatric floors may order PN as a “pended order,” which must be released by a physician. The neonatal nutritionist will work with the neonatal nurse practitioners to educate new interns on the ordering of PN in the NICU on a monthly basis. The neonatal nutritionist is available to assist interns and residents with the ordering of PN for NICU infants, as needed.
Chapter 7 Parenteral Nutrition
87
Monitoring of Pediatric Patients on Parenteral Nutrition (4, 11, 17) Pediatric patients on PN should be monitored according to the following schedule:
Table 7.7 Monitoring Guidelines for Pediatric Patients on PN
Adapted from Reference 16 * Electrolytes should be checked daily for the first 1-2 weeks until stable, then twice weekly. ** Weekly PN labs may be decreased to biweekly to monthly once the child is stable.
At UVA Health System the following labs may be easily collected using the following lab order sets:
Table 7.8 Lab Order Sets for Pediatric Patients on PN (UVA-HS)
Unit Daily Lab Sets Weekly Lab Sets
Pediatric Units PICU
Basic Metabolic Panel Phosphorus/Magnesium
Hepatic Panel A Triglycerides Prealbumin (to assess disease acuity, if needed)
NICU
Basic Metabolic Panel Phosphorus/Magnesium
CMP (includes albumin, triglycerides, AST/ALT, Alk phos & conjugated bilirubin)
Parameter Initial/Daily* Weekly** As needed
Anthropometrics
Weight X
Length X
Head circumference X (for < 3 y.o.)
Metabolic/Serum
Sodium/chloride X
Potassium X
Bicarbonate X
BUN/creatinine X
Glucose X
Calcium/Phosphorus X
Ionized calcium X
Magnesium X
Prealbumin/CRP X
Triglycerides X
Liver function tests (including AST/ALT/Alk Phos/total bilirubin)
X
Conjugated bilirubin X
Trace elements: Copper, zinc, whole blood manganese, selenium, chromium
X (Quarterly in
long-term patients)
Vitamin D X
Iron studies X
Blood cultures X
Chapter 7 Parenteral Nutrition
88
Managing Metabolic and Long Term Complications of Parenteral Nutrition
While parenteral nutrition can provide optimal nutritional therapy for infants and children whose GI tracts cannot be effectively used, the health care professional needs to become knowledgeable of the numerous potential complication which can arise and how to manage them. Infants and children on PN should be monitored regularly according to the above recommended guidelines. Most complications can be avoided or effectively managed through careful biochemical monitoring and timely intervention. Complication rates can also be minimized when PN is administered according to the established protocols by health care professionals who have been trained in administration and delivery of PN therapy (12, 16). Metabolic complications may be generally presented according the following categories (4, 17):
Glucose metabolism
Protein metabolism
Lipid metabolism
Mineral and electrolyte metabolism
Bone demineralization
Hepatic dysfunction and failure Cyclic PN (18) Infants and children on long-term PN, may benefit from cyclic PN infused over 12-20 hours. Constant infusion of dextrose solutions results in high circulating insulin levels which can result in lipogenesis, hepatomegaly, fatty liver and increased risk of cholestasis. Advantages of cyclic PN include:
mobilization of fat and glycogen stores
decreased incidence of cholestasis
increased time for physical activity Cyclic TPN is rarely used in neonates due to the concern of hypoglycemia. However, in metabolically stable infant, cyclic PN can be introduced as follows (16):
Incremental advancements of TPN “break” or “window” by 1-2 hour increments to a 16-20 hour delivery time.
Taper on and taper off period for ½ - 1 hour at ½ the full TPN rate to minimize the risk of hypo or hyperglycemia.
Blood glucose may need to be checked 1-2 hours after TPN is turned off to ensure euglycemia, per unit protocol.
Chapter 7 Parenteral Nutrition
89
Table 7.9 Managing Complications of Pediatric Parenteral Nutrition (12, 14, 17)
Metabolic Complication Possible Causes Management
Glucose Metabolism
Hyperglycemia, glucosuria, osmotic diuresis
Excessive glucose administration, prematurity & insulin resistance Stress response
- Monitor blood glucose frequently - Decrease PN rate or % dextrose - May need to begin insulin therapy, begin at 0.05 units/kg/hr
Hypoglycemia Excess insulin production (i.e. IDM infants); too rapid weaning of dextrose solution
- Monitor blood glucose frequently - Increase PN rate or % dextrose - Wean PN gradually on cyclic PN
Protein Metabolism
Hyperammonemia
Liver disease or hepatic immaturity Excess intake of amino acids (usually > 3 g/kg) Inborn errors of protein metabolism
- Monitor serum ammonia, protein intake and albumin status - May need to decrease protein intake
Prerenal Azotemia Excessive protein intake (particularly in VLBW infants with immature renal systems Intravascular volume depletion
- Lower protein intake by 0.5 –1 g/kg - Monitor BUN and creatinine - Provide adequate calories - Increase fluid delivery
Lipid Metabolism
Hyperlipidemia Excess fat delivery (> 3 g/kg); rapid infusion of lipid (in < 18 hours), infection, stress, preterm (especially SGA infants), excess glucose intake
- Monitor serum triglyceride levels - Decrease IV lipids by 1-2 g/kg - Administer lipids slowly; in preterms, deliver over 24 hours, preferably
Essential Fatty Acid Deficiency
Inadequate provision of EFA (linoleic) Administration of long term fat free PN
- Provide minimal fat for EFA needs: 0.5-1 g/kg
Hyperbilirubinemia Excess lipid infusion may promote the displacement of bilirubin from albumin binding sites
- Limit lipid infusion to no more than 1-1.5 g/kg in the face of clinically significant hyperbilirubinemia
Chapter 7 Parenteral Nutrition
90
Table 7.9 Managing Complications of Pediatric Parenteral Nutrition (12, 14, 17), Continued
Metabolic Complications Possible Causes Management
Hepatic Dysfunction and Hepatic
Failure
Excess caloric and carbohydrate delivery, excess protein as well as vitamin and mineral intake have all been suggested as possible etiological causes of hepatic dysfunction Lack of enteral feeding/stimulation results in decreased bile flow Lack of cycling the parenteral nutrition Phytosterols in soybean based lipid emulsion
-Monitor glucose, protein and total caloric delivery. Maintain caloric delivery at optimal level for infant (may need to decrease % dextrose). -Use pediatric amino acid solution. -Cycle PN for older infants or cycle with a lower dextrose IV solution -Start enteral feedings (even if trophic) as soon as clinically feasible -If cholestatic, remove manganese and copper from the solution (PTES) -Monitor liver function tests weekly. - Consider “rescue use” of fish-oil-
based lipid emulsions in place of soybean based lipid emulsions.
Bone Demineralization Inadequate calcium, phosphorus and/or vitamin D intake in the PN solution, leading to metabolic bone disease, fractures, elevation in alkaline phosphatase Lack of adequate cycling of the PN Excess diuretic dosing.
-Monitor serum calcium, phosphorus, ionized calcium, serum alkaline phosphatase. Optimize calcium and phosphorus intake at optimal parenteral ratios: 1.3-1.7:1 by weight or 1–1.3:1 (molar ratio)
Chapter 7 Parenteral Nutrition
91
Table 7.9 Managing Complications of Pediatric Parenteral Nutrition (12, 14, 17), Continued
Metabolic Complications Possible Causes Management
Mineral and Electrolyte Metabolism
Electrolyte imbalance
General imbalance of sodium, potassium, and chloride are commonly seen in preterm infants during the 1
st
week of life. Other causes include losses from diarrhea, renal disease or medication therapies
- Depending on extent of the imbalance, may need to replace electrolyte via and IV solution - Adjust electrolytes in the PN solution, daily, as indicated
Hypokalemia
Inadequate potassium delivery relative to requirements; diuretic treatment; treatment with Amphotericin B, beta-adrenergic agonists (i.e. Terbutaline)
- Monitor serum potassium daily - Adjust potassium in the PN solution - Alter medication profile, if appropriate
Hyperkalemia
Excessive potassium administration, metabolic acidosis, renal insufficiency
- Monitor serum potassium daily. - Decrease potassium in the PN Solution
Hypophosphatemia High glucose infusions, refeeding syndrome in previously malnourished children, inadequate phosphorus administration
- Monitorsserum phosphorus daily - Increase phosphorus content of PN Solution
Hyperphosphatemia
Excessive phosphorus administration, Impaired renal functions, PTH deficiency
- Decrease phosphorus content of PN solution. Monitor phosphorus and calcium intake and status
Hypocalcemia
Inadequate calcium intake in PN; diurectic administration (i.e. furosemide); PTH deficiency; inadequate magnesium intake.
- Gradually increase the calcium content of the PN solution
Chapter 7 Parenteral Nutrition
92
Table 7.9 Managing Complications of Pediatric Parenteral Nutrition (12, 14, 17), Continued
Metabolic Complications Possible Causes Management
Hypercalcemia
Excessive calcium intake, imbalance in calcium and phosphorus intake with resulting excess PTH
- Depending on degree of hyper- calcemia, may need to decrease calcium in PN solution. Optimize phosphorus delivery and achieve optimal Ca: Phos ratio. Monitor calcium, phosphorus and alkaline phosphatase
Hypomagnesemia
Inadequate magnesium intake relative to requirements, refeeding syndrome in previously malnourished pediatric patient, chronic diarrhea, Amphotericin B administration
- Monitor serum magnesium daily. - Increase magnesium in the PN solution
Hypermagnesemia
Excessive magnesium intake, renal insufficiency, tocolysis in mother
- Monitor serum magnesium. - Decrease magnesium in the PN solution, as needed
Metabolic hyperchloremic acidosis
Excessive chloride content in PN solution If metabolic acidosis in the face of elevations in BUN/Cr, protein load may be contributing to acidosis
-Increase acetate salts in the PN solution - If amino acids playing a role in acidosis, decrease protein in PN by 0.5 – 1 g/kg
Metabolic hypochloremic alkalosis Excessive acetate salts in the PN solution
- Increase chloride content and decrease acetate content of the PN - Monitor blood chloride and bicarb
Adapted from Groh-Wargo, S., Thompson, M. and Hovasi-Cox, J. Nutritional Care of High Risk Newborns. Precept Press, 2000; Pg 97-100. (14)
Chapter 8 Pharmacology and Nutrition Support
93
References
1. Baker SS, Baker RD. Parenteral nutrition. In: Walker WA, Goulet O, Kleinman RE, Sherman PM, Schneider BL, Sanderson IR, eds. Pediatric Gastrointestinal Disease. 4
th
edition. Philadelphia, PA: B.C. Decker, Inc.; 2004:1958-1980.
2. Shwenk WF, Olsen D. Pediatrics. In: Gottschlich M, Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:347-372.
3. Reiter, P. Thureen, P.F. Nutrition Support in Neonatology. In: Gottschlich M, Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:323-346.
4. Cox JH, Melbardis IM. Parenteral Nutrition. In: Samour PQ, King K, 3rd
edition. Handbook of Pediatric Nutrition. Sudbury, MA: Jones and Bartlett Publishers Inc; 2005:525-558.
5. Isaacs JW, Millikan WJ, Stackhouse J, et al. Parenteral nutrition of adults with a 900 milliosmolar solution via peripheral veins. Am J Clin Nutr. 1977;30:552-559.
6. Correia MI, Guimaraes J, Cirino de Mattos L, et al. Peripheral parenteral nutrition: an option for patients with an indication for short-term parenteral nutrition. Nutr Hosp. 2004;19(1):14-18.
7. Bodoky A, Zbinden A, Muller J, et al. Peripheral venous tolerance of hyperosmolar infusion solutions. Helv Chir Acta. 1980;47:151-156.
8. Sapsford A. Parenteral nutrition: energy, carbohydrate, protein and fat. In: Groh-Wargo S, Thompson M, Hovasi Cox J, eds. Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 2000:119-149.
9. Phillips SK. Pediatric parenteral nutrition. J Infus Nurs. 2004;27(3):166-170.
10. Hovasi Cox J, Mara Melbardis I. Parenteral nutrition. In: Samour PQ, King K, 3rd
edition. Handbook of Pediatric Nutrition. Sudbury, MA: Jones and Bartlett Publishers Inc; 2005:483-498.
11. Mirtallo JM. Introduction to parenteral nutrition. In: Gottschlich M, Fuhrman MP,
Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:211 - 224.
12. Matarese LEM. Metabolic complications of parenteral nutrition therapy. In: Gottschlich M, Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral
Chapter 8 Pharmacology and Nutrition Support
94
and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:269-286.
13. Hurley DL, Neven AK, McMahon MM. Diabetes Mellitus. In: Gottschlich M, Fuhrman MP, Hammond KA, Holcombe BJ, Seidner DL, eds. The Science and Practice of Nutrition Support – A Case-Based Core Curriculum. American Society for Parenteral and Enteral Nutrition. Dubuque, IA: Kendall/Hunt Publishing Co.; 2001:269-286.
14. Krug SK. Parenteral nutrition: vitamin, minerals and trace elements. In: Groh-Wargo S, Thompson M, Hovasi Cox J, eds. Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 2000:151-175.
15. Greene HL, Hambidge KM, Schanler R, Tsang RC. Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition. Am J Clin Nutr. 1988; 48:1324-1342.
16. Greene HL, Hambidge KM, Schanler R, Tsang RC. Guidelines for the use of vitamins,
trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: report of the Subcommittee on Pediatric Parenteral Nutrient Rqeuirements from the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition. Am J Clin Nutr. 1988;48:1324-1342.
17. Price PT. Parenteral nutrition: administration and monitoring. In: Groh-Wargo S, Thompson M, Hovasi Cox J, eds. Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 2000:91-107.
18. Collier SB, Crouch J, Hendricks K, et al. Use of cyclic parenteral nutrition in infants less than 6 months of age. Nutr Clin Pract. 1994; 9:65.
Chapter 8 Pharmacology and Nutrition Support
95
Chapter 8
Pharmacology and Nutrition Support
Introduction
Knowledge of a pediatric patient’s medication profile is important for optimizing nutritional support intake and delivery. The clinical nutritionist will review each patient’s medication profile and determine how these drugs impact nutrition. Topics covered in this chapter include:
Common drug-nutrient interactions seen in hospitalized patients
Medications which should be taken on an empty stomach or those that may be affected by enteral nutrition
Medications that are not compatible with parenteral nutrition.
Calcium and phosphorus balance and solubility in parenteral nutrition solutions
Electrolyte supplementation via the enteral route
Critical care medications and nutritional delivery.
Medication Information Resources
Micromedex – This evidence-based clinical information system is available through the Clinical Portal. Micromedex provides information on drug dosing, administration, adverse effects, and drug interactions. For IV drugs, it also provides information on drug compatibility. An on-line tutorial is available on the Micromedex website and the Health Sciences Library offers classes for those interested in learning more about the system.
Websites: Global RPh – www.globalrph.com General info www.noah-health.org/en/pharmacy/drugs/food.html FDA www.fda.gov National Consumers League www.nclnet.org Natural Standard www.naturalstandard.com NIH National Center for Complementary and Alternative Medicine
http://nccam.nih.gov/
For questions or additional information, contact the pediatric pharmacy at 2-0920
Common Drug-Nutrient Interactions Seen in Hospitalized Patients Interactions between certain foods and drugs may reduce or enhance the effect of the drug. Preventing and managing drug-nutrient interactions in the clinical setting are pivotal in order to avoid predisposing patients to treatment failure, toxicity, or life-threatening adverse events. The following table provides common drugs along with their interactions, mechanism of action, and therapeutic management.
Chapter 8 Pharmacology and Nutrition Support
96
Table 8.1 Common Drugs with Potential Nutrient Interactions
Drug or Class Interaction Mechanism Therapeutic
Management
ACE Inhibitors Excessive potassium intake
Pharmacodynamic interaction, risk of hyperkalaemic adverse effects
Avoid consuming large quantities of high potassium foods.
Digoxin Increased fiber intake
Pharmacokinetic interaction, reduced absorption
If fiber intake changes, may need to adjust dosage.
Felodipine Grapefruit, Citrus juice
Pharmacokinetic interaction, inhibition of metabolism
Avoid grapefruit juice.
Levodopa Pyridoxine Pharmacodynamic interaction, decreased dopamine availability
Maintain consistent vitamin B6 intake.
MAO Inhibitors Tyramine
Pharmacodynamic interaction, blocked deamination of dietary pressor amines, risk of hypertensive crisis
Avoid foods containing tyramine. See Table 8.2.
Phenytoin Vitamin D
Alterations in nutrition status, chelation, binding to protein components, decreases absorption
May need calcium + vitamin D supplement.
Spironolactone Excessive potassium intake
Pharmacodynamic interaction, risk of hyperkalaemic adverse effects
Avoid consuming large quantities of high potassium foods.
Tetracycline Calcium Physical interaction, chelation
Avoid dairy products, iron-containing products, or antacids containing calcium, magnesium, and aluminium 1 hr. before or 2 hrs. after medication delivery.
Theophylline Caffeine, fat Pharmacodynamic interaction, additive effects
Limit caffeine to 2-3 cups of coffee, tea, or colas per day. Avoid taking with meals high in fat.
Warfarin Excessive vitamin K intake
Pharmacodynamic interaction, direct antagonism by dietary vitamin K
Vitamin K intake needs to remain consistent. Avoid high doses (>400IU/d) of vitamin E.
Chapter 8 Pharmacology and Nutrition Support
97
Table 8.2 Tyramine Containing Foods
Aged Cheeses Overripe Fruit
Eggplant Figs
Grapes Oranges
Pineapple Plum
Prune Raisin
Avocados Sauerkraut
Processed Foods Aged Meats
Canned Meats Dried Meats
Cured/Pickled Meats Meat by-products
Fava Beans Tofu
Miso Teriyaki Sauce
Soy Products Soy Sauce
Spinach Tomatoes
Alcoholic Beverages Yeast
Bouillon Cubes Commercial Gravies
Drug Interactions with Enteral Products General Guidelines
In most cases, giving drugs to patients receiving enteral nutritional products is similar to drug administration to patients who are eating.
Liquid dosage formulations are preferred for administration through a feeding tube. Solutions or suspensions are preferred. Syrups, especially those which are acidic such as metoproterenol (Alupent) or metoclopromide (Reglan), may cause clumping of the enteral feeding if given concurrently.
If a tablet must be used, it should be crushed and mixed with a small amount of water immediately prior to administration. The tubing should then be flushed with water to prevent clogging.
Enteric-coated, sublingual, and sustained release products should never be crushed. Some sustained release capsules can be opened so that the beads can be administered through a feeding tube. The beads should not be crushed, but should be mixed with a small amount of water immediately prior to administration. The tubing should then be flushed with water to prevent clogging.
If multiple drugs are scheduled for administration, each one should be given separately with a 5 ml water flush between drugs.
Chapter 8 Pharmacology and Nutrition Support
98
Incompatibilities
Drugs that are normally given on an empty stomach should not be administered with tube feeds. Table 8.3 lists common examples of drugs that should be taken on an empty stomach:
Table 8.3 Drugs that Should be Taken on an Empty Stomach
Ampicillin Mercaptopurine
Atenolol Methotrexate
Bisacodyl Mycophenolate
Captopril Nafcillin
Cefibuten Norfloxacin
Ciprofloxacin Ofloxacin
Cloxacillin Oxacillin
Dicloxacillin Penicillin G
Didanosine (DDI) Rifabutin
Isoniazid Rifampin
Levothyroxine Sulfonamides
Lomustine Tetracycline
Melphalan Zidovudine
In addition to the drugs listed above, some drugs that normally can be given with food cannot be given with enteral feeds. Concomitant administration of these drugs (Table 8.4) with enteral feeds can result in a significant decrease in drug absorption.
Table 8.4 Additional Drugs that May be Affected by Enteral Feedings
Aspirin Phenytoin
Calcium supplements Potassium supplements (some products)
Carbamzepine Propantheline
Digoxin Rifampin
Furosemide Theophylline
Iron supplements Voriconazole
Methyldopa Warfarin
To minimize these drug-enteral feeding interactions, the following procedure should be used (when possible):
1. Stop the tube feeding 2. Flush the tube with 20-30 ml water, or an appropriate volume based on the
patient’s size 3. Administer the dose 4. Repeat step 2 5. Wait approximately 30 minutes – 1 hour before restarting feeds
Chapter 8 Pharmacology and Nutrition Support
99
Drug Interactions with Parenteral Nutrition
General Guidelines
Many drugs are compatible with parenteral nutrition solutions when administered through the same tubing. When a drug is administered with parenteral nutrition, it
should be administered through the Y-site closest to the patient to minimize
contact time. An in-line filter may also be placed to trap any precipitants. Incompatibilities
Information on compatibility is best evaluated on an individual case basis. Compatibility may depend on the specific components of a parenteral nutrition solution or the concentration of those components (e.g. electrolytes) in the final solution. Table 8.5 provides a brief list of several drugs known to be incompatible with most parenteral nutrition solutions.
Table 8.5 Drugs that are Incompatible with Most Parenteral Nutrition Solutions
Acyclovir Milrinone
Calcium salts Phenobarbital
Diazepam Phenytoin
Ganciclovir Phosphate salts
Immune globulin products (IVIG)
Calcium/Phosphate Balance
Identifying the most appropriate balance of calcium and phosphate is one of most challenging aspects of pediatric parenteral nutrition. Excessive amounts of one or both of these electrolytes can result in formation of dibasic calcium phosphate, which may precipitate out of solution. Solubility is also affected by:
1. pH 2. temperature 3. fluid volume 4. the sequence of adding the electrolytes 5. protein dose and formulation
A general rule of thumb is that the total mEq of calcium and phosphate cannot exceed 5.2 mEq for every 100 mL for parenteral nutrition solutions made with
Travasol (standard amino acid solution) or 7.2 mEq for every 100 mL for
parenteral nutrition solutions made with TrophAmine (pediatric amino acid solution). To convert phosphorus units, use 0.5 mMol phos = 1 mEq.
When ordering calcium and phosphorus in parenteral nutrition, to prevent precipitation for every 100 mL of PN solution, the maximum amounts to be added are 4 mEq/kg Calcium and 3 mEq/kg Phosphorus (1.5 mMol/kg phos)
Chapter 8 Pharmacology and Nutrition Support
100
Critical Care Medications and Nutritional Delivery
Critically ill infants and children are often fluid restricted and require multiple intravenous medications and infusions that are counted towards the overall fluid delivery. The pediatric nutritionists will work closely with the PICU and NICU team to optimize nutritional support delivery in the face of fluid restriction and multiple intravenous medication intake. Common intravenous infusions used in the pediatric and newborn intensive care unit settings are listed in Table 8.6.
Table 8.6 Critical Care Medications Commonly Used as Infusions
in the Pediatric and Newborn ICU
Medication Classification
Chlorothiazide (Diuril) Diuretic
Cisatracurium Neuromuscular blocker
Dobutamine Inotrope
Dopamine Inotrope
Epinephrine Inotrope
Fentanyl Analgesic
Furosemide (Lasix) Diuretic
Midazolam (Versed) Sedative
Milrinone Inotrope
Morphine Analgesic
Pentobarbital Sedative
Vasopressin Inotrope
Vecuronium Neuromuscular blocker
The PICU dietitian will work with the pharmacist, nurse, and medical team to determine how best to concentrate the intravenous medications, given the child’s dosage and plans for weaning, in order to allow for an increased delivery rate of the parenteral or enteral nutrition fluids. The physician, however, will enter in the medication with new concentration into the computer ordering system. .
Chapter 8 Pharmacology and Nutrition Support
101
Common Enteral Electrolyte Supplementation
Table 8.7 Electrolyte Content of Selected Enteral Supplements (9)
Supplement
(Unit, Strength)
Sodium
(mEq)
[mg]
Potassium
(mEq)
[mg]
Chloride
(mEq)
Elemental
Phosphorus
(mEq)
[mg]
Elemental
Magnesium
(mEq)
[mg]
Elemental
Calcium
(mEq)
[mg]
Neutra-Phos (PhosNaK) (packet)
7.1 [164]
7.1 [278]
0 16 [250]
0 0
Neutra-PhosK (packet)
0 14.25 [556]
0 16 [250]
0 0
Calcium carbonate (ml, 1250 mg/5 ml)
0 0 0 0 0 5 [100]
Calcium glubionate (ie, Neo-Calglucon) (ml, 1.8g/5 ml)
0 0 0 0 0 1.15 [23]
Tums, Regular Strength (tab, 500 mg)
0 0 0 0 0 10 [200]
Tums, E-X Extra Strength (tab, 750 mg)
0 0 0 0 0 15 [300]
Tums, Ultra (Maximum) Strength (tab, 1000 mg)
0 0 0 0 0 20 [400]
Magnesium gluconate (ml, 1000 mg/5 ml)
0 0 0 0 0.9 [10.8]
0
Potassium chloride (ml, 20mEq/15 ml)
0 1.3 1.3 0 0 0
Table salt (tsp)
101 [2325]
0 101
0 0 0
Table 8.8 Recommended Initial Dosages* for Enteral Electrolyte Supplements
Electrolyte Supplements Dosage
Potassium Chloride 2 mEq/kg/day in divided doses
Sodium Chloride 2-4 mEq/kg/day * Dosages given in this table are only initial suggestions. Clinical parameters, such as laboratory values, should be closely monitored and dosages should be titrated accordingly. Dosages given are for replacement of low serum values only.
Chapter 8 Pharmacology and Nutrition Support
102
References
1. Wohlt PD, Zheng L, Gunderson S, et al. Recommendations for the use of medications
with continuous enteral nutrition. Am J Health-Syst Pharm 2009;66:1458-67. 2. Genser D. Food and drug interaction: consequences for the nutrition/health status. Ann
Nur Metab 2008;52 (Suppl 1):29-32. 3. Magnuson BL, Clifford TM, Hoskins LA, Bernard AC. Enteral nutrition and drug
administraction, interactions, and complications. JPEN J Parenter Enteral Nutr. 2005;20: 618-624.
4. Huang S, Lesko LJ. Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned? J Clin Pharmacol. 2004;44: 559-569.
5. Mertens-Talcott SU, Sadenzensky I, De Castro WV, Derendorf H, Butterweck V. Grapfruit-drug interactions: can interactions with drugs be avoided? J Clin Pharmacol. 2006;46:1390-1416.
6. Au Yeung SCS, Ensom MHH. Phenytoin and enteral feedings: does evidence support an interaction? Ann Pharmacother. 2000; 34:896-905.
7. Williams D. The effect of enteral nutrition supplements on serum voriconazole levels. J
Oncol Pharm Pract 2012;18:128-13. 8. Lenz GT, Mikrut BA. Calcium and phosphate solubility in neonatal parenteral nutrient
solutions containing Aminosyn-PF or TrophAmine. Am J Hosp Pharm. 1988;45;2367-71.
9. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 18th
edition. Hudson, OH: Lexi-Comp Publishing; 2011.
103
APPENDIX
A – Growth Charts for Normal Infants and Children • World Health Organization Growth Standards for Infants (Charts 1 – 3) • National Center for Health Statistics (CDC) Growth Charts for Children Aged 2-
20 Years (Charts 4 – 8) • Fenton Growth Chart for Preterm Infants (Chart 9)
B - Specialized Growth Charts: Down Syndrome C – Triceps Skinfold Percentile Charts D – Mid Upper Arm Circumference Percentile Charts E - Developmental Self-Feeding Checklist F - Selected Lab Values with Nutritional Implications G - Estimated Energy Requirements (EER) for Infants and Children H - Guide to Number of Servings and Serving Size for Children I - Electrolyte Conversion Information J - Oral Multivitamin and Mineral Supplements Available at UVA K - Tips for Increasing Calories for Children L - Sites of Nutrient Malabsorption Resulting from Intestinal Resections M – UVA Therapeutic Algorithm for Management of Pediatric Post-operative Chylothorax
Birth to 24 months: BoysLength-for-age and Weight-for-age percentiles
Published by the Centers for Disease Control and Prevention, November 1, 2009SOURCE: WHO Child Growth Standards (http://www.who.int/childgrowth/en)
9895857550251052
98
95
90
75
50
25
1052
Birth to 24 months: GirlsLength-for-age and Weight-for-age percentiles
Published by the Centers for Disease Control and Prevention, November 1, 2009SOURCE: WHO Child Growth Standards (http://www.who.int/childgrowth/en)
98
95
90
75
50
25
1052
9895907550251052
12
Birth
40
38
36
32
20
19
18
17
16
15
14
13
in
HEAD
CIRCUMFERENCE
HEAD
CIRCUMFERENC
30
34
52
48
46
44
cm
20
19
18
in
17
Birth to 24 months: GirlsHead circumference-for-age andWeight-for-length percentiles
NAMERECORD #
42
44
46
52
50
cm
48
50
WEIGHT
WEIGHT
WEIGHT
WEIGHT
kg lb
WEIGHT
14
2018
1416
1210
8642
987
2
incmkglb1
3
WEIGHT
2224
101112
65
E
66 68 70 72 74 76 78 80 82 84 86 88 92 94 969810010210410610890 cmin
Published by the Centers for Disease Control and Prevention, November 1, 2009SOURCE: WHO Child Growth Standards (http://www.who.int/childgrowth/en)
Date Age CommentWeight Length Head Circ.
64
24232221201918
46 4850 52 54 56 58 60 62
987
222018
1416
2426283032343638404244
121314
151617
12
1011
464850
1819202122
65
2324 52
242628
9895907550
251052
989590
75
50
25
1052
11041 424039383735 36343332313029282726 43
4 LENGTH
2 to 20 years: Boys
Stature Weight-for-age percentiles-for-age and
NAME
RECORD #
W
E
I
G
H
T
W
E
I
G
H
T
S
T
A
T
U
R
E
S
T
A
T
U
R
E
lb
30
40
50
60
70
80
lb
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
230
kg10
15
20
25
30
35
80
85
90
95
100
105
110
115
120
125
130
135
140
145
150
155
160
cm
cm
150
155
160
165
170
175
180
185
190
kg10
15
20
25
30
35
105
45
50
55
60
65
70
75
80
85
90
95
100
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
12 13 14 15 16 17 18 19 20
AGE (YEARS)
AGE (YEARS)
40
90
75
50
25
10
90
75
50
25
10
113 4 5 6 7 8 9 10
97
3
97
3
62
42
44
46
48
60
58
52
54
56
in
30
32
34
36
38
40
50
74
76
72
70
68
66
64
62
60
inDate
Mother’s Stature Father’s Stature
Age Weight Stature BMI*
SOURCE: Developed b
(2000).
y the National Center for Health Statistics in collaboration with
the National Center for Chronic Disease Prevention and Health Promotion
http://www.cdc.gov/growthcharts
Published May 30, 2000 (modified 11/21/00).
2 to 20 years: Boys
Body mass index-for-age percentilesNAME
RECORD #
2 543 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
26
24
22
20
18
16
14
12
kg/m2
28
26
24
22
20
18
16
14
12
kg/m2
30
32
34
BMI
BMI
AGE (YEARS)
13
15
17
19
21
23
25
27
13
15
17
19
21
23
25
27
29
31
33
35
90
75
50
25
10
85
Date Age Weight Stature BMI* Comments
97
3
95
SOURCE: Developed b
(2000).
y the National Center for Health Statistics in collaboration with
the National Center for Chronic Disease Prevention and Health Promotion
http://www.cdc.gov/growthcharts
Published May 30, 2000 (modified 10/16/00).
2 to 20 years: Girls
Stature Weight-for-age percentiles-for-age and
NAME
RECORD #
W
E
I
G
H
T
W
E
I
G
H
T
S
T
A
T
U
R
E
S
T
A
T
U
R
E
kg10
15
20
25
30
35
80
85
90
95
100
105
110
115
120
125
130
135
140
145
150
155
cm
150
155
160
165
170
175
180
185
190
kg10
15
20
25
30
35
105
45
50
55
60
65
70
75
80
85
90
95
100
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
12 13 14 15 16 17 18 19 20
AGE (YEARS)
AGE (YEARS)
40
160
cm 113 4 5 6 7 8 9 10
90
75
50
25
10
90
75
50
25
10
97
3
97
3
lb
30
40
50
60
70
80
lb
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
230
Date
Mother’s Stature Father’s Stature
Age Weight Stature BMI*
62
42
44
46
48
60
58
52
54
56
in
30
32
34
36
38
40
50
74
76
72
70
68
66
64
62
60
in
SOURCE: Developed b
(2000).
y the National Center for Health Statistics in collaboration with
the National Center for Chronic Disease Prevention and Health Promotion
http://www.cdc.gov/growthcharts
Published May 30, 2000 (modified 11/21/00).
2 to 20 years: Girls
Body mass index-for-age percentilesNAME
RECORD #
2 543 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
26
24
22
20
18
16
14
12
kg/m2
28
26
24
22
20
18
16
14
12
kg/m2
30
32
34
BMI
BMI
AGE (YEARS)
13
15
17
19
21
23
25
27
13
15
17
19
21
23
25
27
29
31
33
35
Date Age Weight Stature BMI* Comments
90
85
75
50
10
25
97
3
95
SOURCE: Developed b
(2000).
y the National Center for Health Statistics in collaboration with
the National Center for Chronic Disease Prevention and Health Promotion
http://www.cdc.gov/growthcharts
Published May 30, 2000 (modified 10/16/00).
APPENDIX B Source: www.growthcharts.com
APPENDIX B Source: www.growthcharts.com
APPENDIX B Source: www.growthcharts.com
APPENDIX B Source: www.growthcharts.com
APPENDIX B Source: www.growthcharts.com
APPENDIX B Source: www.growthcharts.com
APPENDIX B Source: www.growthcharts.com
APPENDIX B Source: www.growthcharts.com
Table 28 Triceps skinfold in millimeters for persons 3 months-19 years-number of examined persons, mean, standard error of the mean, and selected percentiles, by sex and age : United States, 1988-1994
Selected percentile Number of Standard
Sex and age examined error of persons Mean the mean 5th 10th 15th 25th 50th 75th 85th 90th 95th
Male
3-5 months .................................. 290 10.5 0.21 * 7.9 8.4 9.2 10.7 11.7 12.5 13.2 * 6-8 months .................................. 320 10.2 0.23 * 7.3 7.9 8.5 9.9 11.6 12.5 13.3 * 9-11 months ................................ 275 9.5 0.20 * 7.1 7.4 8.1 9.2 10.7 11.1 11.8 * 1 year .......................................... 647 9.4 0.15 6.4 6.9 7.2 7.9 9.1 10.7 11.7 12.1 13.1 2 years ........................................ 555 9.1 0.13 6.4 6.7 7.3 7.9 8.9 10.4 11.1 11.5 12.4 3 years ........................................ 479 8.9 0.20 * 6.4 6.8 7.3 8.6 10.0 10.8 11.6 * 4 years ........................................ 538 9.0 0.18 6.0 6.6 6.8 7.3 8.6 10.0 11.4 12.0 12.9 5 years ........................................ 493 8.7 0.20 6.0 6.3 6.8 7.2 8.1 9.5 10.3 11.3 13.0 6 years ........................................ 278 9.8 0.46 * 6.0 6.4 7.1 8.5 10.8 12.9 14.9 * 7 years ........................................ 268 9.7 0.45 * 6.1 6.4 7.1 8.7 10.7 13.3 16.8 * 8 years ........................................ 262 10.8 0.59 * 6.3 6.4 7.3 8.8 12.3 15.7 20.1 * 9 years ........................................ 276 12.4 0.69 * 6.6 6.8 7.4 9.7 15.4 21.3 23.9 * 10 years ...................................... 293 12.5 0.63 * 6.0 6.9 8.2 10.4 15.5 20.8 22.3 * 11 years ...................................... 282 13.6 0.70 * 6.7 7.2 8.6 11.3 18.2 19.5 22.3 * 12 years ...................................... 200 13.5 0.77 * * 7.6 8.6 12.9 17.4 19.2 * * 13 years ...................................... 182 12.4 0.89 * * 6.4 7.1 10.5 15.7 19.7 * * 14 years ...................................... 183 11.0 0.82 * * 6.2 6.7 8.3 13.4 17.0 * * 15 years ...................................... 182 12.1 1.00 * * 6.0 6.7 9.5 13.8 19.2 * * 16 years ...................................... 191 11.1 0.86 * * 6.6 7.1 8.6 13.6 17.0 * * 17 years ...................................... 191 11.3 0.82 * * 5.8 7.2 8.9 12.8 19.2 * * 18 years ...................................... 168 10.9 0.90 * * 5.7 6.3 8.3 12.6 16.8 * * 19 years ...................................... 160 12.1 1.05 * * 6.3 7.5 9.5 12.2 21.9 * *
Female
3-5 months .................................. 309 10.4 0.21 * 7.9 8.2 8.7 10.3 11.8 12.3 12.6 * 6-8 months .................................. 261 9.9 0.28 * * 7.6 8.2 9.4 11.3 12.2 * * 9-11 months ................................ 316 9.6 0.24 * 7.1 7.4 8.0 9.2 10.9 11.9 12.7 * 1 year .......................................... 626 9.7 0.16 6.5 7.1 7.4 8.1 9.6 11.0 11.9 12.4 13.5 2 years ........................................ 545 9.5 0.17 * 7.1 7.4 7.9 9.2 10.9 11.6 12.3 * 3 years ........................................ 554 9.7 0.21 * 7.1 7.4 8.1 9.1 10.9 11.6 12.4 * 4 years ........................................ 529 10.3 0.29 * 7.3 7.7 8.4 9.6 11.6 12.8 13.4 * 5 years ........................................ 554 10.3 0.27 * 7.3 7.6 8.2 9.6 11.4 12.8 14.4 * 6 years ........................................ 273 10.3 0.48 * * 7.1 7.5 9.3 11.1 13.6 * * 7 years ........................................ 269 11.9 0.59 * * 7.4 7.9 10.6 14.5 18.0 * * 8 years ........................................ 244 12.4 0.64 * * 7.8 8.5 10.7 14.2 17.6 * * 9 years ........................................ 270 14.4 0.84 * * 8.2 8.9 12.1 16.5 23.9 * * 10 years ...................................... 255 15.0 0.81 * * 8.7 10.1 12.9 18.1 21.7 * * 11 years ...................................... 268 15.1 0.78 * * 8.9 9.9 12.9 19.8 21.2 * * 12 years ...................................... 233 15.2 0.90 * * 8.2 9.6 13.2 19.4 23.4 * * 13 years ...................................... 218 17.5 0.89 * * 10.4 11.7 15.9 22.3 24.4 * * 14 years ...................................... 216 18.7 0.90 * * 11.6 12.4 17.5 22.5 25.4 * * 15 years ...................................... 188 17.8 0.98 * * 11.1 12.4 16.7 20.7 25.7 * * 16 years ...................................... 202 18.6 0.89 * * 12.0 14.0 16.8 21.8 25.4 * * 17 years ...................................... 191 20.0 0.98 * * 12.4 14.2 19.6 24.8 27.3 * * 18 years ...................................... 165 19.4 1.07 * * * 13.8 17.9 24.2 * * * 19 years ...................................... 167 19.6 1.18 * * * 14.0 18.5 24.1 * * *
* Figure does not meet standard of reliability or precision. NOTE: Pregnant women are excluded.
Table 41 Mid-upper arm circumference in centimeters for persons 3 months-19 years-number of examined persons, mean, standard error of the mean, and selected percentiles, by sex and age : United States, 1988-1994
Selected percentile Number of Standard
Sex and age examined error of persons Mean the mean 5th 10th 15th 25th 50th 75th 85th 90th 95th
Male
3-5 months .................................. 289 14.6 0.12 * 13.2 13.5 13.9 14.5 15.4 15.7 16.0 * 6-8 months .................................. 319 15.3 0.12 * 13.8 14.0 14.4 15.2 16.1 16.6 17.0 * 9-11 months ................................ 275 15.6 0.12 * 14.1 14.5 14.8 15.7 16.4 16.8 17.1 * 1 year .......................................... 651 16.1 0.08 14.4 14.8 15.0 15.4 16.0 16.9 17.3 17.7 18.3 2 years ........................................ 574 16.5 0.08 14.8 15.1 15.4 15.6 16.3 17.2 17.8 18.0 18.5 3 years ........................................ 483 16.9 0.13 15.0 15.4 15.7 15.9 16.8 17.7 18.2 18.6 19.0 4 years ........................................ 542 17.3 0.11 15.3 15.6 16.0 16.4 17.1 18.0 18.4 19.0 19.5 5 years ........................................ 495 17.9 0.13 15.5 16.0 16.2 16.8 17.7 18.6 19.3 19.6 20.7 6 years ........................................ 279 18.9 0.28 * 16.4 16.8 17.1 18.4 19.6 20.5 22.7 * 7 years ........................................ 268 19.3 0.24 * 17.1 17.6 17.9 18.9 20.3 21.3 21.7 * 8 years ........................................ 261 20.4 0.31 * 17.5 18.0 18.4 19.6 21.8 23.4 24.7 * 9 years ........................................ 276 21.7 0.34 * 18.3 18.6 19.2 20.7 24.2 25.3 27.0 * 10 years ...................................... 294 22.6 0.34 * 18.7 19.2 20.1 22.0 25.0 26.6 27.5 * 11 years ...................................... 281 23.6 0.38 * 19.7 20.0 21.1 22.7 25.5 27.4 28.1 * 12 years ...................................... 202 25.2 0.45 * * 21.6 23.1 24.1 27.3 28.5 * * 13 years ...................................... 181 25.7 0.49 * * 22.0 23.6 24.6 27.8 28.6 * * 14 years ...................................... 185 28.1 0.78 * * 23.9 24.3 27.0 29.8 30.6 * * 15 years ...................................... 183 28.5 0.51 * * 24.9 25.9 27.5 31.1 33.3 * * 16 years ...................................... 191 29.2 0.50 * * 25.6 26.6 28.4 31.2 32.6 * * 17 years ...................................... 193 30.7 0.51 * * 26.7 27.7 30.0 33.1 35.3 * * 18 years ...................................... 168 30.1 0.55 * * 25.9 27.4 29.6 31.8 34.5 * * 19 years ...................................... 161 31.5 0.52 * * 27.8 28.6 30.8 33.7 35.8 * *
Female
3-5 months .................................. 309 14.0 0.13 * 12.7 12.9 13.3 14.0 14.8 15.2 15.6 * 6-8 months .................................. 262 14.8 0.14 * * 13.6 13.9 14.7 15.4 16.1 * * 9-11 months ................................ 315 15.2 0.12 * 13.8 14.0 14.4 15.2 15.9 16.4 16.7 * 1 year .......................................... 627 15.9 0.09 14.0 14.4 14.7 15.0 15.9 16.7 17.0 17.5 17.9 2 years ........................................ 556 16.3 0.09 * 15.0 15.2 15.5 16.2 17.0 17.4 17.9 * 3 years ........................................ 561 17.0 0.11 15.1 15.5 15.8 16.1 16.8 17.6 18.1 18.5 19.3 4 years ........................................ 527 17.6 0.17 * 15.6 15.9 16.4 17.3 18.2 19.0 19.6 * 5 years ........................................ 555 18.1 0.15 * 16.1 16.3 16.8 17.8 19.0 19.7 20.6 * 6 years ........................................ 273 18.7 0.28 * * 16.7 17.2 18.1 19.5 21.1 * * 7 years ........................................ 270 19.9 0.34 * * 17.1 17.6 19.3 21.4 23.5 * * 8 years ........................................ 245 20.6 0.35 * * 17.9 18.6 20.0 21.5 23.3 * * 9 years ........................................ 272 22.1 0.47 * * 18.4 19.3 20.9 24.0 26.5 * * 10 years ...................................... 255 22.6 0.42 * * 19.0 19.8 21.8 24.6 26.5 * * 11 years ...................................... 268 23.7 0.40 * * 20.1 21.2 23.5 25.7 27.4 * * 12 years ...................................... 233 24.5 0.48 * * 20.0 21.5 23.8 27.1 28.3 * * 13 years ...................................... 217 26.3 0.53 * * 22.1 23.0 25.4 29.1 31.1 * * 14 years ...................................... 218 26.9 0.49 * * 23.0 24.0 25.9 29.5 31.1 * * 15 years ...................................... 189 26.7 0.49 * * 23.8 24.2 25.9 28.1 30.1 * * 16 years ...................................... 204 27.3 0.47 * * 23.5 24.7 26.4 29.5 31.3 * * 17 years ...................................... 195 27.7 0.50 * * 24.2 25.2 27.0 29.3 31.2 * * 18 years ...................................... 170 27.4 0.59 * * * 24.4 26.5 29.8 * * * 19 years ...................................... 168 28.2 0.63 * * * 25.2 27.2 29.6 * * *
* Figure does not meet standard of reliability or precision. NOTE: Pregnant women are excluded.
APPENDIX E Developmental Self-Feeding Checklist
Developmental Age*
Feeding Skill
Two months
Infant brings hands to mouth in both supine and prone.
Three months
Infant brings hands to mouth while holding an object.
Three-and-a-half months
Infant visually recognizes food and the bottle.
Four months
Infant pats bottle with one or both hands.
Four-and-a-half months
Infant holds both hands on the bottle.
Five-and-a-half months
Infant holds bottle independently with one or both hands.
Five or six months
Infant mouths and gums solid foods such as hard baby cookies.
Six months
Infant drinks from a cup held by an adult.
Six-and-a-half or seven months
Infant feeds self a cracker.
Nine months
Infant is capable of independent finger-feeding. Infant holds and bangs spoon.
Nine-and-a-half months
Infant stirs spoon in imitation.
Twelve months
Child holds cup and drinks with some spilling. Child holds the handle of a cup while drinking.
Twelve to fourteen months
Child brings a filled spoon to the mouth, turning the spoon over enroute.
Fifteen to eighteen months
Child scoops food and brings it to the mouth, spilling some.
Eighteen to twenty-four months
Child gives up the bottle and drinks entirely from the cup.
Twenty to twenty-two months
Child can hold a cup in one hand while drinking.
Twenty-four months
Child brings a spoon or fork to the mouth with the hand palm-up.
Thirty months
Child can pour liquid from a small container.
Thirty-one or thirty-two months
Child feeds self with little spilling.
Thirty to thirty-six months
Child uses a fork to stab food.
*Developmental ages are approximate and may vary with individual children Morris, S.E. and Klein, M., Pre-Feeding Skills. p. 306.
APPENDIX F
SELECTED LAB VALUES WITH NUTRITIONAL IMPLICATIONS Lab Parameter Normal Range Possible Reasons for
High Value Possible Reasons for Low Value
BUN
10 – 20 mg/dl Higher in elderly: 10 – 25 mg/dl
Dehydration Renal disease Increased protein metabolism Starvation Stress Diabetes Fever Acute myocardial infarction GI bleed Congestive heart failure Urinary obstruction
Liver failure Increased protein synthesis - Late pregnancy - Infancy Acromegaly Nephrotic syndrome Overhydration Malabsorption Low protein, high CHO diets
Creatinine
0.7 - 1.3 mg/dl
Large muscle mass Muscle disease Starvation Renal disease
CO2 (Bicarbonate)
22 – 30 mEq/L
Metabolic alkalosis Respiratory acidosis Emphysema Vomiting
Metabolic acidosis Respiratory alkalosis Hyperventilation Fever Lack of oxygen
APPENDIX F SELECTED LAB VALUES WITH NUTRITIONAL IMPLICATIONS (cont.)
Lab Parameter Normal Range Possible Reasons for
High Value Possible Reasons for Low Value
Serum Osmolarity Osm = serum sodium x 2 + BUN + Glucose 2.8 18
275 – 295 mOsm/L Calculated values are generally lower than measured values
Inadequate fluid intake Diarrhea Diabetes mellitus Diabetes insipidus Renal disease Hyperlipidemia Hyperglycemia
Excess fluid intake Adrenal disease Inappropriate ADH secretion - Hypothyroidism - Cerebral disease
Porphyria - Bronchogenic cancer
Serum Glucose * Elevated values may give falsely low serum sodium values. For every 100% elevation in glucose, serum sodium should be increased 2 mEq/L
65 – 115 mg/dl
Diabetes mellitus Cushing’s syndrome Acromegaly Hemochromatosis Pheochromocytoma Burns, shock Acute pancreatitis Wernicke’s encephalopathy Dehydration Sepsis Overfeeding Corticosteroids
Liver disease Neoplasms Pancreatic disorders Addison’s disease Hypothyroidism Water overload
APPENDIX F SELECTED LAB VALUES WITH NUTRITIONAL IMPLICATIONS (cont.)
Lab Parameter Normal Range Possible Reasons for
High Value Possible reasons for Low Value
Hematocrit (HCT) Often used to diagnose iron deficiency; not a conclusive measure
Women: 35 – 47% Men: 40 – 52%
Dehydration Polycythemia
Hemorrhage Anemia Water overload Advanced age Late Pregnancy
Hemoglobin (Hgb) More direct measure of iron deficiency than HCT
Women: 12 – 16 gm/dl Men: 14 – 18 gm/dl
Dehydration Polycythemia
Hemorrhage Iron deficiency anemia Protein–calorie malnutrition Advanced age Late pregnancy Renal failure Water overload
Mean Corpuscular Volume (MCV) Indicates average size of the red blood cells. Calculated MCV = HCT x 10 RBC
83 – 95 microns
Macrocytosis - Folate deficiency
- Vitamin B 12 deficiency - Excess alcohol intake
Hemochromatosis
Microcytosis - Advanced iron deficiency - Blood loss
Iron deficiency Iron malabsorption Lead poisoning
APPENDIX F SELECTED LAB VALUES WITH NUTRITIONAL IMPLICATIONS (cont.)
Lab Parameter Normal Range Possible Reasons for
High value Possible Reasons for Low Value
Sodium Body content of sodium is not always reflected in serum levels
137 – 145 mEq/L
Dehydration Renal disease
Extreme sweating Diuretic medication Diabetic ketoacidosis Malabsorption Excessive GI losses SIADH
Potassium Required with nitrogen for replacement of lost muscle mass
3.5 – 5.0 mEq/L
Burns, shock Crush injuries Excess IV potassium Renal failure Diabetic ketoacidosis Dehydration Hyperglycemia
Refeeding Syndrome Starvation Vomiting Excessive GI losses Diarrhea Hypomagnesemia Cushing’s syndrome Diuretic medication Amphotericin
Chloride
98 – 107 mEq/L
Dehydration Renal failure
Gastrointestinal losses Excess urinary losses
APPENDIX F SELECTED LAB VALUES WITH NUTRITIONAL IMPLICATIONS (cont.)
Lab Parameter Normal Range Possible Reasons for High Value
Possible Reasons for Low Value
Calcium Absorption decreased by phytate, oxalate, phosphate, fat malabsorption and high protein diet
8.5 – 10.5 mg/dl
Cancer Renal disease Vitamin D intoxication Hyperparathyroidism Renal calculi Immobilization
Hypoparathyroidism Renal disease Osteomalacia Steatorrhea Rickets Hypomagnesemia
Phosphorous
4.0 – 7.0 mg/dl
Hemolyzed blood Diabetes Renal disease Healing fractures Vitamin D deficiency Skeletal disease
Rickets Insulin injections Malnutrition Malabsorption Refeeding syndrome
Magnesium
1.6 – 2.3 mg/dl
Renal failure Diabetic acidosis Hypothyroidism Addison’s disease Dehydration Overuse of Mg supplements or antacids
Chronic diarrhea Alcoholism Pancreatitis Renal disease Hepatic cirrhosis Toxemia of pregnancy Hyperthyroidism Malabsorption Ulcerative colitis K- depleting diuretics Refeeding syndrome
134
APPENDIX G
Estimated Energy Requirements (EER) for Infants and Children
Normal Weight Infants and Children EER for Ages 0- 36 Months EER = total energy expenditure (TEE) + energy deposition 0-3 months (89 x weight [kg] – 100) + 175 kcal 4-6 months (89 x weight [kg] – 100) + 56 kcal 7-12 months (89 x weight [kg] – 100) + 22 kcal 13-36 months (89 x weight [kg] – 100) + 20 kcal Table 1. Total Energy Expenditure (TEE) For Infants and Children 0-36 Months of Age
Kcals/kg determined as follows: TEE/reference weight (kg)
Boys Girls Age
(months) Reference
weight (kg)
TEE (kcals/day)
Kcals/kg Reference weight (kg)
TEE (kcals/day)
Kcals/kg
1 4.4 472 107 4.2 438 104 2 5.3 567 107 4.9 500 102 3 6.0 572 95 5.5 521 95 4 6.7 548 82 6.1 508 83 5 7.3 596 82 6.7 553 83 6 7.9 645 82 7.2 593 82 7 8.4 668 80 7.7 608 79 8 8.9 710 80 8.1 643 79 9 9.3 746 80 8.5 678 80 10 9.7 793 82 8.9 717 81 11 10.0 817 82 9.2 742 81 12 10.3 844 82 9.5 768 81 15 11.1 908 82 10.3 837 81 18 11.7 961 82 11.0 899 82 21 12.2 1006 82 11.6 952 82 24 12.7 1050 83 12.1 997 82 27 13.1 1086 83 12.5 1033 83 30 13.5 1121 83 13.0 1077 83 33 13.9 1157 83 13.4 1113 83 35 14.2 1184 83 13.7 1139 83
135
APPENDIX G EER for Boys Ages 3-8 Years EER = 88.5 – (61.9 x age [y]) + PA x (26.7 x weight [kg] + 903 x height [m]) + 20 kcal EER for Boys 9-18 Years EER = 88.5 - (61.9 x age [y]) + PA x (26.7 x weight [kg] + 903 x height [m]) + 25 kcal Physical Activity (PA) Coefficient for Boys: 1.00 (sedentary) 1.16 (low active) 1.31 (active) 1.56 (very active) Table 2. Estimated Energy Requirements (EER) For Boys 3-18 Years of Age
PAL = physical activity level Kcals/kg determined as follows: EER/reference weight (kg)
EER Age (yrs)
Reference weight (kg)
Sedentary PAL
Low Active PAL
Active PAL
Very Active PAL
Kcals/kg
3 14.3 1162 1324 1485 1683 81-93 4 16.2 1215 1390 1566 1783 75-86 5 18.4 1275 1466 1658 1894 69-80 6 20.7 1328 1535 1742 1997 64-74 7 23.1 1393 1617 1840 2115 60-70 8 25.6 1453 1692 1931 2225 57-66 9 28.6 1530 1787 2043 2359 53-62 10 31.9 1601 1875 2149 2486 50-59 11 35.9 1691 1985 2279 2640 47-55 12 40.5 1798 2113 2428 2817 44-52 13 45.6 1935 2276 2618 3038 42-50 14 51.0 2090 2459 2829 3283 41-48 15 56.3 2223 2618 3013 3499 39-47 16 60.9 2320 2736 3152 3663 38-45 17 64.6 2366 2796 3226 3754 37-43 18 67.2 2383 2823 3263 3804 35-42
136
APPENDIX G EER for Girls 3-8 Years EER = 135.3 – (30.8 x age [y] + PA x (10.0 x weight [kg] + 934 x height [m]) + 20 kcal EER for Girls 9-18 Years EER = 135.3 – (30.8 x age [y] + PA x (10.0 x weight [kg] + 934 x height [m]) + 25 kcal Physical Activity (PA) Coefficient for Girls: 1.0 (sedentary) 1.13 (low active) 1.26 (active) 1.42 (very active) Table 3. Estimated Energy Requirements (EER) For Girls 3-18 Years of Age
PAL = physical activity level Kcals/kg determined as follows: EER/reference weight (kg)
EER Age (yrs)
Reference weight (kg)
Sedentary PAL
Low Active PAL
Active PAL
Very Active PAL
Kcals/kg
3 13.9 1080 1243 1395 1649 78-89 4 15.8 1133 1310 1475 1750 72-83 5 17.9 1189 1379 1557 1854 66-77 6 20.2 1247 1451 1642 1961 62-72 7 22.8 1298 1515 1719 2058 57-66 8 25.6 1360 1593 1810 2173 53-62 9 29.0 1415 1660 1890 2273 49-57 10 32.9 1470 1729 1972 2376 45-53 11 37.2 1538 1813 2071 2500 41-49 12 41.6 1617 1909 2183 2640 39-46 13 45.8 1684 1992 2281 2762 37-43 14 49.4 1718 2036 2334 2831 35-41 15 52.0 1731 2057 2362 2870 33-40 16 53.9 1729 2059 2368 2883 32-38 17 55.1 1710 2042 2353 2871 31-37 18 56.2 1690 2024 2336 2858 30-36
137
APPENDIX G Overweight Children EER for Weight Maintenance for Boys 3-18 Years of Age* EER = 114 - (50.9 x age [yr]) + PA x (19.5 x wt [kg] +1161.4 x ht [m]) Physical Activity (PA) Coefficient for Overweight Boys: 1.0 (sedentary) 1.12 (low active) 1.24 (active) 1.45 (very active) PA: 1 sedentary, 1.18 low active, 1.35 active, 1.60 very active EER for Weight Maintenance for Girls 3-18 Years of Age* EER = 389 - (41.2 x age [yr]) + PA x (15 x wt [kg] + 701.6 x ht [m]) Physical Activity (PA) Coefficient for Overweight Girls: 1.0 (sedentary) 1.18 (low active) 1.35 (active) 1.605 (very active) *For children who are overweight (>95th percentile BMI for age) or at risk for overweight (85-95th percentile BMI for age) with existing comorbidities, a factor of 108 kcals/day can be subtracted from the calculated weight maintenance EER to promote a slow weight loss of 1 pound per month.
APPENDIX H
GUIDE TO NUMBER OF SERVINGS AND SERVING SIZES FOR CHILDREN
FOOD GROUPS CHILD 1-3 CHILD 4-6 CHILD 7-10 ADOLESCENT 11-14 15-18
Milk Group Milk
Ice Cream Cheese
(3 cups) 6 oz.
(3 cups) 8 oz.
(3 cups) 8 oz.
(3-4 cups) 8 oz.
(3-4 cups) 8 oz.
Meat Group Meat, Poultry or Fish
Eggs Dried Beans, Peas
Peanut Butter
(2 servings) 2-3 oz.
1 ½ cup
2T.
(2 servings) 2-3 oz.
1 ¾ cup
2T.
(2 servings) 2-3 oz.
1 1 cup 2T.
(2 servings) 2-3 oz.
1-2 1 cup 2T.
(2 servings) 2-3 oz.
1-2 1 cup 2T.
Breads & Cereals Group
(Whole Grain or Enriched)
Bread Cereal
(4 small servings)
½ slice ¼ cup
(4 servings)
1 slice 1/3 cup
(4-5 servings)
1 slice ½ cup
(4-6 servings)
1 slice ¾ - 1 cup
(4-6 servings)
1 slice 1 cup
Fruits & Vegetables Group
Vit. C – good source Vit. A – good source
Others
(4 small servings)
¼ cup 2 T. 4 T.
(4 servings)
½ cup 2-3/week 1/3 cup
(4-5 servings)
¾ cup 2-3/week
½ cup
(4-6 servings)
1 cup 2-3/week
¾ cup
(4-6 servings)
1 cup 2-3/week
¾ cup
Miscellaneous Group Sweets
Snack Foods Soft Drinks
Butter/Margarine
0 1 T.
0 1-2 T.
0 1-2 T.
0 2+ T.
0 2+ T.
APPENDIX I
ELECTROLYTE CONVERSION INFORMATION
1. Converting from milliequivalents (mEq) to milligrams (mg) and vice versa:
mgmEq = Conversion factor
Conversion Factors For Major Minerals
• 1 mEq Na = 1 mmol Na = 23 mg Na • 1 g Na = 43 mEq Na = 43 mmol Na • 1 mEq K = 1 mmol K = 39 mg K • 1 g K = 26 mEq K = 26 mmol K • 1 mEq Ca = 0.5 mmol Ca = 20 mg Ca • 1 g Ca = 50 mEq Ca = 25 mmol Ca • 1 mEq Mg = 0.5 mmol Mg = 12 mg Mg • 1 g Mg = 82 mEq Mg = 41 mmol Mg • 1 mmol P = 2 mEq HPO3 = 31 mg P • 1 mEq Cl = 1 mmol Cl = 35 mg Cl • 1 g Cl = 29 mEq Cl = 29 mmol Cl
Major Mineral Content in Various Compounds and Solutions
• 1 g NaCl = 393 mg Na = 17 mEq Na • 1 g NaHCO3 = 273 mg Na = 12 mEq Na • 1000 ml saline = 9 g NaCl = 3.5 g Na = 154 mEq Na • 1000 ml lactated Ringer’s solution = 3 g Na = 130 mEq Na • 1 ampule (50 ml) 7.5% NaHCO3 = 1 g Na = 44 mEq Na • 1 g KCl = 524 mg K = 13 mEq K • 1 g CaCl2 2H2O = 273 mg Ca = 13.6 mEq Ca (when weighed in hydrated forms) • 1 g Ca gluconate = 93 mg Ca = 4.6 mEq Ca • 1 g MgSO4 7H2O = 99 mg Mg = 8.1 mEq Mg (when weighed in hydrated forms) • 1 mg Mg gluconate 2H2O = 54 mg Mg = 4.4 mEq Mg (when weighed in hydrated forms) • 1 g CaCO3 = 400 mg Ca = 20 mEq Ca • 1 g FeSo4 7H2O = 201 mg Fe (when weighed in hydrated forms) • 1 g Fe gluconate 2H2O = 116 mg Fe (when weighed in hydrated forms) • 1 ml Fe dextran (Imferon) = 50 mg Fe
2. Converting sodium chloride to sodium:
NaCl (table salt) is 40% sodium and 60% chloride Therefore: 1 gm sodium chloride = 400 mg sodium 400 mg sodium = 17 mEq sodium
3. Niacin equivalents: 1% available dietary protein = tryptophan 60 mg dietary tryptophan is equivalent to 1 mg niacin
APPENDIX J Oral Multivitamin and Mineral Supplements Available at UVAa
aBrand names are representative of products purchased by the University of Virginia. Contact the pharmacy for additional information. bNephro-vite also contains 300 mcg biotin.
Adult Products A (IU)
D (IU)
E (IU)
B1 (mg)
B2 (mg)
B3 (mg)
B5 (mg)
B6 (mg)
B12 (mcg)
C (mg)
Folate (mg)
Ca (mg)
Iron (mg)
Fluo (mg)
Multivitamin tablet 1 tab. 5,000 400 30 3.0 3.4 20 10 3.0 9.0 90 0.4 66 - -
Multivitamin liquid 5ml 5,000 400 - 10 10 100 21.4 4.1 5.0 200 - - -
- Multivitamin with minerals tablet 1 tab. 5,000 400 30 3.0 3.4 30 10 3.0 9.0 120 0.4 40 27 -
Multivitamin with minerals liquid 15 ml 2,500 400 30 1.5 1.7 20 10 2.0 6.0 60 - - - -
Pediatric Products Multivitamin with minerals Chewable Tab (Centrum Jr.) 1 tab. 5,000 400 30 1.5 1.7 20 10 2 6 60 0.4 162 18 -
Multivitamin drops 1 ml 1,500 400 5 0.5 0.6 8 - 0.4 2 35 - - - -
Multivitamin drops with iron 1 ml 1,500 400 5 0.5 0.6 8 - 0.4 - 35 - - 10 -
Multivitamin drops with fluoride 1 ml 1,500 400 5 0.5 0.6 8 - 0.4 2 35 - - - 0.25
A, D, C drops 1 ml 1,500 400 - - - - - - - 35 - - - -
A, D, C drops with iron 1 ml 1,500 400 - - - - - - - 35 - - 10 -
Sodium fluoride drops 1 ml - - - - - - - - - - - - - 0.5
Ferrous sulfate drops
0.6 ml - - - - - - - - - - - - 15 -
Special Products ADEK tablet 1 tab. 4,000 400 150 1.2 1.3 10 10 1.5 12 60 0.2 - - -
ADEK liquid 1 ml 1500 400 40 0.5 0.6 6 3 0.6 4 45 - - - -
Nephro-vite for dialysis patientsb 1 tab. - - - 1.5 1.7 20 10 10 6.0 60 0.8 - - -
APPENDIX K
Tips for Increasing Calories for Children
Increasing Calories for Children
Milk and Dairy Products • Use whole milk to make milkshakes, soups, cereals and puddings • Use evaporated milk in place of whole milk for desserts, meat dishes and
milkshakes • Add ice cream to milkshakes Fats, Oils and Sweets • Margarine or butter (100 kcal/T): Add to cooked cereals, potatoes, breads
and crackers, rice, cooked vegetables, pasta and casseroles • Vegetable oil (110 kcal/T): Add to soups, casseroles, vegetables, gravies,
cooked cereals and spaghetti sauce • Sour cream (25 kcal/T): Add to vegetables, potatoes, salads and casseroles • Cream cheese (50 kcal/T): Add to breads, crackers, in dips, baked goods • Mayonnaise (100 kcal/T): Add to sandwiches, salads, dips, pasta etc. • Gravy (26 kcal/T): Add to meats, potatoes, pasta • Corn syrup (60 kcal/T): Add to cereals, fruit, formula, milkshakes • Jams, Jellies (50-55 kcal/T): Add to toast, bagels and other baked goods Protein • Peanut butter (94 kcal/T): Add to bread, toast, crackers, fruits and
milkshakes • Cheese (120 kcal/oz): Serve on bread, vegetables, pasta, eggs, hotdogs,
salads, sandwiches • Eggs (60 kcal/yolk): Add egg yolks or hard boiled eggs to casseroles,
meatloaf, soups, salads, ie, tuna salad • Dry powdered milk (25 kcal/T): Add to whole milk, milkshakes, casseroles,
soups, scrambled eggs, meatloaf, gravies and sauces, mashed potatoes, puddings, cereals
Adapted from: : Isaacs J, Cialone J, Horsley, et al. Children with Special Health Care Needs: A Community Nutrition Pocket Guide, 1997.
APPENDIX L
Sites of Nutrient Malabsorption Resulting from Intestinal Resections
Site of Bowel Resection
Implication for Nutrient Malabsorption
Duodenum and Jejunum • Decreased surface area for general nutrient absorption
• Decreased enzyme production: secretin, cholecytikinin.
• Decreased disaccharidase levels: lactase, sucrase
• Decreased pancreatic and biliary secretions • Decreased fat digestion and absorption. • Decreased protein digestion and absorption • Decreased fat soluble vitamin absorption:
vitamins A, D, and E. • Increased water soluble losses: Vitamin C,
folate • Mineral malabsorption: Ca, Fe, Mg, Cu, Cr,
Mn, Zn. • Increased risk of bacterial overgrowth and
osmotic diarrhea Ileum • Significant decrease in Vitamin B12 absorption
• Decreased bile acid reasbsorption • Decrease in enterophepatic circulation
resulting in: decreases in bile acid pool, long chain and fat soluble vitamin absorption
• Increase in steatorrhea and cholerrheic diarrhea
• Trace element malabsorption and losses • Increased risk of renal oxalate stones
Ileocecal valve • Decreases in Vitamin B12 and folate absorption • Decreased intestinal transit time • Increased risk of bacterial overgrowth
Colon • Decreased water absorption • Decreased sodium absorption • Decreased risk of renal oxalate stones
Adapted from: Jones-Wessel J. Short gut syndrome. In: Groh-Wargo, S., Thompson, M. and Hovasi-Cox, J. Nutritional Care of High Risk Newborns. Chicago, IL: Precept Press, 2000.
APPENDIX M UVA Therapeutic Algorithm for Management of Pediatric Post-operative Chylothorax
Initial Evaluation
1. Chylous fluid should be confirmed by laboratory analysis showing a triglyceride level > 110 mgs% (when child is being fed) and a cell count > 1000 cells/microliter with lymphocytes > 80%.
2. If possible central venous pressure (above the diaphragm) should be assessed along with cardiac function by echocardiography
3. Ultrasound and/or venography of major vessels to evaluate for thrombosis should be undertaken. 4. Serum analysis of immunoglobulion levels and coagulation studies should be sent.
Algorithm
Adjunctive Therapy
1. Placement of a central venous catheter should be considered (either PICC or surgically placed line) early on if enteral nutrition is failing and TPN is going to be required. Note that both TPN and the malnutrition consequent to chylous effusions place the child at particular risk for infection so every attempt should be made to limited invasion of the central catheter.
2. If CVP > 15 mmHg standard approaches to lowering central venous pressure including diuretics, inotropes, and afterload reduction should be considered in conjunction with cardiology.
3. Enoxaparin 0.5 mg/Kg subcutaneously every 12 h, adjusted according to anti-FXa levels (drawn 3-4 hrs after 3rd dose)
4. Immunoglobulin levels should be drawn weekly and IVIG given as dictated by immunoglobulin levels. Usual replacement dose is 500 mg/kg infused over 4-6 h. Similar following and supplementation of albumin should be performed. When possible, administer no more than once over at least 2-4 h. Consider use of 25% albumin to minimize fluid.
5. Nutrition is vitally important. As per the algorithm, if CVP < 15 and there is no evidence of SVC thrombosis, enteral feeding with a MCT formula (currently Enfaport) should be rapidly escalated to calculated fluid and nutritional needs. If CVP > 15 or enteral feeding has not decreased chylous effusion then TPN should be advanced to full nutritional requirements as rapidly as tolerated. Nutritional consult is recommended.
6. Octreotide dose should be doubled daily if no reduction in chylous effusion (> 10%) over the previous 24 hours beginning with 1 mcg/kg/hr to a maximum of 10 mcg/kg/hr. If substantive improvement (> 50% reduction) in 5 days the drug should be stopped.
Surgical Management
Surgical consultation should be considered when the above protocol has failed or appears to be failing. Surgical management should be individualized but in general:
1. If effusion < 25 ml/Kg/day and there is no contraindication (e.g., peritoneal dialysis) pleuroperitoneal shunt should be considered
2. If effusion > 25 ml/Kg/day and/or there are contraindications to pleuroperitoneal shunts thoracic duct ligation at the diaphragmatic entry of the duct.
3. Should “a” and “b” fail, bilateral pleurodesis should be performed
Additional Notes
1. Every patient is different and the algorithm should not preclude clinician judgment. 2. If the chylous effusion does not respond to the above measures the possibility of SVC thrombosis and/or
persistent high central venous pressure due to A-V valve incompetence or other cardiac dysfunction should be investigated. Consider cardiac catheterization.
References
1. Panthongviriyakul C, Bines J. Post-operative Chylothorax in Children: An evidence-based management algorithm. Journal of Paediatrics and Child Health. 2008. 44(12): 716-721.
Index A Anthropometrics, 10 Appropriate for gestational age, 28 B Basal energy needs, 23 Body mass index (BMI):, 10 Breast milk
Fortification, 44 Supplementation, 30, 44
Burns, 74-76 Energy requirements, 25
C Carnitine, 88 Catch-up growth, 24 Chylothorax, 71–73 Chylous ascites. See Chylothorax Congenital heart defects, 57–58 Cystic fibrosis, 58–62 D Dietary Reference Intakes, 17, 20 Drug-nutrient interactions, 100 Duocal, 45 E Electrolyte supplementation, 107 Energy, 18 Enteral nutrition, 38–56, 38–56
Advantages, 38 Complications, 51 Continuous feeds, 47 Delivery routes, 45 Feeding guidelines for preterms, 36 Formula selection, 39-40, 67 Indications, 38 Initiation and advancement, 49 Intermittent/bolus feeds, 47
Essential fatty acid deficiency, 71, 93 Estimated needs. See Nutritional
requirements Extremely low birth weight, 27
F Feeding protocols, 36 Fenton growth charts, 27 Fiber, 19 Fluid requirements
Preterm, 30 Term infants and children, 25
Fluoride, 21 Formula selection
Allergy, 67 Enteral, 39 GI, 67 Preterm, 33 Term infant, 40
G Gastrointestinal impairment, 67–70 Glucose infusion rate, 81 Growth, 9–10 Growth velocity, 10
Preterm infants, 28 H Harris Benedict equation, 23 I Increasing caloric density, 34, 42 Insulin, 81 Iron, 89 L Laboratory data, 15 Large for gestational age, 28 Low birth weight, 27 M Malnutrition, 12
Clinical assessment, 12 Medical history, 13 Microlipid, 34, 42, 58 Micronutrients, 19 Midarm muscle circumference, 10 Minerals, 20
N Nepro, 64, 66 Nutrient deficiency
Physican signs, 13 Nutritional assessment, 9–16
Components, 9 Nutritional intake history, 14 Nutritional requirements, 17–26
Chylothorax, 71 Congenital heart defects, 57 Critically ill children, 22 Cystic fibrosis, 59 GI, 67 Non-critically ill children, 17 Preterm, 29 Renal, 63
O Obesity, 10 Overfeeding, 24
P Pancreatic enzymes, 60 Parenteral nutrition, 80-98
Complications, 91 Initiation and advancement, 81
Pharmacology, 100–108 Polycose, 34, 42, 43, 58 Preterm
weight classification, 27 Protein, 19 Refeeding syndrome, 75 Renal, 63–66
Formula modification, 44
S Scandishakes, 59 Small for gestational age, 28 Stress factor, 23 Suplena 64 Supplementation
Vitamin and mineral, 20, 31
T TPN. See Parenteral nutrition Triceps skinfold, 10 Trophic feeding, 36 Tube feeding. See Enteral nutrition Tyramine, 103
V Very low birth weight (VLBW, 27 Vitamin D deficiency, 65 Vitamins, 20
W Waterlow criteria, 12
- NOTES -
- NOTES -
- NOTES -
- NOTES -